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ABSTRACT  
 
Computed tomographic colonography (CTC) is a diagnostic technique involving helical volume 
acquisition of the cleansed, distended colorectum to detect colorectal cancer or potentially 
premalignant polyps. This Thesis summarises the evidence base, identifies areas in need of 
further research, quantifies sources of bias and presents novel techniques to facilitate 
colorectal cancer diagnosis using CTC. 
CTC literature is reviewed to justify the rationale for current implementation and to identify 
fruitful areas for research. This confirms excellent diagnostic performance can be attained 
providing CTC is interpreted by trained, experienced observers employing state-of-the-art 
implementation. The technique is superior to barium enema and consequently, it has been 
embraced by radiologists, clinicians and health policy-makers. Factors influencing 
generalisability of CTC research are investigated, firstly with a survey of European educational 
workshop participants which revealed limited CTC experience and training, followed by a 
systematic review exploring bias in research studies of diagnostic test accuracy which 
established that studies focussing on these aspects were lacking.  Experiments to address these 
sources of bias are presented, using novel methodology: Conjoint analysis is used to ascertain 
patients‘ and clinicians’ attitudes to false-positive screening diagnoses, showing that both 
groups overwhelmingly value sensitivity over specificity. The results inform a weighted 
statistical analysis for CAD which is applied to the results of two previous studies showing the 
incremental benefit is significantly higher for novices than experienced readers. We have 
employed eye-tracking technology to establish the visual search patterns of observers reading 
CTC, demonstrated feasibility and developed metrics for analysis. We also describe 
development and validation of computer software to register prone and supine endoluminal 
surface locations demonstrating accurate matching of corresponding points when applied to a 
phantom and a generalisable, publically available, CTC database. Finally, areas in need of future 
development are suggested. 
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Research described in this Thesis was carried out under the supervision of Professor Steve 
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scheme. The views expressed in this publication are those of the author and not necessarily 
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THESIS OVERVIEW:  
BACKGROUND, HYPOTHESES AND STRATEGY 
 
 
BACKGROUND 
Timely and efficient colorectal cancer diagnosis is an international healthcare priority; the 
disease is responsible for over 600,000 deaths worldwide each year (1). Diagnosis and removal 
of potentially premalignant adenomatous polyps has been shown to reduce the lifetime risk of 
colorectal cancer death by over 25% (2) yet, uptake of colorectal cancer screening remains 
poor (3). The gold-standard whole-colon examination, optical colonoscopy, is expensive, time-
consuming and invasive, carrying a small, but well recognised mortality (4). Therefore, it has 
been suggested that a safer, less invasive investigation could increase screening uptake and 
hence, reduce missed cancer diagnosis. However, for many years, the radiological colorectal 
examination of choice has been the double contrast barium enema (BaE) which has been 
shown to be insufficiently sensitive for screening (5) and, despite being relatively safe, is 
disliked by many patients(6). Consequently, there has been considerable interest in developing 
an alternative radiological technique that could serve as a viable substitute for colonoscopy. 
 
Computed tomographic colonography (CTC) is a relatively novel diagnostic technology used to 
examine the large bowel. The technique combines helical CT scanning and three-dimensional 
(3D) image rendering of the cleansed, distended colorectum mimicking the view of the 
conventional colonoscopist, hence the alternative title ‘virtual colonoscopy’(7). Studies have 
shown CTC to be safe (8) and acceptable to patients (9).  Moreover, CTC is more accurate than 
BaE and preferred by patients(10). Furthermore, multicentre comparative studies from the USA 
have suggested that CTC could rival the sensitivity and specificity of colonoscopy for the 
detection of polyps and cancer in populations with a high incidence of colorectal cancer (11, 
12) and asymptomatic subjects (13, 14); meta-analysis also suggests diagnostic performance is 
comparable to colonoscopy in certain circumstances (15). While these data are encouraging, 
1 9  
 
the results of large trials in academic institutions may not be generalisable to daily practice: 
Several sources of bias that influence the transferability of diagnostic test performance studies 
from the ‘laboratory’ setting to the ‘field’ are recognised but their impact remains unquantified 
presently. For example, observers involved in CTC validation studies have usually undergone 
extensive training and, in some cases, stringent examinations prior to trial participation (16). 
Conversely, the level of training and experience of those interpreting CTC in European clinical 
practice is unknown and, at present, there is no requirement for formal accreditation. 
Moreover, while it is recognised that experienced, trained observers outperform novice 
readers, the mechanism behind this remains poorly understood(17) and a coherent strategy for 
CTC training remains elusive. Other branches of diagnostic imaging such as mammography 
have medical image perception literature to inform implementation(18) yet, to date, this has 
not been applied to complex 3D interpretation tasks such as CTC. 
 
Reacting to the need to improve diagnostic sensitivity, particularly among less experienced 
readers, research groups have developed and validated computer aided detection (CAD) 
technology (19, 20). However, the largest multicase, multireader trials have also utilised 
experienced observers from large academic centres (20, 21). While studies have suggested CAD 
can narrow the gap between novice and experienced readers, sufficiently powered research 
remains awaited(22). Moreover, where CAD increases sensitivity, there is usually an 
accompanying reduction in specificity(23) yet the potential clinical implications of this trade-off 
are poorly understood. While the consequences of a false negative diagnosis (e.g. missed polyp 
or cancer) usually outweigh a false positive detection (e.g. unnecessary colonoscopy) standard 
statistical analyses may not account for this and, hence, underestimate the clinical benefit of 
such technology. For example, regulatory approval often requires comparison of the area under 
the receiver operating characteristic curve (ROC AUC) to approve new diagnostic technology, 
yet this method inherently combines sensitivity and specificity with equal weighting and, 
consequently, may not be appropriate where the clinical consequences of reductions and gains 
in sensitivity and specificity are not equivalent(24). Collaborators have devised a novel 
statistical method (19) to incorporate a weighting based upon the clinical consequences of 
changes in sensitivity vs. specificity but at present, the relative value clinicians and patients 
ascribe to these test attributes remains speculative. 
 
2 0  
 
Finally, despite correct annotation by CAD, even experienced readers incorrectly disregard true 
positive pathology (25). This reinforces the interpretative challenge and suggests there remains 
a need for further developments in human-computer interaction to maximise reader 
performance. By way of example, the importance of matching endoluminal locations between 
prone and supine CT acquisitions to differentiate mobile colonic residue from fixed mural 
pathology is well recognised (26). However, this task is complicated by considerable colonic 
deformation which takes place when the patient changes position (27). Therefore, 
development of computer software which can accurately match endoluminal surface loci 
between prone and supine datasets has the potential to facilitate interpretation. 
  
In summary, extensive research has brought CTC from an experimental technique in specialised 
academic units to everyday radiological practice yet there remains considerable scope to 
improve training, interpretation, CAD and to develop novel computer technologies to improve 
diagnostic accuracy using CTC. 
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RESEARCH QUESTIONS, RATIONALE, HYPOTHESES AND AIMS 
WHAT IS THE RATIONALE FOR CURRENT CTC IMPLEMENTATION?  
 
AIM: 
i) Summarise the history and development of CTC from its inception to present day. In 
particular, to review landmark evidence that has shaped current practice. 
ii) Review CTC literature published between 1st April 2010 and 31st March 2011 to describe 
present status, limitations and areas requiring further research.  
 
 
WHAT IS THE LEVEL OF CTC EXPERIENCE AND TRAINING AMONG EUROPEAN RADIOLOGISTS? 
 
RATIONALE: 
Comparative studies from the USA and Europe have suggested that CTC can achieve high 
sensitivity for the detection of polyps and cancer in at-risk populations (11, 12) and screening 
populations (13, 14). However, the data are heterogeneous and some trials have shown 
discrepant performance (28, 29). While the reasons for this are multifactorial, the level of 
reader training and experience are widely accepted as contributory. Each participating 
radiologist in the ACRIN National CTC trial (16) had experience of >500 CTC cases (or took part 
in 2 days’ focused individual training) and had to achieve a sensitivity of at least 0.90 for large 
polyps in a qualifying examination. Conversely, current European and UK consensus statements 
(30, 31) recommend a minimum experience of just 50 validated datasets and no formal process 
of accreditation exists.  
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HYPOTHESIS: 
At present, the level of training and experience of European radiologists reporting CTC is 
insufficient; diagnostic accuracy suggested by research studies is likely non-generalisable to 
daily clinical practice.  
 
AIM: 
To survey European radiologists attending directed CTC training workshops with a view to 
establishing their level of experience, prior training, and CTC implementation.  
 
TO WHAT EXTENT DOES RESEARCH METHODOLOGY BIAS STUDIES OF DIAGNOSTIC TEST ACCURACY?  
RATIONALE: 
Performing research in an artificial ‘laboratory’ environment, for example, by blinding 
observers to the a priori expectation of disease or by enriching the sample’s prevalence of 
abnormality, can introduce bias. Although essential for evidence-based application of CTC 
performance studies, these sources of bias are poorly researched. Conversely, attempts to 
minimise additional potential sources of bias such as ‘observer recall’ increase time, expense 
and complexity of CTC research but without compelling evidence to support the practice. 
 
HYPOTHESIS: 
Currently employed research methodology may introduce potential sources of bias into studies 
of diagnostic test accuracy but these are poorly researched and their impact, unquantified. 
 
 AIM:  
To perform a systematic review to identify sources of bias in studies of diagnostic test accuracy. 
In particular, to quantify those influencing the generalisability of research performed in the 
‘laboratory’ to the ‘field,’ via manipulating sample prevalence and reporting intensity.  
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WHAT IS THE RELATIVE VALUE OF TRUE VS. FALSE POSITIVE DIAGNOSIS WHEN SCREENING USING CTC? 
 
RATIONALE: 
Qualitative research confirms that patients and clinicians value gains in sensitivity far beyond 
losses in specificity; the clinical consequences of misclassification are profoundly different (32, 
33). However, customary quantitative methods such as Likert scales are unable to determine 
the relative value of these two attributes as there is no requirement for the respondent to 
compromise when test attributes are inter-related. Conjoint analysis is a relatively novel 
technique that could be employed to ascertain the relative weightings clinicians and patients 
ascribe to false positive vs. false negative detection at CTC. This, in turn could be used to inform 
novel statistical methods. 
 
HYPOTHESIS: 
Conjoint analysis can be applied successfully to CTC research to determine the opinions of 
patients and clinicians to false positive and false negative diagnosis.  
 
AIM: 
To develop and perform a discrete choice experiment to determine the relative weighting 
clinicians and patients ascribe to diagnostic sensitivity vs. specificity in the context of colorectal 
cancer screening with CTC.  
 
CAN A NOVEL WEIGHTED STATISTICAL ANALYSIS BE APPLIED TO STUDIES OF CAD FOR CTC? 
RATIONALE: 
CAD increases reader sensitivity, particularly among inexperienced observers, but often at the 
expense of reduced specificity (19, 34). CAD software alerts the reader to suspicious areas on 
the endoluminal surface that may represent genuine polyps or spurious residue. While this can 
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enable detection of pathology, otherwise overlooked, it also increases the likelihood of FP 
characterisation. If CAD increases sensitivity but with a corresponding reduction in specificity, 
contingent upon the statistical analysis used, these changes may ‘cancel each other out’ 
leading to non-significant results. However, the clinical consequences of FP and FN diagnoses 
differ markedly (i.e. unnecessary colonoscopy vs. missed cancer) and statistical analysis should 
be able to account for this.  
 
HYPOTHESIS: 
A weighted statistical measure that considers the discrepant clinical consequences of 
diagnostic misclassifications can be applied to CAD studies.  
 
AIM: 
To apply this novel analysis using the weighting determined by conjoint analysis to the results 
of two previous multireader, multicase CTC CAD studies (19, 34) and compare the incremental 
benefit of CAD when used by experienced readers and inexperienced readers.  
 
 
IS IT POSSIBLE TO MEASURE VISUAL SEARCH STRATEGY DURING CTC INTERPRETATION USING EYE-TRACKING? 
 
RATIONALE: 
Radiological errors usually result from either failure to detect abnormalities (perceptive error) 
or incorrect characterisation of pathology (classification error). The majority of false negative 
diagnoses at CTC (i.e. missed polyps or cancers) have been shown to be perceptive errors, 
particularly among inexperienced readers (35). Therefore, training should focus on improving 
detection. However, CTC data display is complex and interpretation varies considerably 
between readers with little consensus existing regarding the optimum reading paradigm (30, 
31, 36). Consequently, a coherent training strategy remains unclear. Medical image perception 
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research has been central to optimising the display of chest radiographs, orthopaedic films and 
mammograms(37-39). However, eye-tracking technology is currently limited to plain 2D static 
radiographic images. The need to develop state-of-the art eye-tracking methodology has been 
identified (18)  but at present this is impossible for complex, moving 3D displays, such as CTC.  
 
HYPOTHESIS: 
Eye-tracking technology can be successfully applied to CTC; visual search patterns from readers 
with varying expertise can be recorded and compared.  
 
AIM 
To establish if eye-tracking technology can be applied to record visual search strategies during 
CTC interpretation. 
 
CAN AN AUTOMATED PRONE-SUPINE REGISTRATION ALGORITHM ACCURATELY MATCH CORRESPONDING 
ENDOLUMINAL SURFACE LOCATIONS? 
 
RATIONALE: 
Matching corresponding endoluminal locations between prone and supine datasets is a 
cornerstone of competent CTC interpretation (26). However, considerable colonic deformation 
takes place during patient repositioning (27) which complicates the radiologist’s task, prolongs 
interpretation and may engender error. Current vendor platforms enable approximate prone-
supine registration by comparing the distance along the computed colonic centreline(40) but 
this is inherently one-dimensional and therefore cannot provide a 3D endoluminal surface 
location. Moreover, centreline methods are prone to error in cases with luminal collapse (41-
43). Development of a computer algorithm to automate endoluminal location matching would 
likely facilitate CTC interpretation and could improve existing CAD algorithms. 
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HYPOTHESIS: 
A novel computer registration algorithm can establish accurate corresponding endoluminal 
locations between prone and supine CTC acquisitions. 
 
AIM: 
To develop, train and validate computer software that can accurately match 3D endoluminal 
locations between prone and supine CTC acquisitions while remaining resistant to regions of 
colonic collapse or suboptimal distension.  
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THESIS STRATEGY 
 
This Thesis comprises twelve Chapters grouped into five Sections as outlined below. Unless 
otherwise stated, all work is that of the author. Peer-reviewed publications linked to each 
Chapter are outlined in Appendix A. 
 
Section A summarises the evidence base for CTC with a comprehensive review of published 
literature to date. In particular, this Section identifies limitations in existing research and areas 
requiring further development. This provides background to this Thesis and the motivation for 
the original research studies presented in the following Chapters. Chapter 1 introduces CTC 
with a narrative précis of the landmark publications which have shaped the technique from its 
first description as an experimental procedure to becoming the radiological examination of 
choice for detecting colorectal neoplasia. Chapter 2 discusses the current evidence for CTC 
implementation and performance with a review of the literature published during one year (1st 
April 2010 to 31st March 2011). This provides an overview of current CTC research and outlines 
the key themes providing the focus for future development. 
 
Drawing upon recurring themes identified in Section A, Section B attempts to address sources 
of bias and factors limiting the generalisability of CTC research. Chapter 3 aims to establish the 
level of CTC experience and training of European radiologists via a survey of participants 
attending a number of educational workshops. Chapter 4 provides a broader perspective on 
the limitations affecting studies of diagnostic test accuracy via systematic review. Sources of 
bias related to an artificial ‘laboratory’ setting such as enriched disease prevalence, concealed 
clinical information and repeated interpretation of the same data are investigated and 
quantified. Recommendations from this Chapter inform the design of subsequent experiments 
within this Thesis. 
 
Section C builds upon limitations identified thus far and introduces three experimental 
techniques not previously applied to CTC research: Chapter 5 describes the use of ‘probability 
equivalence‘ conjoint analysis (discrete choice experiment) to determine the relative value of 
sensitivity vs. specificity in the context of screening for colorectal neoplasia. Chapter 6 employs 
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the results from chapter 5 to inform a novel statistical method; the results of the discrete 
choice experiment provide the ‘weighting’ required for the analysis. This statistical technique is 
applied to two previous multireader, multicase studies to determine the incremental benefit 
derived by novice and experienced observers when interpreting CTC with CAD. Chapter 6 also 
reinforces the marked discrepancy in polyp detection performance among observers of varying 
experience, despite the assistance of CAD. However, as identified in section A, the reasons for 
this disparity remain poorly researched. Therefore, Chapter 7 describes the technical 
development of eye-tracking methodology to enable assessment of observers’ visual search 
patterns during CTC.   
 
The results of Section C suggest that even experienced radiologists can benefit from computer 
assistance. Therefore, Section D describes the development and validation of computer 
algorithms to match endoluminal locations in prone and supine colonography data despite 
colonic deformation and luminal collapse. Chapter 8 summarises development of a technique 
for applying non-rigid registration of cylindrical representations of the endoluminal surface to 
provide surface correspondence between prone and supine acquisitions. Despite promising 
performance on a carefully selected validation dataset, limitations exist in terms of automation 
and overcoming poor luminal distension. Therefore, Chapter 9 describes a separate algorithm 
to match haustral folds using a Markov Random Field technique. The result of combining these 
algorithms is presented in Chapter 10 using a porcine phantom and Chapter 11 describes the 
results of clinical validation using a well characterised, publicly available CTC database.   
 
Section E concludes the Thesis; Chapter 12 summarises the key findings and suggests topics for 
future development. 
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SECTION A: 
HISTORY, DEVELOPMENT, 
CURRENT STATUS AND 
FUTURE DIRECTIONS OF CT 
COLONOGRAPHY  
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CHAPTER 1 
1.  HISTORY AND DEVELOPMENT OF CT COLONOGRAPHY  
 
 
 
AUTHOR DECLARATION 
The review presented in this Chapter was compiled and written by the author under the 
supervision of Professor Steve Halligan and Professor Stuart Taylor. Related work was published 
in the book chapter:  Boone D, Halligan S, Taylor SA (2013). CTC Background and Development 
in Cash, B. (Ed.), Colorectal Cancer Screening and Computerized Tomographic Colonography: A 
Comprehensive Overview (pp 41-58). New York, USA: Springer 
 
 
 
1.1 INTRODUCTION  
Colorectal imaging using CT coupled with full laxative bowel preparation and gaseous 
insufflation was first described in the early 1980s(44). However, the technique did not gain 
widespread recognition until 1994 when advances in computer processing technology enabled 
Vining and co-workers (45) to demonstrate the feasibility of using volumetric CT data to 
generate a 3D, endoluminal reconstruction, termed ‘virtual colonoscopy.’ Since then, research 
relating to CTC has continued to gather exponential momentum, developing implementation, 
interpretation and diagnostic performance. Consequently, CTC has grown from a novel 
technique practiced in a handful of specialist academic centres to one that has widely 
surpassed the barium enema (BaE) as the preferred colorectal imaging modality in radiological 
departments. This Chapter charts the evolution of CTC over the last two decades, focusing in 
particular on research that has shaped current practice. 
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1.2 THE DECLINE OF THE BARIUM ENEMA 
Prior to the advent of CTC, the preferred radiologic investigation for suspected colorectal 
cancer (CRC) or adenomatous polyps was the double-contrast barium enema (BaE) (Figure 1). 
Compared to the gold-standard, colonoscopy, optimally performed BaE could achieve 
sensitivity for detecting cancer or large polyps in excess of 0.80 (46, 47). This was considered 
reasonable for a safe, relatively non-invasive examination. However, by the turn of the century, 
evidence was accumulating that enthusiasm for performing BaE was deteriorating (48) and 
consequently, so too was its interpretation; accuracy was considerably lower than believed 
previously (49). Confidence in the technique was diminished by the National Polyp Study(50), 
which found a sensitivity of 0.48 for large polyps (>1 cm) prompting an accompanying editorial 
to suggest that it was no longer appropriate to offer BaE for colorectal screening (51). Despite 
strong opposition(52), the radiological community  was unable to provide sufficient evidence to 
refute these claims and interpretation has continued to decline. 
 
Figure 1:  Single oblique, magnified projection 
from a double contrast, BaE examination.  This 
optimally prepared examination demonstrates a 
10mm pedunculated sigmoid polyp (arrow).  
 
 
 
1.3 THE RISE OF MULTI-DETECTOR CT 
Around this time, while BaE was falling out of favour, CT was enjoying a renaissance due to the 
development of helical, multi-detector scanners. The capability to acquire volumetric data 
within a single breath-hold stimulated research interest in abdominopelvic CT. For example, 
while seeking an alternative to BaE in frail, elderly patients, researchers from Cambridge, found 
CT could be used to demonstrate colorectal cancer, particularly after opacifying the colon by 
administering dilute oral contrast hours in advance of the study(53, 54). Therefore, it followed 
3 2  
 
naturally that established techniques to optimise BaE such as bowel catharsis, spasmolysis and 
gaseous insufflation were applied to CT (Figure 2); UK researchers named the resulting 
procedure, ‘CT pneumocolon’ - a term which remains in sporadic use today(55). Although 
related research continued in specialist academic centres (particularly University College, 
London), BaE was well established in daily practice and remained the cornerstone of 
radiological colorectal investigation for several years.  
 
Figure 2:  Axial CT following full bowel catharsis, 
spasmolysis and carbon dioxide insufflation. 
Note the use of oral ‘faecal tagging’ to opacify 
residual colonic content (arrow) and that 
intravenous contrast has been administered. 
Extensive research has taken place over recent 
years to optimise technical implementation (see 
below). 
 
 
1.4 THE BIRTH OF ‘VIRTUAL COLONOSCOPY ’  
By 1994, the radiology community eagerly awaited a technique that could exploit the latest CT 
technology to provide a viable alternative to BaE. In the United States, in particular, there was 
an imperative to develop a radiological alternative to colonoscopic screening; in Europe, 
radiological investigation has historically been reserved for symptomatic patients. Therefore, 
the stage was set for a celebrated presentation at the 23rd Annual Meeting of the Society of 
Gastrointestinal Radiologists where Vining et al introduced ‘virtual colonoscopy’ presenting an 
endoluminal flythrough video accompanied by Wagner’s ‘Flight of the Valkyries’. The 
subsequent publication (45) is widely regarded as the earliest description of CTC (Figure 3). 
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Figure 3:  Endoluminal CTC viewed from the caecum. 
Note the normal ileocaecal valve (arrow).  Although 
‘virtual colonoscopy’ initially required many hours of 
painstaking rendering , three-dimensional 
representations can be obtained almost immediately 
on most modern workstations. 
 
 
 
 
1.5 OPTIMISING TECHNICAL IMPLEMENTATION 
Following this dramatic introduction, ‘virtual colonoscopy’ subsequently gained international 
exposure. However, in reality, access to computer technology capable of endoluminal 
reconstruction was limited and where available, processing remained time-consuming. 
Therefore, initial research focused on 2D interpretation (55, 56) that could be carried out on a 
regular CT workstation directly after image acquisition. Moreover, it soon became apparent 
that further technical refinement was required to realise CTC ’s full potential. Consequently, 
research groups formed and published the initial groundwork which is largely responsible for 
modern CTC. For example, initial research demonstrated that performing scans with the patient 
both prone and supine (Figure 4) could improve colonic distension overall (26) and that 
insufflation with CO2 was superior to room air (57). Nevertheless, research was less conclusive 
regarding the use of intravenous contrast(58), spasmolytics (59, 60) and differing bowel 
preparations (61). Furthermore, early attempts at ‘tagging’ residual stool using oral barium or 
iodine gave conflicting results, with some groups finding it improved sensitivity (62) while 
others finding it less helpful (63). Nevertheless, these studies raised the possibility of ‘prepless’ 
CTC  (64) which remains the goal for many researchers today. 
 
Another consideration since the outset has been the anticipated increase in diagnostic 
radiation exposure compared to BaE, a factor that continues to raise concerns today. Initial 
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research employing phantom models (65-67) was instrumental in optimising acquisition 
parameters and low dose protocols exploiting the intrinsic contrast between soft tissue and gas 
were introduced with promising results (68). Once individual research groups had settled upon 
suitable preparation and scanning parameters, it was not long before they began to perform 
CTC on patients undergoing subsequent colonoscopy in order to compare appearances of 
various colorectal lesions (69, 70). Having demonstrated feasibility (71), exploratory reader 
studies rapidly followed to establish the diagnostic accuracy of this new technique. 
 
 
 
Figure 4:  Left: Supine, axial CTC. The lumen is collapsed around the rectal insufflation catheter 
(arrow).  Right: The same patient was re-examined in the prone position. Note the improved rectal 
distension has revealed irregular mural thickening (arrow); colonoscopy confirmed a 35mm carcinoma. 
 
1.6  EARLY OBSERVER STUDIES 
Initial studies, predominantly conducted in the USA, used small retrospective samples of high-
risk patients scheduled for colonoscopy. For example, Royster et al (72) studied 20 high-risk 
patients and found CTC detected all colonic masses (>2cm) and 12 of 15 polyps (>6mm). 
Similarly, Dachman et al performed CTC in 44 high-risk patients(73) achieving a per-polyp 
sensitivity of 0.83 and 1.00 for two observers compared to the colonoscopic reference 
standard. Ferrucci’s group was also instrumental in providing these initial performance data 
from small, high prevalence cohorts (69, 72). However, while remarkable sensitivity was 
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demonstrated, a prospective trial was needed, preferably without such high disease 
prevalence. This was provided in 1997 by Hara et al (74) who compared 70 patients undergoing 
CTC  to routine abdomino-pelvic CT and to colonoscopy. Two observers read the cases and each 
achieved 0.75 sensitivity and 0.90 specificity for polyps 10mm or larger. Furthermore, this was 
the first study to demonstrate superiority over standard CT, which obtained a sensitivity of 0.58 
for polyps ≥10mm. Interestingly, patients were scanned only in the supine position, illustrating 
that consensus had not been reached regarding what is now established as a fundamental 
element of CTC practice. Indeed, it was seven years before convincing research by Yee et al 
closed the debate on the value of prone and supine acquisitions (75).  Prone/supine matching 
is now considered pivotal to competent interpretation and is the focus of Section D of this 
Thesis. 
 
 
1.7 NEW MEETING, NEW NAME 
By the late 1990’s several research groups were pioneering this new technique independently, 
so in October 1998, key researchers arranged the first international meeting dedicated to CTC: 
The International Symposium on Virtual Colonoscopy(VC) (76) in Boston. It is also worthy of 
note that many opinion leaders in CTC research at this time were gastroenterologists.  Later 
that year, the community settled on ‘CTC’ as the accepted scientific terminology (77). Although 
other descriptive terms such ‘CT colography,’ ‘CT pneumocolon,’ and ‘virtual endoscopy’ were 
subsequently abandoned, ‘virtual colonoscopy’ remains in widespread use, not least because it 
is readily understood by the public.   
 
 
1.8 INTERNATIONAL INTEREST  
The following year, CTC’s international profile was elevated considerably by research published 
in the New England Journal of Medicine led by Dr Helen Fenlon (11), an Irish radiologist 
undertaking a fellowship with Dr Joseph Ferrucci in Chicago. This prospective trial of 100 high-
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risk patients (49 with endoscopically proven colorectal neoplasia, 51 with negative 
colonoscopy) was the largest to date and utilised ‘state-of-the-art’ technique. For example, 
interpretation used both 2D and 3D assessment in all patients - a factor some considered 
instrumental in achieving excellent performance. CTC achieved a sensitivity of 1.00 for cancer, 
0.91 for polyps 10mm or larger and 0.82 for polyps 6–9 mm in diameter. On a per-patient basis, 
a 10mm threshold would have resulted in 0.96 sensitivity and 0.96 specificity. Publication of 
Fenlon’s work stimulated considerable worldwide interest; within a few months the British 
Medical Journal commissioned a review of the technique (7). Thereafter, several other 
European radiologists undertaking Fellowships in the USA returned home and introduced CTC 
to their practice. Subsequently, European research groups formed and began conducting their 
own studies. 
 
 
1.9 EARLY EUROPEAN RESEARCH 
In common with North American research described above, European studies initially focused 
on optimising technical aspects such as acquisition parameters(57, 67, 78, 79), bowel 
preparation(80-82), effect of spasmolytics, and insufflation(60, 83). European researchers were 
also early to recognise that ionising radiation exposure could hinder CTC uptake and developed 
low-dose techniques (84, 85). On the surface, repeating this groundwork may appear excessive, 
yet it was mandatory to account for Europe’s differing legislation, regulation and patient case-
mix. For example, in the UK, hyoscine butylbromide is licensed for diagnostic spasmolysis and 
researchers soon showed it improved distension during CTC (83). In addition, European studies 
have paid particular attention to patient acceptability (9, 86-89), particularly by reducing or 
avoiding cathartic bowel preparation (64, 90).  Around this time, European CTC researchers 
began to collaborate with their neighbours via the European Society of Gastrointestinal and 
Abdominal Radiology (ESGAR).  
 
 
In 2003, opinion leaders from the UK (Halligan, Taylor, Frost, Breen), Italy (Laghi), Belgium 
(Lefere), and the Netherlands (Stoker), established the ESGAR CTC committee and initiated 
3 7  
 
training workshops. The committee has since expanded and has been instrumental in 
promoting pan-European academic collaboration and training. Subsequently, ESGAR has 
actively facilitated CTC research and has funded multicentre studies (91-93). Indeed, research 
outlined in Chapters 3 and 7 of this Thesis would not have been possible without the 
collaborative efforts of ESGAR CTC committee members. 
 
 As described above, the most striking international difference in CTC research has related to its 
potential clinical role; the focus in the USA has been to establish a viable screening tool while in 
Europe there has been an additional focus on symptomatic patients. Inevitably, studies 
specifically investigating patients at increased colorectal cancer risk soon followed (13, 94-96). 
However, European researchers also recognised that the vast majority of published studies 
from the USA had actually examined symptomatic patients even though the emphasis of 
interpretation was directed towards screening. ESGAR funded a systematic review and meta-
analysis that established CTC had high sensitivity for diagnosis of symptomatic colorectal 
cancer (15) (Figure 5) and paved the way for CTC  implementation in Europe. 
 
 
 
Figure 5:  2D coronal (Left) and 3D endoluminal CTC (right) at the level of the mid-rectum. Although 
the emphasis of early research focused upon polyp detection in screening populations, CTC can be 
used to detect polyps or invasive cancer in symptomatic patients. Here, a large annular carcinoma is 
clearly demonstrated (arrow) 
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1.10  THE FIRST LARGE MULTI-CENTRE TRIALS 
While European research was still gaining momentum, in the USA further prospective trials 
continued to demonstrate good sensitivity for large polyp detection (12, 97). Moreover, 2003 
saw the publication of the largest and most influential CTC study to date: Dr Perry Pickhardt’s 
Department of Defence (DoD) trial(14). This three-centre prospective study of 1233, 
asymptomatic, average-risk adults compared CTC against a new, enhanced reference standard: 
‘unblinded colonoscopy.’ Prior to this, studies had been subject to potential verification bias 
due to an imperfect gold-standard (i.e. a polyp seen on CTC that is not subsequently verified at 
colonoscopy would be considered a CTC FP whereas, in reality, it could represent ao OC FN). 
The DoD study ‘unblinded’ the colonoscopist to CTC findings after their initial assessment, to 
allow re-evaluation of each colonic segment in the light of CTC findings. Primary 3D 
endoluminal reading was performed in all cases; most studies thus far had used 3D for 
problem-solving only. CTC achieved sensitivities of 0.94 and 0.89 for polyps at least 10 mm and 
6mm respectively. Using the same thresholds, colonoscopy’s sensitivity was 0.88 and 0.92. The 
impact of these results was moderated by the ensuing publication of preliminary findings from 
the American College of Radiology Imaging Network (ACRIN) National CTC trial(98) led by Dr 
Daniel Johnston: Johnson et al studied 703 higher-than-average risk, asymptomatic patients 
who underwent CTC followed by same-day colonoscopy. Results were disappointing with wide 
intra-observer variability and sensitivities for detecting large polyps of only 0.34, 0.32, 0.73, for 
three experienced readers. The following year, Cotton et al (29) published further disappointing 
results in a multicentre study which examined 615 patients undergoing CTC  and same-day, 
unblinded colonoscopy. CTC achieved a sensitivity of 0.55 for polyps at least 10 mm, compared 
to 0.99 for colonoscopy. Furthermore, CTC missed 2 out of 8 cancers. Finally, in 2005 Rockey et 
al (28) obtained similar results to Cotton in a prospective evaluation of high risk patients: CTC 
achieved a sensitivity of only 0.59 for polyps of 10mm or larger compared to 0.99 for 
colonoscopy. The reasons for these conflicting results were debated fiercely; overall the success 
of the DoD trial was attributed to well-trained, experienced observers using primary 3D 
interpretation of fluid-tagged cases. It is the author’s opinion that, unfortunately the DoD 
results do not reflect current performance in daily practice, which provides the rationale for 
Section B of this Thesis. In any event, these discrepant results prompted the development of 
clearly defined standards for both implementation and interpretation. 
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1.11 INTERNATIONAL CONSENSUS ON CTC   
Discussion of these recent trials at the 2005 annual Boston VC symposium led to the 
development of the first international CTC standards document. Barish et al (36) surveyed 31 
key opinion leaders’ attitudes to cathartic preparation, faecal tagging, prone and supine 
positioning, intravenous contrast, scanning parameters, spasmolytics, optimal reading 
paradigm and polyp size threshold for reporting. The results were collated, drafted, sent to 
respondents for approval, and a consensus statement published. At around the same time, 
Zalis et al published the CRADS system for CTC reporting (99)and shortly thereafter, ESGAR 
commissioned its own consensus statement to provide a European perspective (30). It is 
important to note at this juncture that in 2006, the American Gastroenterological Association 
(AGA) released a position statement (100), aimed primarily at gastroenterologists with an 
interest in reporting CTC . Disappointingly, the ensuing controversy provided clear evidence of 
an evolving ‘turf battle’ between specialties which has inevitably shaped the direction of 
research over recent years. Therefore, it is encouraging to note that the most recent guidelines 
from the International Collaboration for CTC Standards have been developed in direct 
collaboration between a radiologist, Dr David Burling and the UK National Lead for Endoscopy 
Services, Dr Roland Valori, supported by an extensive multidisciplinary team (31).  
 
 
 
1.12 ONGOING RESEARCH THEMES  
By 2005, comparative trials and meta-analysis had suggested that CTC could achieve a 
sensitivity approaching that of colonoscopy for large polyps and the technique was starting to 
disseminate outside academic environments(101). Furthermore, publication of consensus 
guidelines shifted research focus away from technical issues and towards several discrete 
themes: Training, reading technique, CAD, patient experience, and reducing bowel preparation. 
The current status of these topics is covered in greater detail in Chapter 2; important 
milestones are described briefly below. 
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1.12.1 TRAINING, VALIDATION AND AUDIT 
It is unsurprising that the earliest CTC performance studies suggested a learning curve for this 
novel technique. Indeed, some authors experienced this first hand while collating their initial 
data. For example, Spinzi et al (102) studied a random selection of 96 patients undergoing CTC  
followed by colonoscopy and failed to detect five out of six polyps during review of the first 25 
cases, with a resulting sensitivity of just 0.32. However, by the final 20 patients, they obtained a 
far more satisfactory sensitivity of 0.92.  The authors openly attributed their poor initial 
performance to inexperience. In 2005 an editorial by Soto et al (103) reviewed the available 
evidence and concluded a variable learning curve exists for all readers and that many readers 
may never achieve satisfactory performance regardless of training. Nevertheless, the nature of 
the learning curve remains elusive, as does the optimal training programme: For example, an 
early study of 3 radiologists of differing general experience revealed interesting results; 
performance varied considerably and one observer actually deteriorated after training(17). The 
authors extended this work to a multi-centre European setting, funded by ESGAR, investigating 
the effect of administering a directed training schedule of 50 cases to novice readers and then 
comparing their performance to that of experienced observers. Again the authors found that 
there was considerable variation and that competence could not be assumed after training. 
Moreover, the performance of some experienced readers was far from ‘expert’ (104).  
In allied radiological sub-specialties, such as mammography, medical image perception studies 
have provided valuable insight into the interpretation technique of readers with varying 
expertise(18). Despite extensive eye-tracking of plain radiographic interpretation, none exists 
currently for complex cross-Sectional imaging, least of all 3D modalities where the image is 
moving. The development of new eyetracking metrics for this scenario and a feasibility study 
provide the focus of Chapter 7 of this Thesis.  
 
Guidelines from The American College of Radiology (105), the American Gastroenterological 
Association Institute(106) and the International Collaboration for CT Colonography Standards 
(31) have all recommended individual training with exposure to a range of endoscopically 
validated pathology. Hands-on training workshops are now well established to meet this need; 
ESGAR CTC courses have trained over 1000 radiologists worldwide (Chapter 3) while in the 
USA, the Society of Gastrointestinal Radiologists, American Roentgen Ray Society, and 
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American College of Radiology all offer hands on workshops. However, the level of prior 
experience and training of those attending workshops and details of their clinical practice are 
unknown. Therefore, while there is professional and political imperative for European 
radiologists to interpret CTC, it remains unclear how many have sufficient training or 
experience to do so at present. This is explored in Chapter 3 of this Thesis. 
 
Once outside of a research environment, assessment of CTC performance becomes more 
challenging, not least because it is impossible in most cases to establish a reference standard. 
To address this, in 2009, the American College of Radiology recommended quality metrics 
including complication rates, the proportion of technically inadequate studies, and significant 
extracolonic findings (Figure 6) to establish benchmarks against which departments can audit 
their performance in the absence of same-day comparisons with colonoscopy(105). Given the 
heterogeneous response to training, it is likely that only ongoing performance review will 
enable readers to ascertain their fitness to practice the technique. 
 
 
 
Figure 6:  Coronal CTC. Note 
the calcified, ectatic 
abdominal aorta detected 
incidentally on this 
unenhanced CTC 
examination. The potential 
impact of these 
serendipitous extracolonic 
detections has become the 
subject of extensive debate. 
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1.12.2 OPTIMAL READING PARADIGM 
It is difficult to speculate about what would have become of CTC without the advent of 3D 
endoluminal reconstructions; it was the ‘virtual colonoscopy’ aspect that sparked medical and 
media interest in the technique. However, by necessity many researchers with neither the time 
nor resources to generate 3D reconstructions, initially published research using a 2D reading 
approach alone. Subsequently, computer hardware developed rapidly and it was not long 
before workstations capable of rapid endoluminal reconstruction were readily available (albeit 
at considerable expense) and debate surrounding the relative benefits of 2D and 3D reading 
has existed ever since. The explanation for this revolves primarily around reading time: Even 
once resource-intensive 3D reconstructions could be generated rapidly, studies soon confirmed 
what many researchers already suspected – primary 3D reading was considerably slower than 
2D interpretation (107). Indeed, as early as 1998, Dachman et al had suggested using a 
compromise of 2D images for the primary read while reserving endoluminal views for ‘problem 
solving’(73). Nevertheless, studies by Fenlon et al and Pickhardt et al (14) that used primary 3D 
interpretation prompted some authors to claim that their interpretation technique was 
responsible for the impressive sensitivity in these trials. Furthermore, perceived limitations of 
2D reading provided a plausible explanation for the poor performance achieved by Johnson et 
al (98), Cotton et al (29) and Rockey et al(28) around the same time. Nonetheless, in 2005, the 
majority of key opinion leaders were familiar with 2D interpretation and, given the 
considerable differences which existed between software platforms (40), despite relatively 
compelling evidence, the International Consensus Statement recommended 2D reading(36).  
However, before long, most software platforms were considered 3D-ready and by the time the 
ACRIN II protocol was designed, readers were encouraged to read cases using the paradigm 
with which they were most familiar/comfortable. Subgroup analysis showed no significant 
difference in diagnostic performance between reading paradigms(16) and recent consensus 
guidelines do not favour one primary method over another (31). The debate subsequently 
subsided and the matter has largely become one of personal preference (108); all agree that a 
combination of 2D and 3D visualisation is optimal. 
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1.12.3 COMPUTER AIDED DETECTION 
The time-consuming, laborious nature of interpretation, together with the well-documented 
problems of perceptive error, makes CTC an ideal candidate for computer-aided detection 
(CAD). Indeed, development and validation of CAD algorithms began in tandem with the early 
observer studies outlined above (Figure 7). In 2000, Summers et al reported one of the first 
documented CTC CAD systems by applying  a prototype system developed for ‘virtual 
bronchoscopy’ to artificially generated polyps in CTC  datasets (109). The following year, the 
same group published a preliminary validation study using 20 patients with 50 endoscopically 
proven polyps and achieved a sensitivity of 0.64 for polyps 10mm or larger(110). These cases 
were optimally prepared but nonetheless, the sensitivity was comparable with many human 
readers at that time. Within months, Yoshida and Nappi, validated a different CAD system with 
43 endoscopically confirmed cases and achieved comparable results (111). 
 
Figure 7:  Endoluminal CTC with CAD. The CAD 
prompt (arrow) correctly alerts the reader to a 6 
mm sessile polyp.  
 
 
 
 
 
 
 
By now, CAD was well established for assisting mammographic interpretation yet research from 
this field suggested that unless a CAD system could achieve near-perfect sensitivity, its role 
would remain one of alerting the reader to potentially missed regions (i.e. ‘second–reader’ 
CAD) rather than acting autonomously (‘first- reader CAD’). The first study to explore potential 
‘second-reader’ interaction also came from Summers’ group who applied CAD to the results of 
an observer study in which readers had relatively poor sensitivity (0.48 for polyps >10mm.) 
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CAD detected four large polyps out of 13 which had not been reported by human readers, 
allowing the authors to infer that CAD could potentially increase reader sensitivity by alerting 
them to polyps which they had missed during their unassisted read (112). Because observer 
studies to assess the direct effect of CAD on readers’ interpretations are time-consuming and 
expensive, algorithm ‘standalone’ performance is usually used as a surrogate to gauge its 
potential impact on interpretative accuracy. Consequently, several such studies have been 
published in recent years, their size reflecting the ever increasing availability of algorithms and 
endoscopically validated data. For example, a screening cohort of 1186 well-characterised 
datasets, all of which had undergone unblinded colonoscopy, was used to test standalone CAD 
performance (113), which achieved a sensitivity of 0.89 for polyps >1cm and, on average, 2.1 
FP detections per patient.  
 
However, excellent standalone performance does not necessarily translate into equivalent 
levels of diagnostic accuracy when integrated with radiologist interpretation in clinical practice. 
There are likely two main reasons for this: readers may be misled by FP CAD prompts, reducing 
their specificity, or they may incorrectly classify a true positive CAD prompt as false-negative, 
reducing potential gains in sensitivity. Taylor et al examined 111 polyps that had been 
incorrectly dismissed by radiologists despite appropriate CAD prompting(25) and found, 
surprisingly, that large polyps were often disregarded incorrectly when atypical. Also, the 
optimal reading paradigm for integrating CAD into workflow is yet to be established (114, 115). 
 
Therefore, realistic estimates of CAD utility in clinical practice require that large numbers of 
observers interpret cases with and without CAD assistance. Recently, two groups have 
published multi-reader, multi-case studies (19, 20) and these are described in greater detail in 
Chapter 2. However, common to large trials involving unassisted observers, these studies 
recruited experienced readers who are unlikely to reflect those interpreting CTC in daily 
practice. While one could reasonably speculate that novice readers with low baseline 
performance may benefit more from CAD than those with extensive CTC experience (who may 
already be performing optimally) as yet, no published study has sufficient statistical power to 
confirm this (22). This is the subject of Chapter 6 of this Thesis.  
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1.12.4 PATIENT EXPERIENCE 
Although early diagnosis and removal of adenomatous polyps can reduce colorectal cancer 
mortality significantly (116), fewer than 50% of eligible patients attend colorectal screening 
(117). The reasons for this are poorly understood but inconvenience, embarrassment, 
discomfort and safety concerns are all likely to contribute. Given that patients may expect 
‘virtual colonoscopy’ to be less invasive than other whole-colon tests, high hopes exist that a 
CTC screening program could increase compliance. Consequently, recent years have seen 
considerable efforts to compare patient preferences for CTC, colonoscopy, and BaE.  
Early questionnaire surveys (86, 89) comparing the attitudes of patients who had undergone 
both CTC and colonoscopy found the majority favoured CTC.  Subsequently, more elaborate 
studies also suggested patients would prefer subsequent investigation with CTC rather than 
colonoscopy (118) or BaE (9). However, in common with diagnostic performance studies 
conducted at the time, research relating to patient preference was rapidly evolving from small, 
high-risk cohorts to large screening populations. In 2003, Glueker et al  published a large 
prospective study of asymptomatic individuals(88);  696 patients scheduled to undergo 
colonoscopy and 617 patients due to have BaE were offered additional CTC . Patients 
completed questionnaires exploring their attitudes to inconvenience, discomfort, preparation, 
willingness to repeat examinations and examination preference. Overall, patients preferred CTC 
to colonoscopy (72% vs 5%) and to BaE (97% vs 0.4%). Moreover, regardless of the modality, 
the majority of patients found bowel preparation the most uncomfortable and inconvenient 
aspect. 
 
Most patient preference surveys thus far had been led by a radiologist with an interest in CTC 
(often without gastroenterologist co-authors) which prompted accusations of bias; studies led 
by gastroenterologists found that CTC failed to offer any advantage over colonoscopy (29).  
Consequently, multidisciplinary research has been considered essential for ensuring the 
modality is presented fairly and patients’ views are represented correctly. For example, in 2005, 
a study by van Gelder(119), working with health psychologists and gastroenterologists, 
obtained interesting results: While patients initially preferred CTC  to colonoscopy, this was no 
longer the case after a five week interval. The authors suggested that once short-term concerns 
such as pain and inconvenience had subsided, long-term considerations such as test accuracy 
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became more influential. Moreover, a recent qualitative study has suggested that patients may 
be willing to trade considerable discomfort for very modest increases in sensitivity (32) yet no 
quantitative preference survey to date has provided patients with crucial diagnostic 
performance information.  
 
In any event, the rationale for comparing CTC to colonoscopy is questionable; patients with 
positive or equivocal CTC findings will continue to need therapeutic colonoscopy regardless. 
Therefore, stimulated by cost-effectiveness debate, research focus has returned to the 
germane consideration: Can CTC increase screening uptake? Recent research addressing this 
question is presented in Chapter 2. 
 
1.12.5 OPTIMISING BOWEL PREPARATION 
Although a certain degree of overlap exists with patient acceptability research, studies 
investigating reduced bowel preparation have a somewhat different emphasis: Although 
reducing the laxative burden during CTC preparation may improve the experience, ensuring 
comparable sensitivity with full laxative preparation is the primary concern. Initially, bowel 
preparation prior to CTC reflected that used for BaE or colonoscopy. Although this varied from 
one institution to the next, as a general rule, laxative ‘wet’ preparations involving two or more 
litres of polyethylene glycol (PEG) were favoured in the USA while ‘dry’ preparations based 
around sodium picosulfate were preferred in Europe. However, it soon became apparent that 
residual faecal fluid and residue represented a barrier to accurate diagnosis and researchers 
began to investigate alternative preparations. An early study confirmed picosufate resulted in 
less residue than PEG (61) while others found drinking large volumes of PEG was disliked by 
some patients more than the ensuing diarrhoea(120). Subsequently dryer preparations 
replaced PEG in many centres. 
 
While studies continued to compare the quality of various laxative regimens(82), a small 
number of researchers directed their efforts on avoiding catharsis altogether. The first study 
suggesting adequate performance could be achieved by non-laxative CTC was published in 
2001(64) and since then a limited number of studies have continued to produce impressive 
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results(90, 121, 122). Despite the obvious attraction of non-laxative CTC, it remains unpopular 
with readers who favour primary endoluminal interpretation (which necessitates a clean 
colon). Nevertheless, it is likely that early research into laxative-free preparation was 
responsible for the introduction of positive oral contrast faecal tagging during full-preparation 
CTC (123), which is considered routine practice today. From experience with BaE, colonoscopy 
was considered unsatisfactory in the presence of colonic barium, so to enable same-day 
colonoscopy, oral iodine solutions were included in the DoD(14) and ACRIN(16) study protocols 
instead of barium. Given the performance demonstrated by these studies, full colonic cleansing 
coupled with iodine solutions is generally regarded as the ‘gold standard’(31) (Figure 8).  
 
 
Figure 8:  Axial CTC following oral contrast. 
Homogenous fluid ‘tagging’ enables 
confident diagnosis of a 10mm 
pedunculated polyp (arrow) despite being 
partially submerged in colonic residue. Note 
the fat attenuation in this endoscopically 
proven lipoma. 
 
 
 
However, it is important to note that some oral iodinated contrast (e.g. melgumine diatrizoate) 
acts as a strong osmotic laxative in its own right, and in combination with full catharsis may 
give a rather harsh preparation. Nevertheless, these additional laxative properties have been 
used to advantage by several groups for designing new regimens: These so-called ‘reduced 
preparation’ techniques have proved particularly popular in Europe where CTC is generally 
used to investigate symptomatic patients(87, 124-126). However, in common with non-laxative 
preparations, the main obstacle to reduced preparation is the difficulty in reading 3D 
endoluminal CTC in the presence of residual fluid. The development of ‘digital cleansing’ (62, 
121) aims to make reduced preparation CTC a realistic compromise between diagnostic 
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performance and tolerability.  Nagata et al (127) published convincing claims that full purgation 
is no longer required: One-hundred and one consecutive high-risk patients scheduled to 
undergo CTC were alternately assigned to either full (2l PEG) or ‘minimal’ preparation (45ml 
sodium diatrizoate for 3 days and 10ml sodium picosulfate solution the night before CTC). 
‘Minimal’ preparation CTC achieved a comparable, high sensitivity for detecting polyps 6 mm or 
larger (0.88 compared to 0.97 for full laxative CTC). While the regimen could not be described 
as ‘non-laxative,’ a questionnaire survey indicated a strong preference for the reduced 
preparation. However, as previously demonstrated, retaining high sensitivity comes at a cost: 
Specificity was markedly reduced from 0.92 to 0.68. Intriguingly, the authors concluded that 
patients should be offered the reduced laxative CTC if they were willing to accept the decrease 
in specificity – very little is known about patients’ understanding of specificity, least of all how 
they might trade-off against side-effects. The complex relationship between patients’ attitudes 
to sensitivity and specificity is the focus of Chapter 5 of this Thesis.  
 
 
1.13 MULTICENTRE PERFORMANCE STUDIES; EVIDENCE BASED TECHNIQUE 
While research described above was instrumental in shaping current practice, three recent 
studies have been central to validating CTC performance when conducted using evidence-
based technique in asymptomatic populations. In particular, the ACRIN II(16), IMPACT(128) and 
Munich(129) study groups, all performed prospective trials comparing CTC against an 
enhanced reference standard comprising same-day colonoscopy with segmental unblinding 
(p.38) (Table 1): The ACRIN National CTC Trial (16) recruited 2600 average risk, screenees from 
15 centres. The primary end point was detection of endoscopically proven large adenoma or 
adenocarcinoma (≥10mm). The trial employed meticulous technique and highly experienced 
observers achieving a mean per-patient sensitivity of 0.90 (SD 0.03) and specificity of 0.86 (SD 
0.02). However, despite either completing a 1.5 day training course or reading over 500 cases, 
more than half of would-be observers in the ACRIN II study(16) failed to meet the basic entry 
requirements for the trial (0.90 sensitivity for polyps >1cm over 50 cases) leading to concerns 
regarding the generalisability of these results into daily practice. 
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The IMPACT study(128) recruited patients at increased risk of colonic neoplasia such as those 
with a personal history of adenomatous polyps, a family history of advanced colorectal 
neoplasia, or a positive faecal occult blood test (FOBT). Overall, 1103 patients were recruited 
from 11 Italian sites and one in Belgium. CTC detected 151 of 177 participants with advanced 
neoplasia (≥ 6 mm) resulting in a sensitivity of 0.85 (95% CI, 0.79 to 0.90) and a specificity of 
0.88; (95% CI, 0.85 to 0.90). Considering larger polyps (≥10mm), CTC had sensitivity of 0.91 
(95% CI, 0.84 to 0.95) with positive and negative predictive values of 0.62 and 0.96, 
respectively. Subgroup analysis of the FOBT-positive group found a significantly lower negative 
predictive value (0.85; 95% CI, 0.76 to 0.91; p < 0.001), which is of concern given the high 
prevalence of important colonic abnormalities in these patients.  
 
Table 1:  Diagnostic performance of CTC compared to same-day, unblinded colonoscopy; Comparison 
of three recent trials. 
  Johnson et al, 2008 (16) Regge et al, 2009 (128) Graser et al, 2009 (129) 
Risk of neoplasia Predominantly average risk (89%) All considered at increased risk 
(see text) 
All considered average risk 
Mean age (years) 58 60 61 
    
Per patient sensitivity    
Cancer 86% 95% 100% 
Per patient specificity     
Adenoma ≥6 mm* 88% 88% 93% 
Adenoma ≥10 mm* 86% 85% 98% 
*Munich trial(129) used >5 and >9mm thresholds  
 
 
The Munich Colorectal Cancer Prevention Trial (129) examined asymptomatic patients with an 
average colorectal cancer risk. 307 patients with 511 endoscopically detected adenomas 
underwent five different screening tests in parallel: CTC, colonoscopy, flexible sigmoidoscopy, 
5 0  
 
and guaiac-based FOBT and immunochemical stool tests. Akin to the IMPACT study, 
performance was compared to same-day colonoscopy as the reference standard. CTC detected 
94% of adenomas larger than 9mm and although sensitivity for sub-centimetre adenomas 
(including those less than 5mm) was lower at 0.66, only one missed adenoma showed 
advanced histology, enabling the authors to report a sensitivity of 0.94 for ‘advanced 
neoplasia.’ Encouragingly, per-patient specificity for polyps larger than 5 mm was 0.93. 
 
 
1.14 SO WHAT EVER HAPPENED TO THE BARIUM ENEMA? 
By now, the reader would be forgiven for assuming the appetite and justification for BaE among 
radiologists and referring clinicians has all but disappeared; the evidence is compelling that CTC 
is far superior (130) and more acceptable (88). However, barium examinations have been, by 
no means, consigned to the pages of history. Indeed, it is estimated that 3.7 million procedures 
were performed worldwide in 2008 (pers. comm. Bracco Diagnostics Inc.) The reasons for this 
are beyond the scope of this Thesis, but it is important to note that the examination is often 
performed by radiographic technicians using fully depreciated fluoroscopic equipment with 
minimal impact on valuable radiologist resources or CT capacity. Given the economic climate at 
the time of writing, even convincing evidence is not always sufficient to ensure policymakers 
endorse a potentially expensive, resource-intensive technique. Moreover, in the USA, BaE 
remains approved for colorectal cancer detection while the recent landmark decision by the 
Centers for Medicare and Medicaid Services (CMS) has declined approval of CTC for screening 
(131). The main criticism levelled at CTC was the absence of ‘level 1’ evidence in the form of a 
randomised controlled trial (RCT). However, as no RCT supports BaE, some authors have 
claimed new health technologies are being subjected to tougher standards than existing 
techniques, provoking international debate (132). 
 
The UK Department of Health, via the Health Technology Assessment programme (HTA), 
commissioned a RCT to determine the likely future role of CTC within the NHS, via comparison 
with BaE or colonoscopy. The resulting SIGGAR trial(10), (named after the UK Special Interest 
Group in Gastrointestinal and Abdominal Radiology) was led by the supervisor of this Thesis, 
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Professor Steve Halligan and Professor Wendy Atkin with the first patient randomised in April 
2004 and accrual completed by November 2007: The primary end point was detection rates for 
colorectal cancer or polyps ≥1cm in symptomatic adults (133). The results of this trial (10, 133-
136) are described in detail in Chapter 2 but suffice it to say that as a result of these data, the 
DH has deleted BaE from its colorectal cancer national screening program and recommends 
CTC in its place. The repercussions are expected to have worldwide impact on CTC 
implementation. 
 
 
1.15 THE END OF THE BEGINNING 
Advances in both CT and computer technology have allowed techniques established for BaE to 
be successfully transferred to CTC. Since then, developments in the USA and later worldwide, 
have seen CTC grow from feasibility studies in academic units to international daily practice 
(Table 2). Recent research has established excellent comparative performance with 
colonoscopy and accuracy which supersedes BaE but concerns exist regarding generalisability 
of these results to daily practice. This is explored in greater detail in Section B of this Thesis. 
Research continues apace to refine technical implementation, particularly reduced preparation 
methods which may increase adherence with screening programs and to ensure that readers, 
potentially with the assistance of CAD, achieve the same diagnostic performance as those from 
successful multicentre trials.  
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Table 2:  Milestones in the history of CTC 
Year Milestone in the history of CT Colonography development 
1983  First report of CT imaging of the cleansed, distended colorectum (44) 
1994 Vining et al  present ‘virtual colonoscopy’ (45) 
1997  First exploratory observer study of CTC  performance (74)  
1998 Feasibility demonstrated in patients with endoscopically proven findings (69) 
1998 Boston International Symposium on Virtual Colonoscopy introduced (76). 
1998  ‘CTC’ becomes preferred terminology (77) 
1999 Landmark study shows very favourable performance for CTC  and initiates  international interest (11)  
2000  The National Polyp Study published; poor performance brings BaE use into question (50) 
2000 First CAD systems developed for CTC  (109) 
2001 Iodine tagging of liquid stool shown to benefit (62, 121)   
2001 First attempts at non-laxative CTC  reported (64)  
2001  CAD undergoes preliminary clinical validation (110) 
2003 Prospective patient attitude survey finds CTC  preferable colonoscopy and to BaE(88) 
2003  ESGAR form CTC  working group  
2003  DoD trial published (14).  
2003  ACRIN trial published (98) 
2004  Comparative study shows CTC  superior to Barium enema (130)  
2005 Metaanalysis of CTC  performance for cancer detection published (15)  
2005 First International CTC  standards document published (36)  
2007 AGA release own guidelines (106)  
2007  ESGAR publish consensus statement (30) 
2008  ACRIN II study published (16)  
2009 CMS declines coverage of CTC for screening (131)  
2010 Studies provide convincing evidence for ‘second reader’ CAD (19, 20)  
2010 Preliminary results of first RCT of CTC  presented (SIGGAR trial) (133) 
2010 UK Department of Health discontinues Barium enema in favour of CTC  for CRC screening program 
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CHAPTER 2 
2. CTC: CURRENT STATUS AND FUTURE DIRECTIONS 
 
AUTHOR DECLARATION 
Work presented in this Chapter was led by the author; literature searching, compilation and 
manuscript writing was completed under the supervision of Professor Steve Halligan and 
Professor Stuart Taylor. A proportion of this Chapter forms the basis of: Boone D, Halligan S, 
Taylor SA. Evidence review and status update on computed tomography colonography. Curr 
Gastroenterol Rep. 2011; 13(5):486-94. (Appendix A) 
 
 
2.1 INTRODUCTION 
Chapter 1 summarised the key milestones which have shaped current CTC practice; inevitably, 
for an emerging technique, early studies concentrated on optimising technical implementation 
and providing sufficient evidence to ‘validate’ CTC for routine clinical use. Subsequently, the 
landscape of CTC research has changed considerably: The focus has moved towards 
generalisability of CTC into daily practice (the focus of Section B), cost effectiveness and the 
impact of extra-colonic findings (137). Furthermore, the debate over who is should interpret 
CTC (radiologists, gastroenterologists, radiographic technicians or even computer algorithms) 
continues to intensify. The focus of this Chapter is to present the current status of CTC research 
with review of literature published between 1st April 2010 and 31st March 2011. 
 
 
2.2 DIAGNOSTIC PERFORMANCE 
As outlined in Chapter 1, excellent sensitivity for detecting advanced colorectal neoplasia has 
been reported in several large comparative studies. However, until recently, randomised 
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controlled trail data have been unavailable to support this evidence base. Therefore, 
presentation of preliminary results from the UK Special Interest Group in Gastrointestinal and 
Abdominal Radiology (SIGGAR) trial (133) was one of the most significant developments during 
the period under review.  
 
2.2.1 DIAGNOSTIC PERFORMANCE IN SYMPTOMATIC PATIENTS: THE SIGGAR TRIAL 
The SIGGAR multi-centre study comprised two parallel randomised controlled trials (RCT) 
comparing CTC to BaE and CTC  to colonoscopy(10); a total of 5,448 patients were randomised. 
The primary end point was the detection rate for colorectal cancer or polyps ≥ 1cm in 
symptomatic adults. In the BaE subtrial, patients aged 55 or over with symptoms suggestive of 
colorectal cancer who were referred by their clinician for BaE were randomised (in a 2:1 ratio) 
to either BaE (2,541) or CTC (1,280). In an intent-to-treat analysis, colorectal cancer or polyps ≥ 
10mm were diagnosed significantly more frequently in patients assigned to CTC than to BaE 
(7.4%  vs. 5.6% , p=0.0312). Using national registry data to capture cancer miss rates 
(diagnosed within 2-years of randomisation), BaE had twice the miss rate of CTC (14% vs. 7%). 
Additional colonic investigations occurred significantly more frequently following CTC than BaE 
(23% vs. 18%), mainly due to higher polyp detection rates. 1,338 previously unknown extra-
colonic findings were reported in the 1,206 patients who underwent CTC as their randomised 
procedure. Eighty-six patients were referred for further tests as a result of their extra-colonic 
findings, leading to diagnosis of a malignant tumour in 12 patients (13).  
The colonoscopy subtrial (12) found a much higher prevalence of endpoints amongst those 
randomised (11% vs 4% for the BaE subtrial). In an intent to treat analysis, there was no 
significant difference in the detection rate of significant colorectal neoplasia between the two 
arms (11.6% for colonoscopy vs. 10.7% for CTC, p=0.61) but the referral rate for a subsequent 
confirmatory procedure was much higher after CTC (31.4% for CTC  vs. 7.2% for colonoscopy), 
raising important questions regarding cost efficiency and the need for well-defined, evidence-
based criteria for referral following CTC  in symptomatic patients. As stated in Chapter 1, 
consequent upon these data, the UK Department of Health no longer endorses BaE for 
screening but recommends CTC instead in those patients in whom colonoscopy is 
contraindicated or cannot be performed. 
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2.2.2 DIMINUTIVE LESIONS 
Few authors, if any, would disagree that the sensitivity and specificity of CTC is relatively poor 
for diminutive polyps and the focus has therefore been on detecting polyps larger than 5mm, 
ideally those with high-grade dysplasia (i.e. advanced adenomas). Benson et al compared 1700 
average-risk screening patients undergoing colonoscopy and 1,307 having CTC (138) finding 
nearly five times more non-advanced adenomas were removed in the colonoscopy group. 
However, while all referrals were made from the same patient population, groups were not 
randomised. Moreover, no significant difference was observed for detection of advanced 
adenomas. Furthermore, while much is known about the natural history of colorectal cancer, it 
remains unclear whether detection and excision of small adenomas is clinically desirable. For 
example, a meta-analysis of four studies comprising 20562 screening patients by Hassan et al 
(139) found that advanced adenomas were detected in 1155 (5.6%) subjects, with the overall 
incidence of advanced histological characteristics in polyps <6mm, 6-9mm and ≥10mm of 4.6%, 
7.9% and 87.5% respectively. They concluded that a 10-mm threshold for colonoscopy referral 
would identify 88% of advanced neoplasia while a 6-mm polyp size threshold would identify 
over 95%. Additional complexity results from the well-documented systematic differences in 
polyp measurement between radiological and endoscopic techniques. De Vries et al assessed 
endoscopic and colonographic measurement of 51 polyps (140) and found CTC judged polyps 
to be between 0.7 to 2.3 mm larger than equivalent endoscopic estimates. Debate also 
continues as to how endoscopic and colonographic definitions of flat neoplasia can be 
reconciled to allow meaningful comparisons. Ignjatovic et al performed a comprehensive 
review of the subject (141), and suggested the most appropriate  radiological definition was 
that based upon a well-established pathological description (i.e. the Paris classification) and 
that flat neoplasia should be defined on CTC  as lesions with a vertical height of 3mm or less 
above the surrounding mucosa. In support, a single centre study of 5107 consecutive CTC  
screening patients found that 125 (93.2%) lesions characterised as flat at endoscopy measured 
less than 3mm at CTC (142). Interestingly, the study also noted that flat lesions between 6 and 
30 mm in size were less likely to be neoplastic than similar sized sessile polyps (25.0% vs. 
60.3%).  
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2.3 COST-EFFECTIVENESS OF CTC FOR PRIMARY SCREENING 
Although CTC has proven efficacy for advanced adenoma detection, whether it represents a 
cost-effective primary screening tool remains under scrutiny. Just prior to the period reviewed, 
conflicting recommendations were published by two North American consensus guideline 
groups: A joint statement by the American Cancer Society, the Multi-Society Task Force on 
Colorectal Cancer and the American College of Radiology, recommended CTC as a first-line 
preventive screening test in patients at average risk of developing colorectal cancer (143). 
Conversely, the US Preventive Services Task Force considered the existing evidence insufficient 
(144) and CTC  has been rejected for coverage by the Centers for Medicare and Medicaid 
Services(131). Although full discussion of this debate is beyond the scope of this Thesis, 
excellent commentaries are provided by Cash (145) Schoen (146) and Burke (147). 
Although these developments primarily concern North American practice, their impact on CTC 
implementation and future research has international ramifications. In particular, recent 
research has focussed extensively upon addressing uncertainties in baseline assumptions used 
to drive cost-effectiveness modelling analyses, notably the impact of low specificity, extra-
colonic findings, management of diminutive polyps and the potential to increase patient 
compliance with colorectal cancer screening. These topics are considered separately 
throughout this Chapter. 
 
 
2.4 TRAINING, STANDARDS, AND VALIDATION  
A consistent theme in the CTC literature, even amongst the larger successful studies, has been 
notable variation in diagnostic accuracy for individual radiologists. It is therefore surprising that 
recent research has contributed relatively little to our understanding of the effects of reader 
experience and training on interpretative accuracy. Fletcher et al compared the performance of 
ten radiologists during a one-day educational workshop with their subsequent diagnostic 
accuracy in a prospective multi-centre screening study (148) and found a 1.5-fold increase in 
the odds of making a true positive diagnosis for every additional 50 validated cases studied.  
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The latest CTC  standards document, developed by the International CT Colonography 
Standards Collaboration(31), has reinforced the need for adequate training and has suggested 
formal accreditation. Furthermore, the American college of Radiology has recently published 
guidance on recommended quality metrics(105) including rates of complications, inadequate 
studies and significant extracolonic findings. Where patients undergo subsequent colonoscopy 
they advise registering sensitivity and per-patient specificity for polyps ≥1cm. The aim is to 
establish benchmarks against which departments can audit their performance. 
 
 
2.5 PATIENT ACCEPTABILITY AND BOWEL PREPARATION  
Early research regarding patient acceptability was described in Chapter 1. While these initial 
studies remain widely cited, methodology has improved considerably over recent years, in 
particular, minimising bias through multidisciplinary collaboration. Moreover, there has been a 
change in focus from establishing patients’ post-procedural experience to gauging the potential 
for CTC to increase screening uptake. For example, analysis by Knudsen et al (149) concluded 
that a substantial increase in screening attendance (>25%) would be required for CTC to be cost 
effective in comparison to colonoscopy. In response, Pickhardt et al argued that CTC screening 
would increase compliance comfortably, notably amongst patients who currently refuse 
colonoscopic screening (150). They cite a survey by Moawad et al, which found 40% of patients 
attending CTC screening would have foregone investigation altogether had the examination not 
been available (151) and a survey of colonoscopy non-attendees, of whom over 80% stated 
that they would have attended CTC if offered (152). However, caution must be applied to both 
surveys - the first was prone to selection bias as all respondents had already chosen to attend 
CTC and the second had a response rate of only 39% raising concerns about the generalisability 
of results. Moreover, patient preference for CTC is by no means universal or consistent in the 
indexed literature. 
It is worth noting at this juncture that qualitative patient preference studies are particularly 
susceptible to framing bias. For example, the sensitivity quoted for CTC varies considerably but 
the value presented to participants (and the manner in which they are presented) will have 
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considerable impact on their attitudes and responses. The methodological challenge involved 
in minimising bias when designing quantitative research is explored in Chapter 5.   
 
Recent abstracted data (153) (subsequently published in 2012 by Stoop et al (154)) provide the 
most convincing evidence to date that CTC can enhance screening adherence. A recent RCT 
recruited 2920 asymptomatic screenees to reduced-preparation CTC and 5924 to colonoscopy, 
completing accrual in August 2010. Significantly fewer invitees attended screening with 
colonoscopy compared to CTC (22% vs 34%; p<0.0001) (34%). However, detection rate for 
advanced neoplasia was significantly higher for colonoscopy than CTC (8.7 vs 6.1 per 100 
examinations; p=0.02). Consequently, overall diagnostic yield per 100 invitees did not differ 
significantly (1.9 vs 2.1 detections for CTC and colonoscopy respectively; p=0.56) suggesting 
primary screening with reduced preparation CTC would be effective, in part due to improved 
uptake. 
 
 
2.6 SAFETY 
While it is widely accepted that CTC is safe, with a perforation rate considerably lower than 
that of colonoscopy, risks do exist, both related to bowel preparation and colonic insufflation, 
and knowledge of these continues to inform best practice. A meta-analysis by Atalla et al, 
supplemented by a retrospective multicentre study (155), identified only two cases of 
perforation from 3458 CTC procedures resulting in an incidence of 0.06%. Risk factors common 
to both cases were older age, manual colonic insufflation, diverticulosis, recent colonoscopy 
and biopsy. The potential relationship to prior colonoscopic biopsy is of interest, but given the 
low rates of CTC-related perforations in the literature, there remains insufficient evidence on 
which to base clear guidelines for the timing of CTC following endoscopic biopsy. This issue will 
likely become of increasing importance as many institutions attempt to offer same-day CTC 
following incomplete colonoscopy. Likewise, CTC has been shown to be safe following metallic 
stent placement for obstructive colorectal cancer (156). It is well established that aggressive 
bowel purgation carries a risk of biochemical disturbance, particularly in frail elderly patients. 
However, a retrospective study of patients aged over 70 years demonstrated no significant 
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changes in serum urea, sodium, potassium or estimated glomerular filtration rate when using 
sodium picosulphate-magnesium citrate catharsis prior to CTC  (157). Finally, although it has 
been suggested that bacteria introduced during insufflation could risk infection of prosthetic 
vascular grafts, a study of 100 consecutive patients subject to serial blood cultures following 
CTC  failed to showed significant bacteraemia and suggested antibiotic prophylaxis is not 
required (158).  
 
 
2.7 WHO SHOULD REPORT CTC? 
Due to pressure of work, European radiologists have studied the feasibility of delegating CTC 
interpretation to radiographers, albeit with the assistance of computer aided detection (CAD) 
software (159). Radiographers performed the primary interpretation in 303 consecutive 
symptomatic patients detecting 100% cancers, 72% of large polyps and 70% medium (6-9mm) 
sized polyps. However, observer specificity was poor and would have resulted in inappropriate 
referral for colonoscopy in 37% of the patients studied. Overall, the authors concluded that CTC 
interpretation by radiographers may be useful for rapid patient triage post-procedure, but 
ultimately not for independent reporting.  
 
 
2.8 EXTRACOLONIC FINDINGS 
One factor which cannot be ignored when considering who should report CTC is the high 
prevalence of incidental extra-colonic findings. The additional cost and patient morbidity from 
the work-up of extra-colonic findings is likely to be considerable; a recent study of 2777 
screening patients identified extra colonic findings in 46%, and ‘significant’ findings in 
11%(160). Further evaluation resulted in 280 radiological examinations and 19 surgical 
operations. Conversely, the incidence of unexpected extracolonic malignancy is relatively low: 
A retrospective review of 10,286 outpatient adults undergoing screening CTC (137) reported 36 
unexpected extra-colonic malignancies (0.35%) including 11 renal cell carcinomas, eight lung 
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cancers and six cases of non-Hodgkin’s lymphoma. In addition, Pickhardt et al assessed 
incidental indeterminate adnexal masses in 2869 asymptomatic women undergoing 
colonography screening (161) and found that while ovarian lesions were common (4.1%), 
subsequent work-up revealed no ovarian cancers. Moreover, a normal CTC did not exclude 
subsequent development of ovarian cancer.  
 
Intuitively, the serendipitous discovery of incidental extra-colonic malignancy should be of 
benefit to patients yet long term data on improved patient outcomes are currently lacking and 
the financial implications are complex.  
 
 
2.9 COMPUTER AIDED DETECTION (CAD) 
As described briefly in  Chapter 1, CAD has been applied to CTC for over 12 years (109) but akin 
to research relating to  CTC diagnostic performance, sufficiently powered observer studies have 
only emerged relatively recently due to the resource requirement for such studies. Therefore, 
for several years, standalone CAD detection characteristics were utilised by extrapolation as a 
surrogate measure for diagnostic performance when used by radiologists, often with striking 
results. For example, a recent retrospective study of a cohort of 3042 screening patients, 373 of 
whom had medium or large polyps, found standalone per-patient sensitivities for CAD of 93.8% 
and 96.5% at 6 and 10mm thresholds respectively (162). Moreover, the median FP rate was 
only 3 per CTC series. Similar high levels of CAD performance were obtained in a much smaller 
study of 29 patients at high-risk of colorectal neoplasia (with 86 polyps) (163). However, as 
discussed in Chapter 1 (p43) standalone performance does not necessarily translate into 
diagnostic accuracy when CAD is used by a radiologist in daily clinical practice: Readers may be 
misled by FP CAD prompts, reducing their specificity, or they may incorrectly classify a TP CAD 
prompt as false-negative, reducing potential gains in sensitivity. Therefore, realistic assessment 
of CAD’s impact on reader performance requires studies where observers read cases both with 
and without CAD assistance.  
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Two groups have recently published multi-reader, multi-case studies using CAD as a ‘second 
reader’, i.e. the CAD prompts are only interrogated by the reader only after a thorough 
unassisted review has been performed first.  Dachman et al (20)used a cohort of 100 
endoscopically-validated cases, 48 of which were normal and 52 of which contained 74 polyps. 
19 readers interpreted each case unassisted and with CAD as a second-reader. Readers' per-
segment, per-patient, and per-polyp sensitivity were significantly higher (p < 0.011, 0.007, 
0.005, respectively) with CAD compared to unassisted readings when using a ROC AUC analysis. 
However CAD reduced readers’ specificity by 0.025 (p =0.05). Halligan et al found similar results 
(19): Sixteen experienced radiologists interpreted CTC  from 112 patients (132 polyps in 56 
patients) on three separate occasions either unassisted, using CAD concurrently, or with CAD as 
a second-reader (Please see Chapter 6 for a more detailed explanation). CAD significantly 
increased mean per-patient sensitivity both when used as a second-reader (mean increase, 
0.07; 95% confidence interval (CI): 0.04 to 0.098) or when used concurrently (mean increase, 
0.045; 95% CI: 0.008 to 0.082). Furthermore, CAD resulted in no significant decrease in per-
patient specificity for these readers. These are the largest reader studies of CAD to date and 
argue strongly that CAD would be beneficial if used in clinical practice by experienced 
radiologists.  
 
Nevertheless, there remains considerable scope for research into how CAD should best 
integrate into radiologists’ workflow (115). Furthermore, a recent pilot study by Summers’ 
group found that TP CAD prompts were more likely to be correctly classified by readers when 
prompts were present on both the prone and corresponding supine acquisitions (164). 
Therefore, there is growing interest in automating the registration task between prone and 
supine acquisitions(165) and this forms the focus of Section D of this Thesis. 
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2.10 CONCLUSION 
Recent research has continued to demonstrate that CTC has excellent sensitivity compared to 
colonoscopy and is significantly more accurate than BaE, which should be abandoned. Adverse 
events are uncommon and patient acceptability is good. Reduced bowel preparation regimens 
continue to show considerable promise. Evidence is mounting that the impressive stand-alone 
detection rates of CAD translate into improved radiologist accuracy. Controversy continues 
regarding the impact of incidental extra-colonic detections, who should interpret CTC, whether 
compliance with screening programmes is genuinely enhanced by CTC, and whether the 
technique is ultimately cost effective. Moreover, doubt remains whether results from those 
trials cited as exemplars by the radiology community can be generalisable to daily practice. This 
is explored in further detail in Section B. An additional recurring theme is the trade-off 
between sensitivity and specificity for CTC, particularly when assessing adjuncts to 
interpretation such as CAD. This forms the main focus of Section C.  
 
Finally, alongside the high-profile multicentre studies described in this Section, there is a 
wealth of published literature that occupies the periphery of the CTC research field. Doubtless, 
some of this research which will evolve into the mainstream over the upcoming years. For 
example, over 30 papers were published over the 1-year period reviewed detailing algorithms 
designed to improve digital cleansing, 3D data display, and other complex computer 
applications. Therefore, while on the surface, the rate of progress may appear to have slowed, 
it has simply taken new directions. The development of novel computer algorithms to improve 
colonographic interpretation is explored in Section D of this Thesis.  
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SECTION B:  
IDENTIFYING AND 
QUANTIFYING LIMITATIONS 
IN CTC RESEARCH 
 
OVERVIEW 
As outlined in Section A, it is now widely accepted that CTC has undergone sufficient validation 
for widespread clinical implementation. However, most multicentre trials, upon which these 
assumptions are based, have been carried out on healthy screening populations using highly 
experienced observers in North American academic centres. It is unlikely that either the 
observers or patient sample reflect European daily practice. However, this remains speculative 
as practically nothing is known about the level of training and experience of those interpreting 
CTC in Europe. Likewise, while historically, radiological investigation in Europe has been 
reserved for symptomatic patients, there are no recent data to confirm this remains the case. 
In addition to factors influencing the generalisability of CTC research, studies of diagnostic test 
accuracy must make pragmatic compromises (such as repeat reading of the same cases or 
enriching sample prevalence to ensure adequate statistical power) to reduce the complexity 
and resource demands of the study. This may introduce further sources of bias, yet their 
impact remains unquantified.  
Thus, Section B consists of two Chapters exploring generalisability of research data and sources 
of bias in CTC research: Chapter 3 describes the level of training, experience and pattern of 
clinical practice across Europe via a survey of participants at educational CTC workshops. 
Chapter 4 encompasses a broad investigation into bias affecting studies of diagnostic test 
accuracy by means of a systematic review. 
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CHAPTER 3 
3. WHO ATTENDS CTC TRAINING? A SURVEY OF PARTICIPANTS AT EUROPEAN 
EDUCATIONAL WORKSHOPS 
 
 
AUTHOR DECLARATION 
Work presented in this Chapter was led by the author with the guidance of the ESGAR CTC 
committee (including both Supervisors). The online survey was distributed by ESGAR 
administrators; data collection, analysis and presentation were performed by the author. The 
manuscript was compiled under the supervision of Professor Steve Halligan and Professor 
Stuart Taylor. This research has been published in:  Boone D, Halligan S, Frost R, et al. CT 
Colonography: Who attends training? A survey of participants at educational workshops. Clin 
Radiol. 2011;66(6):510-6.(166) 
 
 
3.1 INTRODUCTION 
As described in Section A of this Thesis, the last two decades have seen sustained CTC research 
with several clinical trials confirming that the technique can detect colorectal polyps and 
cancers with high accuracy (14, 16, 167). Consequently, CTC is currently disseminating widely 
into clinical practice, both in Europe(101, 168) and the USA(169). Furthermore, recently 
released data from the SIGGAR trial (10, 133) have prompted the UK Department of Health to 
delete BaE from its FOBT-based, colorectal cancer screening programme, instead endorsing 
CTC. It is expected that other European states will follow suit. Increased public awareness and 
saturation of endoscopy services has placed clinical and political imperatives on radiology 
departments to provide a CTC service: In comparison to a 2006 study where just over one third 
of UK NHS hospitals were performing the technique (101), preliminary data from a recent UK 
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survey suggest over 80% of departments are now providing a service(170). However, it is well 
recognised that CTC is difficult and time-consuming to interpret, has a defined learning curve 
and that reader accuracy is closely related to experience (17, 102, 171). As a result, 
international expert consensus statements from both Europe(30) and the USA (36) agree that 
specific training is essential for competent interpretation. In particular, hands-on educational 
workshops, where participants receive face-to-face training using real case data, have been 
shown to measurably improve reader accuracy (172).  However, at present there is no formal 
requirement for training, validation or accreditation to interpret CTC in Europe, raising 
concerns about the standard to which the technique is being performed in daily practice.  
Moreover, despite clinicians, policy makers and well-motivated patients expecting CTC 
performance to reflect that seen in the North American literature, this is unlikely unless the 
local radiologist has equivalent expertise.   
While much is known about the opinions of key leaders in the field (30, 36), relatively little is 
known regarding those who interpret CTC in daily practice. In particular, data are lacking 
regarding the professional background of workshop attendees, their prior expertise and 
experience of CTC interpretation, their motivation for attending, and their future intentions. In 
order to obtain these data, the author surveyed participants attending hands-on educational 
CTC workshops.  
 
 
3.2 METHODS 
A waiver to publish an analysis of demographic data obtained anonymously from workshop 
attendees was obtained from the author’s local Research Ethics Committee; no patients were 
involved in this study. The author surveyed participants at five CTC workshops conducted in 
Edinburgh (UK), Malmo (Sweden), Amsterdam (Netherlands), Pisa and Stresa (Italy) between 
February 2007 and April 2010. Workshops were organised by ESGAR and advertised on their  
website several months in advance (www.esgar.org). Participants registering for the workshops 
were contacted by the course organisers via email one week prior to the event. The invitation 
contained a hyperlink that directed the recipient to an anonymous, online questionnaire 
(Appendix B). The most recent workshop (Amsterdam) was cancelled due to the volcanic 
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environmental crisis of April 2010, but data from participants registered in advance are 
included below. 
The questionnaire was designed by members of the ESGAR CTC Workshop Committee, who are 
radiologists of consultant grade experienced in interpretation of CTC in day-to-day clinical 
practice. A multiple-choice format meant that the questionnaire could be completed in less 
than five minutes since minimal free text was required. The questionnaire was broadly divided 
into four sections relevant to this Thesis:  
 The professional background of the participant and their prior experience of CTC 
(including numbers of cases and preferred interpretation display if relevant). 
 The personal intentions for subsequent clinical practice of the technique. 
 Current CTC practice in the host institution(s) including details of how the examination 
was performed and subsequently interpreted.  
 Respondents’ opinions on the potential clinical role of CTC in their future practice.  
Responses were collated and raw frequencies calculated by the author.  
 
 
3.3 RESULTS  
Overall, 476 participants were registered for the five workshops and 348 of these completed 
the survey; a response rate of 73%. The workshops attracted a wide geographical variation 
(Figure 9) with a mean of 64% attendees working outside the host country (range 26% to 84%). 
Indeed, the two most recent workshops (Stresa, Italy; September 2009 and Amsterdam, 
Netherlands; April 2010) attracted registrants from 20 European member-states and seven 
countries outside Europe, namely North America (4 participants), Australia (5 participants), 
Brazil, Israel, United Arab Emirates, Singapore and Thailand (1 each).  
The courses were attended almost exclusively by radiologists (97%), with radiographic 
technologists and gastroenterologists representing only 3% and 0.6% respectively during the 
period studied (Table 3). Overall, 20% of the radiologists were trainees. The remainder where 
staff radiologists of whom 40% considered themselves subspecialists in gastrointestinal 
radiology. The remainder was approximately equally divided between general radiologists and 
radiologists with a subspecialty interest in cross-sectional imaging (Table 3).  
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Figure 9:  Geographical distribution of delegates attending ESGAR CTC courses.  Mean number of 
delegates per workshop:  Blue 1 to 10; orange 11 to 20; red 21 or above.  
 
Three-quarters (63%-85%) of respondents were already providing a CTC service in their own 
hospital (Table 4) and practically all remaining participants (99%) intended to practice CTC in 
the near future.  
Practice setting, split by workshop, is shown in Figure 10. Overall 69% reported CTC exclusively 
in the public sector; 23% were restricted to private practice; 8% reported in both settings. Of 
those reporting in the private sector, 45% were carrying out screening investigations only.  
Prior to the course, 86% of respondents had been reporting CTC. Amongst these, there was a 
broad range of prior experience; 76% had interpreted less than 50 cases, and of those, 63% had 
reported less than 10. In contrast 6% of respondents stated they had already personally 
interpreted over 300 cases). 
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Figure 10:  Participants’ CTC practice 
  
Table 3:  Occupation of workshop participants 
 Edinburgh 
 (Feb 07) 
Pisa   
(Sep 07) 
Malmo      
(Sep 08) 
Stresa     
 (Sep 09) 
Amsterdam 
 (Apr 10) 
Total Mean 
Occupation Number(%) Number (%) Number (%) Number (%) Number (%) Number  (%) 
Trainee radiologist 19(20) 12(16) 19(23) 7(15) 12(27) 69 20 
Staff radiologist 
with interest in GI 
imaging 
29(31) 28(36) 24(29) 14(29) 13(29) 108 31 
Staff radiologist 
with interest in CT 
28(30) 9(12) 12(14) 11(23) 5(11) 65 18 
Staff radiologist 
with general 
interest 
17(18) 24(31) 24(29) 15(31) 14(31) 94 28 
Non-radiologist 
physician 
0(0) 0(0) 1(1) 1(2) 0(0) 2 1 
Radiographic 
technician 
2(2) 4(5) 3(4) 0(0) 1(2) 10 3 
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Table 4:  CTC service provision at participants’ local hospitals 
 Edinburgh 
 (Feb 07) 
Pisa       
 (Sep 07) 
Malmo  
(Sep 08) 
Stresa   
(Sep 09) 
Amsterdam  
(Apr 10) 
Total Mean 
CTC service Number(%) Number(%) Number(%) Number(%) Number(%) Number  (%) 
Do not offer a 
service 
24(25) 21(37) 21(25) 7(14) 6(13) 79 23 
Public sector 
service 
63(66) 36(63) 52(63) 37(77) 34(76) 222 69 
Private sector 
service 
26(27) 0 (0) 13(16) 11(23) 9(20) 59 17 
 
Table 5:  Workshop participants’ previous CTC training and experience 
 Edinburgh 
(Feb 07) 
Pisa       (Sep 
07) 
Malmo (Sep 
08) 
Stresa   (Sep 
09) 
Amsterdam 
(Apr 10) 
Total Mean 
Previous training in 
CTC 
Number(%) Number(%) Number(%) Number(%) Number(%) Number  (%) 
None whatsoever 27(28) 19(25) 27(33) 3(6) 13(29) 89 24 
Watched others 
report locally 
21(22) 20(26) 22(33) 15(31) 11(29) 89 24 
Interpreted cases 
independently 
49(52) 41(53) 34(27) 25(52) 20(24) 169 49 
Attended a 
previous workshop 
0(0) 0(0) 5(6) 13(27) 3(7) 21 8 
Interpreted 
validated datasets 
6(6) 9(12) 6(7) 8(17) 9(20) 38 12 
Validated cases        
<10  24(38) 22(38) 50(60) 17(35) 31(69) 144 48 
10-49 27(42) 21(36) 16(19) 15(31) 4(9) 83 28 
50 – 99 5(8) 6(10) 5(6) 5(10) 7(15) 28 10 
100-299 7(11) 4(7) 7(8) 5(10) 2(4) 25 8 
300 or more 1(2) 5(9) 5(6) 6(13) 1(2) 6 13 
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 Likewise, the level of prior hands-on training was highly variable.  Of those currently practicing 
CTC, 8% had attended a previous dedicated workshop, 12% had interpreted educational 
datasets and 26% had observed others reporting. Surprisingly, the remaining 54% had no prior 
formal training 
Table 5). Indeed, 8% of those reporting CTC independently at the time of their course 
registration had no prior training and had reported less than 10 cases (Figure 11). 
 
 
Figure 11:   Level of prior training among inexperienced readers 
 
Full cathartic colonic cleansing was adopted by the majority of respondents (88%) with the 
remainder using a reduced preparation regimen in young and elderly patient groups equally 
(Figure 12). There was a slight increase in the use of water-soluble contrast material for tagging 
residual faecal material and fluid over the study period, with one third (97; 35%) routinely 
using such preparation. Moreover, there had been a sustained upward trend with only 11% 
tagging in 2007 compared with 44% in 2010. Half of respondents were using carbon dioxide to 
insufflate the colon rather than room air and 76% routinely used an antispasmodic in the 
majority of cases (Figure 12).  
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Figure 12:  Technical implementation of CTC 
 
Regarding CT technology, on average just under half (48%) had access to a machine with 64 
detector rows or more. However, there was a steady rise in the number using such machines 
from 23% to 65% over the study period. Likewise, the proportion routinely employing 3D 
reconstruction software for interpretation saw an increase from 59% to 82% (Figure 13).  
Concerning interpretation, over the course of the survey the proportion restricting themselves 
exclusively to 2D interpretation fell from 23% to 11%, while those performing a primary 3D 
read increased from zero to 38%. The majority continued to favour a primary 2D read with 3D 
reconstruction reserved for problem solving.  
Approximately half of the respondents predicted the future role of CTC would focus on the 
investigation of symptomatic patients while those remaining predicted a role for screening 
(Table 6). 
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Figure 13:  Participants’ preferred reading paradigm 
 
Table 6:  Attitudes of workshop participants to the optimal role of CTC  
 Edinburgh 
(Feb 07) 
Pisa          
(Sep 07) 
Malmo 
(Sep 08) 
Stresa   
(Sep 09) 
Amsterdam 
(Apr 10) 
Total Mean 
Preferred role of 
CT Colonography 
Number(%) Number(%) Number(%) Number(%) Number(%) Number  (%) 
Cancer detection 
in symptomatic 
patients -all ages 
0(0) 0(0) 52(62) 15(31) 19(42) 86 27 
Cancer detection 
in symptomatic 
patients-elderly 
33(42) 19(29) 19(23) 5(10) 11(24) 87 26 
Screening - all 
relevant ages 
45(58) 47(71) 34(42) 36(75) 26(58) 188 61 
Screening - 
elderly  
0(0) 0(0) 14(17) 9(19) 12(27) 35 12 
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The incidental detection of extra-luminal disease was believed to be beneficial by, on average, 
83% of respondents for symptomatic patients and by 61% for the screening population (Table 
7). 
Table 7:  Attitudes of participants to extracolonic findings at CTC 
 Edinburgh 
(02/2007) 
Pisa   
(09/2007) 
Malmo 
(09/2008) 
Stresa  
(09/2009) 
Amsterdam 
(04/2010) 
Total Mean 
Attitude to 
extracolonic findings 
Number(%) Number(%) Number(%) Number(%) Number(%) Number  (%) 
A good thing in 
symptomatic 
patients. 
83(87) 67(87) 77(92) 33(69) 35(78) 295 83 
A bad thing in 
symptomatic 
patients. 
1(1) 3(4) 2(2) 0(0) 2(4) 8 2 
A good thing in 
asymptomatic 
screening patients 
57(60) 45(58) 43(52) 38(79) 24(53) 207 61 
A bad thing in 
asymptomatic 
screening patients  
23(14) 14(18) 10(12) 4(8) 10(22) 61 17 
 
 
3.4 DISCUSSION 
This research has determined the professional background and prior expertise of workshop 
registrants wishing to learn CTC, their motivations for attending for training, and their future 
intentions for clinical practice. While we anticipated that the majority of attendees would be 
radiologists, we were surprised that this group represented practically all of those registered, 
despite apparent interest from other professional groups in interpreting the procedure (92, 
100, 173). While international consensus statements strongly recommend that those intending 
7 4  
 
to practice CTC attend a hands-on training workshop (30, 36), there is a perception that access 
to such courses is restricted (174). This may account for the striking geographical spread of 
workshop attendees with participants travelling from many different countries to attend.  
The workshops attracted not only those individuals intending to practice CTC in the future but 
also a significant proportion of those currently providing a CTC service. The majority of these 
had not interpreted 50 cases, which is commonly believed to be the minimum level of 
experience recommended for independent reporting (30). Likewise only a small proportion had 
any formal training prior to the workshop. These data are worrying because they imply strongly 
that medical practitioners are interpreting radiological examinations in daily practice for which 
they have no prior experience. The consequence is that the test characteristics suggested by 
large clinical trials(14, 16, 28, 167, 175) and meta-analysis (15), often performed in centres with 
experienced practitioners, are unlikely to reflect performance in generalised practice. 
 
While suggested criteria for prior training and experience were not fulfilled, most respondents 
satisfied the technical requirements for obtaining good-quality image data and were 
performing CTC in accordance with published European guidelines; the majority employed 
antispasmodics, full cathartic cleansing, modern scanning technology, and dedicated 3D 
visualisation software. We identified a recent trend towards reduced bowel cleansing and 
tagging of liquid residue that is likely to reflect subsequent uptake of recent research evidence 
supporting these modifications (90, 127). We also identified a recent increase in the proportion 
of those currently practicing CTC who choose to interpret using a primary 3D read, which again 
may reflect subsequent uptake of research findings that have predominantly attributed high 
sensitivity to this method of data display for interpretation (176, 177). 
Despite the undoubted economic burden posed by incidental detection of extra-luminal 
pathology and its subsequent evaluation (178), the majority of respondents believed that 
detection of extra-colonic lesions was an advantage of CTC in both symptomatic and screening 
populations, beliefs that are in accord with the concerns of patients themselves (33). It will be 
interesting to observe if these beliefs change if health-economic data from large, randomised 
pragmatic trials show that there is no net benefit, or even disutility from this practice(10). 
 
Our study does have limitations. A potential limitation is the online nature of the survey. 
However, a response rate of over 60% is generally considered a representative sample(179), 
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and we achieved 73%. While the workshops themselves were concentrated in only four 
countries, there was a wide geographical variation amongst those who attended which should 
enhance the generalisability of our results. Although no restrictions were placed on registration 
there may have been a spectrum bias. Radiologists are more likely to be aware of ESGAR 
workshops than gastroenterologists or radiographers. Advertising is aimed primarily at the 
radiological literature with discounts available for society members. These factors may explain 
the very low number of gastroenterologists attending the workshops.  
 
In summary, this survey suggests that hands-on educational CTC workshops primarily attract 
radiologists, with limited interest from other groups. Participants are generally inexperienced 
and untrained but, despite this, a significant proportion is actively interpreting CTC in their 
daily practice, which gives rise to considerable concern.  
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CHAPTER 4  
4. SYSTEMATIC REVIEW: SOURCES OF BIAS IN STUDIES OF DIAGNOSTIC TEST ACCURACY   
 
 
AUTHOR DECLARATION 
Work presented in this Chapter was led by the Author under the supervision of Professor Steve 
Halligan and Professor Stuart Taylor with significant statistical contributions from Dr Susan 
Mallett and Professor Douglas Altman. The author designed the literature search strategy, 
performed the systematic review, extracted data and drafted the manuscript. This research has 
been published in: Boone D, Halligan S, Mallett S, Taylor SA, Altman DG. Systematic review: bias 
in imaging studies - the effect of manipulating clinical context, recall bias and reporting 
intensity. Eur Radiol. 2012; 22(3):495-505. 
 
 
4.1 INTRODUCTION 
Studies of diagnostic test performance should be designed to minimise bias, a principle that 
underpins guidance for both reporting (180) and appraising the quality of diagnostic test 
research (181, 182). At the same time, study results should ideally be generalisable to everyday 
clinical practice. Balancing bias against generalisability is not straightforward. For example, in 
order to reduce the risk of clinical review bias, it is generally accepted that study observers 
should be blind to prior investigations (183). However, concealing information contrasts with 
daily practice where patients’ clinical history, examination and prior investigations are known 
to the observer when formulating a diagnosis. Particularly in the fields of radiology, 
histopathology and endoscopy, test interpretation involves a significant subjective element that 
could be influenced by methods which manipulate the clinical context.  
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In addition to individual patient information, study observers are often unaware of sample 
characteristics, notably disease prevalence. This issue is potentially important when assessing 
diagnostic tests intended for screening: In daily practice, observers will expect asymptomatic 
patients to have low likelihood and lower stage of disease (i.e. more subtle pathology). 
However, it is unclear how the observer’s a priori expectations influence subsequent 
interpretation, if at all: Some studies have found diminished vigilance when prevalence is low 
(184) while clustering of abnormal cases in high prevalence situations may also bias 
interpretation (185). Nevertheless, studies of diagnostic test accuracy usually increase the 
prevalence of abnormality to achieve adequate statistical power within a feasible study size 
(23, 186). Therefore, results of studies performed in the ‘laboratory’ may not be transferable to 
lower prevalence, screening populations in ‘the field.’ 
 
Other pragmatic issues may also influence generalisability. For example, in order to complete 
research within a reasonable time-scale, reporting intensity (the number of cases reported 
within a given timescale) frequently exceeds normal practice and is often exacerbated by the 
requirement to re-evaluate cases under different conditions (e.g. when comparing MR to CT) 
(23) or on more than one occasion (e.g. with and without computer aided detection). 
Moreover, because it is widely believed that prior exposure will influence subsequent 
interpretation (observer recall bias), it is recommended that consecutive interpretations are 
separated by a ‘washout phase’ (187). However, the ideal duration is unknown and there is 
little evidence that such procedures are effective or necessary. 
 
While these potential ‘laboratory effects’ (188, 189) have been discussed in the methodology 
literature(185, 189-192), their impact remains unverified. In order to attempt to quantify their 
magnitude, we performed a systematic review of studies where the context of interpretation 
was manipulated or investigated (i.e. ‘laboratory’ versus ‘field’). In particular, we wished to 
investigate the effect of varying sample characteristics, for example, enriching disease 
prevalence or increasing reporting intensity. Moreover we aimed to explore the effect of 
concealing sample information (especially prevalence) from observers. We were also interested 
in studies that addressed ‘memory effect’ due to observer recall bias.  
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4.2 METHODS 
4.2.1 DATA SOURCES AND SEARCH STRATEGIES 
 
The author searched the biomedical literature to March 2010 using three complementary 
search strategies. A primary search identified any existing systematic reviews dealing with our 
research questions (Table 8).  
Table 8:  Primary search strategy: Search for related systematic reviews using six keywords or phrases 
identified by hand-searching the ten ‘key publications’ described in Table 9. 
Keyword /phrase queried through Pubmed  
using the ‘systematic(sb)’ systematic review filter 
Total abstracts 
(including duplicates) 
Full text examined for  
relevance 
   
Report* & intens*  123 1 
Recall &bias 71 1 
Prevalen* 5142 44 
Prior & knowledge 301 2 
Lab*& effect* 45 1 
Clinical & info* 368 6 
Additional relevant references  via ‘snowballing’   1 
Total 6050 56 
Articles for data extraction following application of selection criteria  1 
 
Because our review was not restricted to a specific test, diagnosis or clinical situation (which 
would facilitate keyword identification), we initiated our search by identifying 10 key 
publications (185, 188, 193-200) known to the authors in the fields of radiology, medical 
statistics and image perception, that had dealt with case-specific information (Table 9). 
Relevant keywords/phrases identified from these 10 articles were; clinical information; recall 
bias; intensity; prevalence; prior knowledge; and laboratory effect. The MEDLINE database was 
then searched via PubMed (http://www.nlm.nih.gov/pubmed) applying the systematic review 
filter to each term in turn. ‘Snowballing,’ an iterative process for searches of complex material 
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(201), identified potentially relevant publications by reintroducing new key words, repeating 
the process until no new relevant material emerged. 
 
Table 9:  Secondary search strategy: Details of the 10 ‘key publications’, the related record search, and 
the number of publications citing each key publication. 
Key publication Number of references 
cited by key publication  
Related record search for 
publications with ≥2 references in 
common with the key publication 
Number of articles citing 
key publication 
Kundel, 1982(199) 2 279 15 
Swensson, 1985 (200) 7 567 39 
Berbaum,1988a (195) 12 232 45 
Berbaum1988b (196) 5 152 42 
Berbaum,1989 (194) 8 59 25 
Good, 1990(198) 8 86 37 
Samuel, 1995 (193) 10 92 36 
Aideyan, 1995 (194)  9 67 16 
Egglin, 1996(185) 16 544 63 
Gur, 2008 (188) 5 335 15 
    
Total abstracts reviewed 
Full texts examined 
Full texts included 
82 
2 
0 
2413 
27 
4 
333 
5 
2 
 
A secondary search was performed to, A) identify indexed literature that shared two or more of 
the references cited by the 10 key publications and, B) identify all indexed literature citing a key 
publication (using ‘related records’ and ‘citation map’ searches through Web of Knowledge - 
http://www.isiknowledge.com). Citations were collated, duplicates eliminated and abstracts 
reviewed (or titles if abstracts were unavailable) for potential inclusion (Table 9).  
Lastly a tertiary search (Table 10) was initiated by retrieving Medical Subject Heading (MeSH) 
terms from each potentially relevant publication identified by the primary and secondary 
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searches. Terms were ranked in order of frequency and terms likely to be non-discriminatory 
excluded (e.g. adult, male, female, mammography, CT). Multiple suffixes (e.g. radiology, 
radiological) were substituted by a truncated heading (e.g. radiol*). Related disciplines (e.g. 
histopathology, endoscopy) were linked with ‘OR’ operators. Ultimately there were three 
‘modality’ terms (endoscop*, radiol* and (cyto* OR histo* OR patho*)) and six ‘manipulation’ 
terms (prevalen*, attention, Bayes theorem, bias*, observer varia*, and research design), 
which were paired using the ‘AND’ operator. MEDLINE was searched using these strings using 
the ‘diagnosis’ option in the ‘Clinical Queries’ filter. Duplicates were excluded and abstracts 
examined (Table 10). Potentially relevant publications were expanded using the secondary 
search strategy previously described and any new publication introduced using snowballing 
(201). 
The search strategies were tested: The secondary search identified all 10 key publications. The 
tertiary search identified all articles from which the MeSH headings had been compiled, and 7 
of the 10 key publications. 
 
4.2.2 INCLUSION CRITERIA 
English language studies to March 2010 inclusive were eligible if they investigated the effect of 
experimentally modifying the context of observers’ interpretations on diagnosis. In particular, 
the effects of varying disease prevalence, blinding to sample characteristics, reporting intensity, 
and studies investigating recall bias. Studies exploring artificial ‘laboratory’ conditions on 
outcome were also eligible. However, we excluded studies whose focus was manipulation of 
case-specific information (e.g. concealment of individual-patient information) since this has 
been investigated previously by systematic review(183). Participants were human observers 
(interpretation solely by computer-assisted detection was excluded), making subjective 
diagnoses based on interpretation of visual data, blind to reference results. Studies were 
excluded if the number of observers or cases interpreted was unreported. There was no 
restriction to disease type. We anticipated most studies would be radiological, but subjective 
interpretation of any medical image (e.g. endoscopy, histopathology) was eligible. Non-medical 
interpretation was excluded (e.g. airport security X-ray), as were narrative reviews.  
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Table 10:  Table detailing the Boolean search strings used for the tertiary search strategy and the 
number of individual abstracts identified by each term, with details of the full texts subsequently 
examined. 
‘Modality'  MeSH term  ‘Manipulation' MeSH 
term 
Total Abstracts 
(including 
duplicates) 
Full texts 
retrieved 
(Duplicates 
removed) 
Full text examined 
for relevance 
      
 & Attention 25 1 0 
 & Bayes theorem 6 0 0 
Endoscopy1 & bias* 84 8 3 
 & observer variation 86 3 0 
 & prevalen* 64 2 0 
 & research design 69 1 1 
      
 & Attention 2 1 1 
 & Bayes theorem 0 0 0 
Radiology2 & bias* 708 14 1 
 & observer variation 699 36 0 
 & prevalen* 89 5 2 
  & research design 185 10 0 
      
 & Attention 4 0 0 
 & Bayes theorem 21 1 0 
Pathology3 & Bias 96 3 3 
 & observer variation 19 10 2 
 & prevalen* 131 14 0 
 & research design 81 2 0 
   2369 111 13 
Selection criteria applied  
Additional references via 
‘snowballing’  
    3 
2 
Total for data extraction     5 
Search String: Endoscopy1 =(endoscop*(MH));   Radiology2 =  (radiol* (MH));  Pathology3 = ((cyto* OR histo* OR patho*)(MH)) 
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4.2.3 DATA EXTRACTION 
The author extracted data from the full-text articles consulting Professors Halligan and Taylor, 
who are both experienced in systematic review, if uncertain. Differences of opinion were 
resolved by consensus. Data were extracted into a data-sheet incorporating measures 
developed from QUADAS(181) and QAREL(182), with additional fields specific to the review 
question. The following was extracted: Author, Journal; imaging modality; topic; number of 
observers/cases and their characteristics (e.g. professional background and experience); 
reference standard; case and observer concealment of population characteristics; blinding 
observers to study participation and purpose; reporting intensity; washout period; prevalence 
of abnormality and whether this varied; data clustering (grouping of normal/abnormal cases). 
 
4.3 RESULTS 
The primary search (Table 8) found 6050 abstracts. 56 full articles were retrieved; one was 
suitable(202). The secondary search (Table 9) identified 2828 publications with the full text 
retrieved for 34: ultimately 6 were included (185, 189, 203-206) and 28 rejected because the 
research focused on case-specific information. The tertiary search (Table 10) identified 74 
MeSH terms which were combined into 18 Boolean search strings: These identified 111 
potential articles with a further 2 via snowballing; 5 articles were ultimately included (190, 191, 
207-209). Overall, 11247 abstracts were reviewed, 201 full articles retrieved, and 12 ultimately 
included for systematic review (Table 11).  
 
4.3.1 DESCRIPTION OF STUDIES INVESTIGATING CLINICAL CONTEXT 
Of the 12 identified studies that investigated the effect of manipulating clinical context, 3 
focused on varying the prevalence of abnormality (185, 189, 203). The remaining 9 studies 
investigated observer performance in different situations with fixed prevalence: 4 compared 
performance in the laboratory to daily practice (188, 190, 209); 3 investigated observer 
blinding to previous clinical investigations (206-208); 1 investigated training (204); 1 
investigated varying reporting conditions(202); 1 investigated recall bias (205). The 4 studies 
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that investigated interpretation in ‘the field’ used retrospective data obtained from normal 
clinical practice (188, 190, 202, 209). 1 study recruited from an international conference (207). 
The remaining 7 used a laboratory environment exclusively. 
 
4.3.2 STUDY CHARACTERISTICS AND SETTINGS (TABLE 11) 
The following diagnostic tests were investigated by the 12 included studies: 9 studies were 
radiological (5 mammographic (188, 190, 202, 205, 206), 3 chest radiology (189, 203, 204), 1 
angiographic(185)), 2 endoscopic (207, 209), and 1 histopathological (208). A single research 
group contributed 5 studies (188, 189, 203-205).  
 
4.3.3 PRIMARY STUDY DESIGN 
All primary studies used a design with an independent reference standard excepting a single 
study of observer agreement (208). With the exception of that one study (208), all observers 
were blinded to the research hypothesis. Furthermore, one study (207) used observers who 
were unaware that they were taking part in research. However, despite attempts to overcome 
‘study knowledge bias’ (192) (an area of interest to this review) this was not formally 
quantified, for example by repeating the study with observers who were aware of they were 
participating in research. 
 
4.3.4 OBSERVER AND CASE CHARACTERISTICS (TABLE 11) 
In all primary studies, the observers were medically qualified/board certified with a median of 
8 observers per study (inter-quartile range (IQR) 3.5 to 14, range 2 to 129), with 6 studies 
restricted to observers who were ‘specialists’ (188, 202, 208) or ‘experienced’ (205, 206, 209); 
but only 2 studies (188, 205) quantified this. Five studies included less-experienced observers, 
e.g. residents (185, 189, 203, 204, 207). In one study, the authors did not detail experience 
(190). The median number of cases per study was 300 (IQR 100 to 1761, range 5 to 9520). Case 
selection criteria were well-defined for 9 (75%) studies. Of these, in 4 studies (188, 190, 202, 
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206) recruitment was consecutive, 4 (189, 203, 207, 208) selected cases for optimal technical 
quality, and 1 (205) selected ‘stress’ cases (specifically, cases misinterpreted previously in 
clinical practice). In all 12 studies technically acceptable material was used, e.g. genuine 
radiographs, video endoscopy. 
 
4.3.5 EFFECT OF SAMPLE DISEASE PREVALENCE (TABLE 12) 
Three articles investigated the effect of varying the prevalence of abnormality on observers’ 
diagnoses (Table 12). The earliest (185) investigated context bias (to determine if clustering of 
abnormal cases influenced interpretation of subsequent cases), finding that sensitivity for 
pulmonary embolus increased significantly (from 60% to 75%) when prevalence was increased 
from 20% to 60% (7). Two studies by Gur and colleagues (189, 203) increased the prevalence of 
subtle chest radiographic findings from 2% to 28% in a sample of 3208 cases read by 14 
observers of varying experience, in a laboratory environment. While no significant effect on 
observer performance (via ROC AUC) was demonstrated (189), reader confidence scores 
increased at higher prevalence levels (203). However, the effects on sensitivity, or indeed the 
ROC curve itself were not addressed. Furthermore, the maximum prevalence used was 28% but 
researchers frequently increase prevalence far beyond this level: 6 (50%) studies in this review 
used prevalence between 50 and 100% (23, 185, 204, 207-209).  
 
4.3.6 EFFECT OF BLINDING OBSERVERS TO DISEASE PREVALENCE (TABLE 12)  
Of the 12 primary studies reviewed, 8 (66%) concealed the prevalence of disease from 
participants. One mammographic study(188), informed observers that the prevalence of 
abnormality in the sample was enriched (while concealing the exact extent and proportion) but 
that BiRads ratings should be assigned as if reading in a screening environment. Of the 
remaining three studies, observers were told the sample prevalence (205), aware of prevalence 
because they designed the study (208), or aware of prevalence because the entire study was 
performed in the clinic (202).  
8 5  
 
Table 11:  Details of the 12 publications included in the systematic review. 
Publication Diagnostic test assessed 
and condition tested 
Research focus and relevance to the 
review 
Sample 
size 
Case sample selection   
 
Sample prevalence 
of abnormality 
Observer 
Sample 
size 
Observer 
qualification and 
experience 
Observer blinding to 
prevalence of disease  
Summary of findings 
Gur 
1990(204) 
Chest radiography: Lung 
nodules, interstitial 
disease and 
pneumothorax 
Laboratory effect; The effect of 
training observers to use the extent 
of the ROC scale in observer studies 
300 Unclear Enriched; 80% 4 Board certified, 
variable experience 
 
Yes No significant training affect for detecting 
interstitial disease and pneumothoraces. 
Accuracy of Lung nodule detection was affected 
for two readers and the overall accuracy 
increased for one reader. 
Egglin 
1996(185) 
Pulmonary angiography: 
Pulmonary emboli 
 
Tests prevalence effect, context bias. 
Effect of deliberate clustering of 
abnormal cases during observer 
interpretation of enriched datasets.  
24 Unclear Enriched; 20% or 
60% 
6 Board certified, 
variable experience 
Yes Enriching prevalence from 20% to 60% led to an 
increase in observer  sensitivity from 60% to 75%.  
Rutter 
2000(190) 
 
Mammography: 
Breast cancer 
Lab vs field, population blinding, 
prevalence effect.  
1890 in 
clinic 
120 in 
lab 
Consecutive for field 
cases. Characteristics 
of laboratory cases 
unclear 
Enriched;25% in ‘lab’ 
cases 
Population 
prevalence in ‘field’ 
cases 
27 Board certification 
implied 
Yes Mean sensitivity and specificity are both higher in 
routine practice compared to an artificial 
research setting. 
 
Meining 
2002(209) 
 
Endoscopic ultrasound: 
Oesophageal and 
pancreatic cancer 
 
Lab vs field, effect of blinding. 
Performance of interpretation in 
artificial setting both with and 
without prior information 
100 Unclear Enriched; 
100% in ‘lab’ cases, 
but not in ‘field’ 
cases 
 
2 Board certified, 
Experienced  
 
Yes Observer performance was reduced in the 
research setting compared to interpretation in 
the clinic but this effect was reduced when 
observers were unblinded to prior information. 
Gur, 
2003(189) 
Imaging, radiography: 
Lung nodules, fractures 
pneumothorax and 
consolidation  
Prevalence effect, blinding to 
population characteristics. Effect of 
deliberately enriching prevalence of 
abnormality 
1632 Selected for optimum 
quality 
Enriched,  
2 to 28% 
14 Board certified, 
variable experience 
 
Observers instructed to 
consider the cases as 
screening tests. Yet 
prevalence up to 25% 
No significant increase in sensitivity when 
observers report studies in a sample with 
prevalence enriched up to 28% 
Burnside, 
2005(202) 
Mammography: 
Breast cancer 
Reporting intensity; Effect of 
changing clinical reporting 
environment to high intensity 
9522 Consecutive Population risk; 
0.05% 
5 Board certified, 
specialist 
No; known screening 
population 
Recall rates were 20.1% before and 16.2% after 
the introduction of high intensity batch reading. 
Cancer detection rates were not significantly 
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 reading different. 
Hardesty, 
2005(205) 
Mammography: 
Breast cancer 
Memory effect, recall bias. 
Effect of reading cases which had 
been previously interpreted in the 
past and recall of those cases 
182 Difficult to interpret 
cases only (previously 
incorrectly reported)  
 
5%, enriched 
compared with 
screening population 
8 Board certified, 
Experienced 
7-20 years 
Observers correctly 
informed the population 
was enriched 
No significant difference in average performance 
between mammograms observers had 
interpreted in clinic and those they had not. 7 out 
of 8 observers did not remember previously 
interpreting any of the mammograms 
Irwig 
2006(206) 
 
Mammography, and 
ultrasound: Breast cancer 
Blinding. Interpretation bias due to 
incorrect interpretation of test 
results in the light of contextual 
information.  
 
480 Consecutive Enriched; 
50% 
2 Board certified, 
Experienced  
 
Yes Blind analysis of USS read with mammography was 
4.6% higher than without mammography. Comparing 
combined accuracy of mammography and ultrasound 
read with and without prior knowledge showed much 
smaller differences 
Bytzer, 
2007(207) 
 
Gastroscopy: 
Ulceration, gastritis, 
cancer 
Effect of providing misleading 
contextual information. Effect of 
population blinding and ‘study 
knowledge bias’ 
 
5 Attendees at a medical 
conference 
Enriched; 
100% 
129 Board certified, 
variable experience 
 
Yes; observers unaware of 
study participation 
Only 23% observers gave the same diagnosis for 
two identical cases when deliberately misleading 
contextual information was provided. 
Gur 
2007(203) 
Chest radiography: Lung 
nodules, interstitial 
disease and 
pneumothoraces 
Prevalence effect, blinding to 
population characteristics. Effect of 
deliberately enriching prevalence of 
abnormality 
1632 Selected for optimum 
technical quality 
Enriched;  
2 to 28%  
14 Board certified, 
variable experience 
 
Observers instructed to 
consider the cases as 
screening investigations 
yet prevalence up to 28% 
Varying prevalence resulted in no significant bias 
demonstrated in terms of reader accuracy. 
However, observer confidence that a specific 
abnormality is truly present is higher in low (2%) 
than in high prevalence (28%) settings 
Fandel 
2008(208) 
Histopathology: Prostate 
cancer 
Lab vs field bias. Interpretation bias 
due to unavoidable exposure to bias 
inherent in the interpretation 
techniques.  
178 Selected for optimum 
technical quality 
Enriched; 100%  3 Board certified, 
specialist 
 
No; two observers 
involved in study Design 
Blinding pathologists to features present on low 
power in the lab significantly improved accuracy 
of high power field interpretation 
Gur 
2008(188) 
Mammography:  
Breast Cancer 
Lab vs field. Comparison between 
observer performances when lab 
interpretations are compared to 
performance reading the same 
mammograms in the clinic.  
3000 Consecutive Enriched; 25% in ‘lab’ 
cases, population 
prevalence in ‘field’ 
cases 
9 Board certified, 
specialist >3000 read 
per year. 6 to 32 
years experience 
Observers instructed to 
consider the cases as 
screening investigations 
yet prevalence up to 28% 
Mean sensitivity and specificity were both higher 
in the clinic compared to a research setting. 
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Although 2 studies (189) (203) varied the sample prevalence without informing readers, these 
studies did not specifically test the effects of revealing the sample prevalence on observers‘ 
interpretation. Hence the effect of blinding readers to the spectrum of abnormality in the study 
sample remains uncertain. 
Table 12:  Articles investigating the effect of manipulating the prevalence of abnormality on studies of 
diagnostic test accuracy 
Publication Imaging modality Observers blinded to prevalence of 
pathology  in study sample 
Clustering of abnormal 
cases avoided 
Prevalence of abnormality 
in study sample 
 
Egglin, 
1996(185) 
Imaging, 
angiography 
Yes Deliberate clustering of 
abnormal cases  
 
60% or 20% 
Gur, 
2003(189) 
Imaging, chest 
radiographs 
Yes Yes 2-28% 
Gur, 
2007  (203) 
Imaging, chest 
radiographs 
Yes Yes 2-28% 
 
 
4.3.7 EFFECT OF REPORTING INTENSITY (TABLE 13) 
We did not identify any research that specifically manipulated reporting intensity (i.e. burden 
of cases requiring interpretation) in the laboratory or compared it to daily practice. While a 
retrospective analysis of mammography in daily practice found that false-positive diagnoses 
diminished, following implementation of high-intensity, batch-reading (202), the change was 
unquantified. The researchers believed improved performance was due to decreased 
disruption. Of the remaining 11 studies, 6 detailed setting, observer experience, and case-load 
enabling an inference of reporting intensity vs. normal practice (Table 13). Observers each read 
a median of 300 (IQR 100 to 3208) cases at a median rate of 50 (IQR 40 to 50) cases per 
session. One angiographic study (185) stipulated interpretation within three minutes, which 
likely exceeded normal practice. Intensity was either unreported or unclear in 5 studies. No 
article attempted to justify reporting intensity.
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Table 13:  Estimation of reporting intensity and generalisability to daily practice of ‘lab’ studies 
Publication Total number 
of cases read 
per reader 
Reporting intensity Diagnostic test employed in 
test conditions as per clinical 
practice 
Reporting intensity 
and environment 
judged equivalent 
to daily practice 
Gur 1990(204) 300 50 per session ?interval Yes Yes 
Egglin 
1996(185) 
40 Three minutes per angiogram. 
Selected images only reviewed.  
 
Selected images only 
reviewed. No additional views 
available 
No: higher 
Rutter 
2000(190) 
 
120 30 per hour every 2 weeks Yes Yes 
Gur, 2003(189) 3208  >50 per session, fortnightly over 
18 months 
Yes Yes 
Gur 2007(203) 3208  >50 per session, fortnightly over 
18 months 
Yes Yes 
Gur 2008(188) 
  
300 20-60 films per session 
 
Yes Yes 
 
 
 
4.3.8 EFFECT OF OBSERVER RECALL BIAS (FIGURE 14) 
One article investigated recall bias specifically (205), asking observers to reinterpret 
mammograms reported by them in clinical practice 14 to 36 months previously. One observer 
recognised a single mammogram, but subsequently reported it incorrectly. The authors 
concluded that recall is rare and unlikely to bias studies. The same group (189) tested for 2 
week recall via subgroup analysis, finding no effect, but the study was neither designed nor 
powered for this analysis. 8 (66%) studies included repeated observations of the same cases. 
One study(207), did not account for recall bias at all, requiring reinterpretation within minutes. 
The remaining studies incorporated a washout period between observations, with 3 studies 
using between 2 to 8 weeks and 3 indicating 14 to 36 months, and the exact duration unclear 
in 1 article (Figure 14). Moreover, only one article (189) justified the interval and, even then, 
based this upon anecdotal opinion.  
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Figure 14:  Duration and scientific justification of the ‘washout’ interval to reduce observer recall bias 
in studies requiring repeated observations of the same data 
 
 
4.3.9 ‘LABORATORY’ VS. ‘FIELD’ STUDY CONTEXT 
All articles considered aspects of generalisability to daily practice, which was the primary focus 
of 6 articles (Table 4). Three studies (188, 190, 209) compared ‘laboratory’ interpretation with 
observers’ prior interpretation of the same cases in clinical practice. Gur (188) and Rutter (190) 
found higher mean observer sensitivity and specificity in normal clinical practice. However, 
while Meining et al also found improved accuracy in the clinical environment, laboratory 
performance improved significantly when observers had access to clinical information (209).  
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Irwig (206) questioned whether results from standard tests should be revealed when new 
diagnostic alternatives are assessed, believing that observers may give undue weight to 
standard tests with which they are familiar, and so confound the assessment. The authors 
concluded that such practice is acceptable only when the standard test is both sensitive and 
specific. One histopathological study examined whether unavoidable initial viewing of low-
magnification images may bias subsequent interpretation of high-magnification images (208), 
arguing that performance would be diminished if studies were restricted to high-power fields. 
One article (204) explored ‘checkbox’ bias in ROC methodology, concluding that measures 
encouraging readers to use the full extent of confidence scales might itself introduce bias.  
 
 
4.4 DISCUSSION 
We wished to investigate and quantify the effect on diagnostic accuracy results of blinding 
observers interpreting medical images to sample information, including disease prevalence.  
We found that, although manipulation/concealment of individual case information is relatively 
well-investigated, including a 2004 meta-analysis of 14 studies(183), few researchers have 
addressed information relating to the study sample. Our systematic review identified only 12 
primary studies (9 radiological) that investigated generalisability of results from laboratory 
environments to daily practice and, of these, only 3 focused specifically on prevalence (185, 
189, 203), 2 from the same research group. Furthermore, only 2 modalities have been 
investigated, angiography (185) and chest radiography (189, 203). The literature base is 
therefore very insubstantial indeed. We had originally intended to perform a meta-analysis to 
quantify the effect of the potential biases investigated, but the paucity of available data 
prevented this. 
 
Enriched prevalence may be an unavoidable aspect of study design, in order to complete within 
an acceptable timeframe, within available resources and without undue observer burden. It is 
important to distinguish between two potential reasons why prevalence might affect 
sensitivity: Firstly, high prevalence clinical settings are often associated with a more severe 
disease spectrum, which in itself, will increase sensitivity. Secondly, prevalence may be 
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increased without an increase in disease severity, a situation often encountered in research 
studies, especially of screening technologies. In this latter situation, it is uncertain how 
increased prevalence will affect study results. For results to be generalisable we must know the 
effect, if any, of these enriched study designs on measures of diagnostic test performance, and 
to what degree and in what direction. It is widely believed that increasing prevalence raises 
sensitivity because disease is encountered more frequently than in daily practice (199); a view 
supported by Egglin et al(185). However, it is only where an increased prevalence is associated 
with an increase in disease severity that there are theoretical reasons to expect prevalence to 
affect the ROC curve(210). It is important to note that although Gur et al did not demonstrate a 
significant difference in ROC AUC, despite varying prevalence(189), it does not necessarily 
follow that a prevalence effect does not exist. Indeed the authors cautioned in a separate 
editorial(191) that while results obtained in enriched populations should be generalisable to 
lower prevalence lab-based studies (provided they were analysed using ROC AUC methods), 
this is not the case for clinical practice. In addition, it is important to consider that while the 
maximum prevalence was 28%, this level is still well below that often employed by researchers. 
 
Our interest in sample prevalence was precipitated by studies of CTC for colorectal cancer 
screening but we could find no research that addressed the design of these studies. Screening 
for lung and colorectal cancer by CT, and for breast cancer by mammography, are the subject of 
considerable primary research but it is currently impossible to draw evidence-based 
conclusions regarding the effect of sample prevalence on measures of diagnostic test accuracy.  
 
It is intuitive that observers’ prior knowledge of sample prevalence in a study will influence 
their expectation of disease and we were interested whether this might affect measures of 
diagnostic accuracy. For example, it is believed that vigilance is reduced in situations where 
expected (and actual) prevalence is low (e.g. screening), because disease is encountered 
infrequently (211). Surprisingly, we could identify no research that specifically addressed this 
issue, either by blinding/unblinding, or by misleading readers. Most studies concealed 
prevalence altogether whereas some altered prevalence, but without readers’ knowledge. 
Recall bias (i.e. where interpretation is influenced by recollection of prior interpretations) is a 
related issue. Many studies incorporated a ‘washout’ phase between consecutive 
interpretations of identical cases but we could find no research that specifically investigated the 
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impact of varying the duration of the washout phase. It could be argued that the repetitive 
nature of screening (in terms of material and task) argues for short washout. Indeed, one study 
concluded recall bias does not exist (205). We could find no research that specifically addressed 
the effect of manipulating reporting intensity on measures of diagnostic test performance.  
 
Although anecdotal opinion suggests that observers’ performance in an artificial ‘laboratory’ 
environment (reviewing cases enriched with pathology, remote from the pressures of normal 
daily practice) should exceed that achieved in ‘the clinic,’ the available evidence identified by 
our review (188, 190, 209) actually suggests the opposite. The fact that clinical information is 
available in normal practice might help explain this but meta-analysis suggests the effect is 
small(183). Another possible explanation is that observers in laboratory studies are aware their 
assessments will have no clinical consequences; ‘study knowledge bias’ is also likely to 
influence observer studies but we found no research to substantiate this. Lastly, a substantial 
reporting burden associated with research studies (often performed at unsocial hours so as to 
not interfere with normal duties) may explain why accuracy is diminished. This discrepancy 
between ‘lab’ and ‘field’ performance has important implications, not only for evaluation of 
diagnostic tests, but also for how radiologists’ performance is assessed in isolation. For 
example, the PERFORMS programme for evaluating mammographic interpretation uses a 
cancer prevalence of 22%(212) and so may not reflect radiologist performance in clinical 
practice. Toms et al suggested a more accurate assessment would be obtained by sporadically 
introducing abnormal test cases into normal daily reporting (213) 
 
Our review revealed that the existing evidence-base is too insubstantial to guide many aspects 
of study design. High-quality research is needed to investigate and quantify the biases we 
investigated. Inevitably, studies specifically designed to answer the questions we posed will be 
expensive and time-consuming. For example, most studies we identified used observer 
samples in the single digits and variance is likely to be high; much larger studies are required. 
The authors predict that funding would be difficult to achieve for large-scale methodological 
research specifically designed to quantify these potential biases. However, given that funding 
agencies have previously provided very substantial support for large-scale studies of screening 
technologies, the authors suggest that future studies incorporate additional research that aims 
to estimate bias and generalisability. For example, this could be achieved via sub-
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studies/parallel/nested studies that incorporate unblinded observers, different contexts, or by 
varying the duration of washout period for different groups of observers. Such an approach 
would combine large-scale diagnostic test accuracy studies with methodological research for 
relatively little additional cost.  
 
Our review does have limitations. In particular, relevant research may have been missed 
because of a lack of search terms specific to our review question. For example, many papers 
will discuss potential bias but few will test this as a primary outcome. Aware of this, we used 
multiple search strategies and snowballing to maximise studies retrieved. Even so, the total 
body of relevant literature we identified was rather small and was heterogeneous in the issues 
addressed.  
 
In summary, this systematic review revealed that several issues central to the design of studies 
of diagnostic test accuracy have not been well-researched, with the result that there is an 
insufficient evidence-base to guide many aspects of study design. High quality research is 
needed to address potential bias resulting from observers’ knowledge of prevalence and the 
effects of recall bias across several imaging technologies and diseases, most notably for studies 
of screening methodologies. 
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SECTION C:  
IMPLEMENTING NEW 
TECHNIQUES AND 
STRATEGIES IN CTC 
RESEARCH  
 
OVERVIEW 
Section A established there is a relatively sound evidence base for current CTC implementation. 
However, Section B has shown that commonly utilised methodology for assessing diagnostic 
test accuracy may introduce presently unquantified sources of bias that may encumber 
transferability into daily practice. Furthermore, at present, the suboptimal level of CTC training 
and experience among European radiologists may impact upon the generalisability of such 
studies’ results. Although consensus guidelines(30, 36) recommend a minimum level of 
experience for safe CTC interpretation, the relationship between performance and experience 
is not straightforward(214); this is the focus of this Section.  
 
Studies have shown CAD can increase reader sensitivity for both inexperienced radiologists 
(215) and radiographic technicians (159) but the potential benefit to patients in clinical practice 
is poorly understood, not least due an accompanying increase in false positive (FP) detections. 
When sensitivity and specificity change simultaneously, as is usually the case(216), a summary 
statistic combining both measures is convenient for comparing results from different research 
studies. For example, the area under the receiver operating curve (ROC AUC) could be 
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compared for observers interpreting CTC with and without CAD assistance. However, the 
limitation of this technique is that gains in sensitivity are considered statistically equivalent to 
losses in specificity when both are equal in magnitude yet the clinical consequences of FP and 
FN detections (e.g. unnecessary colonoscopy vs. missed cancer diagnosis) are clearly far from 
equal. Therefore, if an increase in sensitivity due to CAD assistance is counterbalanced by an 
equivalent fall in specificity, there will be no significant difference in ROC AUC, potentially 
underestimating the benefit of this technology in clinical practice(24). In order to account for 
different clinical utilities of FP and FN diagnoses, collaborators, Dr Susan Mallett and Professor 
Douglas Altman have developed a novel statistical analysis as an alternative to ROC AUC: the 
‘CAD net effect measure’ (21).  
 
CAD net effect = ΔSE + (ΔSP · (1/W) · ((1 – P)/P))) 
 
P denotes the prevalence of abnormality within the sample. 
W denotes the relative ‘weighting’ ascribed to the clinical value of sensitivity vs. specificity.  
 
However, the value of ‘W’ is not presently quantified with precision. While qualitative research 
suggests patients and clinicians value sensitivity far above specificity, existing quantitative 
assessments have not assessed willingness to trade these attributes against one-another. 
Therefore, Chapter 5 describes a conjoint analysis (discrete choice experiment) to ascertain the 
relative value clinicians and patients place upon sensitivity and specificity when using CTC for 
colorectal cancer screening. Having established the weighting value ‘W’, Chapter 6 implements 
the novel statistical method to compare the incremental benefit of CAD when employed by 
experienced and inexperienced observers during two previous multireader, multicase studies. 
 
The results of Chapter 6 reaffirm the complex relationship between experience and 
performance. However, differences in interpretative technique between readers remains 
poorly understood. Medical image perception has featured extensively in plain radiographic 
research (18) yet eye-tracking technology has not previously been applied to 3D radiological 
image display. Therefore, Chapter 7 concludes this Section with a technical description and 
preliminary evaluation of novel eye-tracking methodology to assess differences in visual search 
during CTC interpretation.  
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CHAPTER 5  
5.  WHAT IS THE RELATIVE IMPORTANCE PLACED ON FALSE POSITIVE VS TRUE POSITIVE 
DETECTIONS AT CTC? A DISCRETE CHOICE EXPERIMENT 
 
 
AUTHOR DECLARATION 
Work presented in this Chapter was led by the author under the supervision of Professor Steve 
Halligan and Professor Stuart Taylor with significant contributions from Dr Susan Mallett, 
Professor Douglas Altman and Professor Richard Lilford. The author obtained ethical approval, 
designed and piloted the discrete choice experiment, compiled survey software, and recruited 
and interviewed participants. Approximately 50% of interviews were performed by 
psychologist, Miss Nichola Bell. Statistical analysis was performed by the author and Dr Susan 
Mallett with contributions from Dr Shihau Zhu and Dr Lily Yao. 
 
Abstracted data have been published in:  Boone D, Halligan S, Bell N, et al. How do patients and 
doctors weight the relative importance of false-positive and false-negative diagnoses of cancer 
by CT colonography: Discrete choice experiment. Insights into Imaging. 2012; 3 (suppl 2):455-
503. A journal article is currently under consideration for indexed publication: Boone D, 
Halligan S, Mallett S, et al. Patients’ and healthcare professionals’ preferences regarding false 
positive diagnosis during colorectal cancer screening with CT colonography: Discrete choice 
experiment.  
 
 
5.1 INTRODUCTION 
Understanding the diagnostic performance of a test is essential for evidence-based practice 
(182, 217), particularly for screening where risks and benefits must be balanced carefully(187). 
No screening test is 100% sensitive and disease may be missed. Consequences of imperfect 
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sensitivity are readily understood: A false-negative (FN) diagnosis may delay or prevent cure. 
Specificity is also important for screening because prevalence of abnormality is low. Therefore, 
while relatively few will benefit from early detection, many healthy individuals may undergo 
procedures such as endoscopy, biopsy or surgery because of a false-positive screening result. 
False-positive (FP) diagnoses cause anxiety, morbidity, and even mortality, all for no 
benefit(218). Test modifications that increase sensitivity usually diminish specificity. For 
example, CAD (219), digital imaging(220), and a shorter interval between screenings(221) all 
increase mammographic sensitivity for breast cancer but decrease specificity.  
 
As described above, a combined measure of sensitivity and specificity, such as the area under 
the receiver-operating-characteristic (ROC) curve, facilitates comparisons between different 
tests or tests under different conditions (187, 210, 222, 223). The ROC curve displays 
graphically how sensitivity and specificity change with the test result; regulatory bodies may 
require a significant increase in area-under-the-curve (AUC) to approve a new imaging test. 
When calculating curve shape and AUC, similar changes in sensitivity and specificity are 
weighted equally. For example, if an increase in sensitivity (e.g. from use of CAD) is offset by an 
identical decrease in specificity, net AUC may not change, and the new intervention could be 
judged ineffective. However, although similar changes in sensitivity and specificity assume 
equal statistical importance, they may not be clinically equivalent.  
In the case of screening for colorectal cancer with CTC, qualitative work suggests that patients 
value sensitivity over specificity(33), but the magnitude of that preference is unknown. Such 
data are important because analyses not accounting for differential weightings may 
underestimate test value. For example, the Medicaid/Medicare decision to not reimburse CTC 
did not consider that gains in sensitivity over alternative tests may be regarded more positively 
by screenees even when specificity is reduced (131).  
Net-benefit methods offer an alternative combined measure to ROC AUC and have the 
advantage of being able to incorporate clinically relevant relative values for TP versus FP 
diagnoses(24) but these values have not been determined for colorectal cancer screening. 
Accordingly, we aimed to establish the relative weighting given by patients and healthcare 
professionals to additional TP diagnoses versus additional FP diagnoses when using CTC for 
colorectal cancer screening. 
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5.2 METHODS 
Ethical committee approval was granted; all participants gave written informed consent. 
Participants’ opinions were elicited using a discrete choice experiment (DCE)(224-226), 
designed and conducted according to recent guidelines(226). Scenarios encompassing paired 
hypothetical tests were presented and specificity systematically varied, asking participants to 
indicate their preference. We then ascertained the relative value participants ascribed to 
sensitivity and specificity.  
5.2.1 CHOICE OF ATTRIBUTES AND LEVELS 
Specificity is conceptually challenging for patients; many are unaware that FP detections occur 
(32). It is also known that patients value sensitivity so highly that even small changes may mask 
the influence of other attributes(226). We therefore used a ‘probability equivalence’ design to 
establish respondents’ attitudes to just two attributes: Sensitivity and specificity. We devised a 
hypothetical ‘alternative’ screening test differing from ‘standard’ CTC only in sensitivity and 
specificity. No other attributes were changed, to simplify/focus decision-making. 
For ‘standard’ CTC we chose sensitivity and specificity for cancer of 0.85 and 0.95 respectively 
and 0.80 and 0.85 for polyps ≥6mm. ‘Alternative’ CTC raised sensitivity to 0.95 for cancer and 
0.90 for polyps. These values were arrived at because we wished to present a relative 
difference in sensitivity of 0.10 but did not wish the ‘alternative’ test to be perfect, since this is 
rarely achieved. Screening data suggest 0.2% cancer prevalence (i.e. 10 patients per 5000 
screened) (227) and 25% polyp prevalence (i.e. 1250 patients per 5000 screened) (228, 229), 
thus increasing sensitivity by 0.10 detects one additional cancer and 125 additional polyps per 
5000 screenees. We then varied specificity of ‘alternative’ CTC incrementally from 0.95 down 
to 0.10 to form test scenarios presented (Table 14). Such extremely low specificity is unlikely in 
real practice but necessary to calculate ‘trade-off values’ for the DCE.  
 
5.2.2 INFORMATION PROVISION 
Because DCEs are difficult to comprehend, especially via postal questionnaires (230), for 
patients an interviewer-led face-to-face design was used to maximise participant spectrum 
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(231). A multimedia presentation of colorectal cancer screening by colonoscopy and CTC was 
presented on a laptop, including information on survival benefit and clinical consequences of 
FP diagnosis (e.g. need for colonoscopy following CTC; risk of perforation). Since inconsistent 
framing may introduce bias (232), both absolute and relative risks were displayed textually and 
graphically (Figure 15).  
Table 14:  Discrete choice experiment design: Overview of attributes and levels presented in cancer (A) 
and polyp (B) detection scenarios. 
  A: CANCER DETECTION SCENARIO 
Question 
number 
‘STANDARD’ CTC 
Baseline diagnostic 
performance 
‘ALTERNATIVE’ CTC 
Increased sensitivity but 
variable specificity 
PARTICIPANT TRADE-OFF REQUIRED IN EXCHANGE FOR 0.1 
INCREASE IN SENSITIVITY 
 
 Sensitivity 
for 
detection 
of cancer 
(%) 
Specificity 
for 
detection 
of cancer 
(%) 
Sensitivity 
for 
detection 
of cancer 
(%) 
Specificity 
for 
detection 
of cancer 
(%) 
Change in 
specificity 
compared to 
baseline           
(%) 
Additional FP 
detections per 
5000 screening 
examinations 
Additional true 
positive detections 
per 5000 screening 
examinations 
1c 85 95 95 95 0 0 1 
2c 85 95 95 95 0 0 1 
3c 85 95 95 90 5 250 1 
4c 85 95 95 80 15 750 1 
5c 85 95 95 70 25 1250 1 
6c 85 95 95 50 45 2250 1 
7c 85 95 95 40 55 2750 1 
8c 85 95 95 30 65 3250 1 
9c 85 95 95 20 75 3750 1 
10c 85 95 95 10 85 4250 1 
 
Questions 1 to 10 are delivered in random order using an interactive multimedia presentation which displays the diagnostic 
performance data of both tests graphically and numerically. Please see Figure 15 
*Questions 1 and 2 both favour test B for both sensitivity and specificity. Respondents choosing test A in response to both 
questions are considered to have misunderstood the task. 
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Table 15:  Discrete choice experiment design: Overview of attributes and levels presented in cancer (A) 
and polyp (B) detection scenarios. 
 
  B: POLYP DETECTION SCENARIO 
Question 
number 
‘STANDARD’ CTC 
Baseline diagnostic 
performance 
‘ALTERNATIVE’ CTC 
Increased sensitivity but 
variable specificity 
PARTICIPANT TRADE-OFF REQUIRED IN EXCHANGE FOR 0.1 
INCREASE IN SENSITIVITY 
 
 Sensitivity 
for 
detection 
of polyps 
(%) 
Specificity 
for 
detection 
of polyps 
(%) 
Sensitivity 
for 
detection 
of polyps 
(%) 
Specificity 
for 
detection 
of polyps 
(%) 
Change in 
specificity 
compared to 
baseline           
(%) 
Additional FP 
detections per 
5000 screening 
examinations 
Additional TP 
detections per 
5000 screening 
examinations 
1p* 80 85 90 90 -5 -250 125 
2p 80 85 90 85 0 0 125 
3p** 80 85 90 80 5 250 125 
4p 80 85 90 80 5 250 125 
5p 80 85 90 70 15 750 125 
6p 80 85 90 60 25 1250 125 
7p 80 85 90 50 35 1750 125 
8p 80 85 90 40 45 2250 125 
9p 80 85 90 30 55 2750 125 
10p*** 80 85 90 20 65 3250 125 
 
**Questions 4 and 5 are identical and hence this is a test for internal consistency. 
***Participants choosing ‘Alternative’ CTC in response to question 10 are considered potential non-traders: Rather than disregard 
these responses, additional information is displayed and the question repeated.  
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Figure 15:  Example question from the cancer detection scenario. Each tally mark represents one of 
5000 potential outcomes for a patient undergoing screening: TP (blue), FN (yellow), true negative 
(white), or FP (red).  Participants were informed that if they were to undertake the test in question, 
their odds of receiving any of the above outcomes are represented by the chance of picking any of 
these tally-marks at random. Data are also represented numerically using both relative and absolute 
percentages. This question represents the median ‘trade-off’ for patients and professional 
respondents: On average, participants favoured ‘alternative’ CTC in view of its enhanced sensitivity up 
to, but not beyond, this level of additional FPs; where scenarios presented a lower specificity patients 
usually opt for ‘standard CTC’ 
 
5.2.3 EXPERIMENT CHARACTERISTICS 
For both cancer and polyp detection scenarios, participants were asked to assume they were 
average risk: Polyp prevalence 25%, cancer prevalence 0.2% (lifetime risk 5%). Participants 
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were asked to assume more timely polypectomy due to enhanced sensitivity would reduce 
lifetime disease-specific mortality by 25% (lifetime risk of 5% to 4%) (233).  Participants were 
asked to assume that while early cancer detection facilitated early treatment(234), this was not 
always curative. Subjects were told that FP CTC resulted in unnecessary colonoscopy. For 
clarity, only the most serious complication was presented, perforation, at 1:500 risk, based on 
combined North American and European estimates (3, 235). 
 
5.2.4 PILOT 
To inform design and sample size (236) the questionnaire was piloted on 10 ‘naïve’ staff. 
Although they comprehended attributes and levels, and completed the DCE without undue 
burden, we noted some did not trade (i.e. the lowest level of specificity presented was judged 
acceptable in exchange for 0.10 gain in sensitivity). We therefore introduced additional 
information reinforcing pros and cons of each test. Repeat piloting on the same staff found the 
number of ‘non-traders’ reduced. Piloting also showed that simultaneously considering both 
cancer and polyp scenarios confused participants. We therefore divided the DCE into separate 
polyp and cancer scenarios. 
 
5.2.5 DISCRETE CHOICE EXPERIMENTS 
For both cancer and polyp DCEs, participants indicated their preference for ‘standard’ or 
‘alternative’ CTC during 10 scenarios. To recap, ‘standard’ CTC had fixed sensitivity and 
specificity throughout. In every scenario, standard CTC and was presented against a variant of 
‘alternative’ CTC whose sensitivity was always 0.10 higher but whose specificity varied 
incrementally between 0.90 and 0.05. Scenario ordering was randomised. There was no opt-
out; participants had to indicate a test preference for each scenario. Participants accepting the 
lowest specificity for ‘alternative’ CTC (‘non-traders’) were automatically presented with 
additional information by the software, stressing risks (e.g. of perforation in false-positive 
cases), to assess whether heuristic bias anchored their decision. A random scenario was 
repeated in order to test response consistency. A scenario in which one option was 
1 0 3  
 
unquestionably superior for both sensitivity and specificity sought ‘irrational’ responders. 
Finally, we incorporated ‘willingness-to-pay’ assessment to provide a generic metric with which 
to compare how participants value specificity: Standard CTC was pitched against CTC with 
sensitivity raised by 0.10 but with no reduction in specificity. Participants were told the 
alternative test cost more and were asked how much they would pay (if anything) over-and-
above standard CTC.   
The author and a clinical psychologist, Nichola Bell, conducted DCEs in random order. We 
clarified understanding for participants where necessary, and had the opportunity for 
qualitative exploration afterwards, especially with non-traders.  All participants were asked 
their age, ethnicity, education, and household income bracket. Medically-qualified participants 
(see below) could opt to perform the DCEs online to facilitate their recruitment since they were 
already familiar with the concepts presented. 
 
5.2.6 RECRUITMENT 
We recruited consecutive consenting adults of screening age (55-79 years), scheduled for non-
cancer outpatient ultrasound/plain-radiographic investigations at a teaching hospital, identified 
via booking systems. Information/consent forms were mailed and responders interviewed on 
the day of their appointment. We excluded respondents with a personal history of/or being 
investigated for bowel cancer since their opinions may be biased(33). All participants were 
offered a £10 gift voucher. To investigate any attitudinal difference between patients and 
healthcare professionals, via internal email we recruited staff who requested, performed, or 
interpreted colorectal imaging: Radiologists, gastroenterologists, surgeons, nurse-specialists 
and radiographers.  
 
5.2.7 ANALYSIS 
Our primary outcome measure was the decrease in specificity participants were willing to 
‘trade’ for a 0.10 (i.e. 10% absolute) increase in sensitivity for cancer and for polyp detection. 
Participants’ responses were collated and scenarios ranked in descending order of specificity. In 
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general, participants favour ‘alternative’ CTC when it provides equivalent or higher specificity 
to ‘standard’ CTC. However, as the false positive rate (FPR; 1-specificty) increases, trading 
participants switch to preferring ‘standard’ CTC at a certain point (the ‘tipping point’). This 
point reflects the maximum FPR participants would accept before deciding that the additional 
risk of unnecessary colonoscopy outweighed improved sensitivity. Correcting for baseline FPR 
(by subtracting from 0.05 for cancer and 0.15 for polyp detection scenarios) gives the 
additional FPR (∆FPR) compared to ‘standard’ CTC the participant would consider in exchange 
for 0.10 increase in sensitivity for cancer or polyps (∆FPRcancer and ∆FPRpolyp respectively).  
Our pilot suggested the mean ∆FPRcancer approximated 0.45 (i.e. on average, participants traded 
a fall in specificity from 0.95 to 0.50 in exchange for a 0.10 increase in sensitivity for cancer 
detection). To estimate ∆FPRcancer within ±5% at two-sided alpha 0.05 (within 95% CI) required a 
sample of 96 (N= 4σ zcrit
2/W2 where, σ =p(1-p), P=0.45, Zcrit =1.960, W=0.10 (237)).  Mean 
∆FPRpolyp approximated 0.3, requiring a sample of 81. We pre-specified a secondary outcome 
comparing patients and professionals, for which we estimated 62 participants (two equal 
groups of 31) were required for 90% power to detect an absolute difference in ∆FPRcancer  of 
0.10. Because our pilot suggested a non-normal distribution, we aimed to recruit a further 15% 
participants(237), requiring 72 participants in total. 
 
Non-traders were defined as participants accepting ‘alternative’ CTC despite a FPR increase of 
0.65 for polyps and 0.85 for cancer (i.e. rejecting ‘standard’ CTC in favour of a test with 
absolute specificity 0.2 and 0.1, respectively). Where their opinion changed following 
additional information, their highest ∆FPR value was taken; others were deemed persistent 
non-traders and excluded from primary analysis but retained for socio-demographic 
comparison between traders and non-traders.   
 
The mean values of ∆FPRcancer and ∆FPRpolyp  were calculated for participants overall and for 
patients and healthcare professionals separately. 95% confidence intervals were calculated 
using 1000 bootstraps. Relative weightings (Wpolyp and Wcancer) ascribed to changes in sensitivity 
vs. specificity were obtained by dividing ∆FPRcancer and ∆FPRpolyp by the increase in sensitivity 
(0.10). Incorporating prevalence allows calculation of the absolute number of additional FPs 
participants would trade for a single cancer or polyp detection. For example, when screening a 
population with cancer prevalence of 0.2%, an increase in sensitivity of 0.10 would yield 1 
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additional detection per 5000 examinations. Therefore, FPs per additional cancer detection was 
calculated by multiplying ∆FPRcancer by 5000, and FPs per additional polyp by multiplying 
∆FPRpolyp by 40 (0.10 increase in sensitivity at 25% prevalence detects 1 additional polyp per 40 
screenees). Tipping points were compared between participants interviewed by the two 
researchers and also between professionals’ responses accrued face-to-face versus online. 
Kolmogorov-Smirnov analysis suggested non-normality. The Mann-Whitney U test statistic was 
used for continuous data and Pearson’s Chi-squared test statistic used for categorical 
proportions (Stata V11.0, Stata Corporation, College Station, Texas). 
  
5.3 RESULTS 
75 patients and 50 healthcare professionals participated (5 radiologists, 5 surgeons, 5 
gastroenterologists, 10 specialist registrars, 5 nurse-specialists, 20 radiographers). In total, 
invitations were sent to 112 consecutive patients and 62 professionals resulting in response 
rates of 67% and 81% respectively. Three patients’ attempted but could not complete the 
survey and two medical professionals gave partial responses resulting in 120 complete and 2 
partial responses. No participant failed the internal consistency test. The author interviewed 53 
participants, Ms Bell interviewed 48; 21 responses were obtained online. Demographic data are 
presented in Table 16. Compared to professionals, patients were significantly older, 
discontinued education earlier, and had lower household income. 
 
5.3.1 NON-TRADERS 
Four professionals (8%) failed to trade during the cancer scenario; of these, 2 (4%) would not 
trade during the cancer scenario. In contrast, significantly more patients were non-traders 
(p<0.001); 27 (38%) patients refused to trade during the cancer scenario and of these 18 (25%) 
continued to refuse trading during the polyp scenario.  All non-traders in the polyp scenario 
also refused to trade when considering cancer detection. Non-traders were significantly older 
(median age 64.5 vs 44.5; p=0.001) and less educated than traders (15% vs 2% with no formal 
qualifications; p<0.001). 
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Table 16:  Demographic characteristics and household annual income of patient and professional 
participants including non-traders 
Characteristic  Patients (n=72)* Professionals (n=50)** Total (n=122) 
 N (%) N (%) N (%) 
Gender     
Female 49 (68) 24 (48) 73 (60) 
Male 23 (32) 26 (52) 49 (40) 
    
Age (year)    
25-34 0 (0) 26 (52) 26 (21) 
35-54 0 (0) 23 (46) 26 (21) 
55-59 18 (25) 1 (2) 16 (13) 
60-69 40 (56) 0 (0) 40 (33) 
70-79 14 (19) 0 (0) 14 (11) 
    
Ethnicity    
White  49 (69) 33 (69) 82 (69) 
Other  22 (31) 15 (31) 37 (31) 
    
Income/GBP    
< 10000/yr 3 (6) 0 (0) 3 (3) 
10001-20000/yr 14 (28) 0 (0) 14 (25) 
20001-30000/yr 19 (38) 3 (7) 22 (23) 
30001-40000/yr 10 (20) 10 (23) 20 (21) 
>40000/yr 4 (8) 31 (70) 35 (37) 
 
 
*Of the original 75 patient participants accrued to the study, 3 discontinued the survey, without providing any consistent data. 
Qualitative exploration by the interviewer revealed they did not comprehend the concept of false positive diagnosis. 
**Comprising 5 gastroenterologists, 5 radiologists, 5 colorectal surgeons, 10 Specialist registrars in these specialities, 5 bowel 
cancer screening nurses and 20 CT radiographers. 
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There was no difference in gender (59% vs 61% female; p=0.56) or ethnicity (30% vs 33% non-
white; p=0.57). Considering patients alone, non-traders (n=27) were older (median age 66.8 vs 
60.1; p=0.001), less affluent (median household income GBP10001 to 20000 vs. GBP20001 to 
£30000 per annum; p=0.029) and less qualified (median school leaving age 16 vs 18yrs; 
p=0.021) than traders (n=45). Excluding non-traders and incomplete responses, 56 patients and 
48 professionals were included for the polyp detection scenario, with 45 and 44 respectively 
for the cancer scenario. 
 
5.3.2 CANCER DETECTION 
Overall, the mean false positive rate(FPR) increase accepted for cancer diagnosis scenarios 
(∆FPRcancer) was 0.41 (95%CI: 0.35 to 0.47;Table 17; Figure 16). Therefore, on average, 
participants would trade a 0.41 reduction in specificity for a 0.10 increase in sensitivity for 
cancer, resulting a weighting of 4.1x. At population prevalence of 0.2%, this equates to 2050 
(95% CI: 1750 to 2350) additional false-positives per additional true-positive diagnosis.  
∆FPRcancer was significantly higher for patients (mean 0.57. 95%CI: 0.49 to 0.66) than 
professionals (mean 0.24, 95%CI: 0.19 to 0.31, p=0.001). The data were not normally 
distributed and were almost bimodal (Figure 16). Therefore we calculated both means and 
medians for participants willing to trade (Table 17). Many of the participants reporting higher 
values were asked extra questions because of unwillingness to trade (Figure 17). There was no 
difference in patients’ overall mean ∆FPRcancer elicited by different interviewers, (0.55 vs. 0.59; 
p=0.57) nor between professionals’ ∆FPRcancer obtained face-to-face vs. online (mean 0.25 vs. 
0.21; p=0.59). 
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Figure 16:  Distribution of patients’ and professionals’ maximum decrease in specificity traded for 0.1 
increase in sensitivity for polyps (∆FPRpolyp ) top, and for cancer (∆FPRcancer ) bottom. 
* indicates choices not presented to participants for this scenario 
 
5.3.3 POLYP DETECTION 
Overall, the mean increase in FPR accepted for the polyp diagnosis scenarios (∆FPRpolyp) was 
0.25 (95%CI: 0.21 to 0.30).  Thus, on average, a 0.25 reduction in specificity was considered fair 
exchange for a 0.10 increased sensitivity for polyp detection, giving a weighting of 2.5x. At 
population prevalence of 25%, this equates to 10 (95% CI: 8.4 to12) additional false-positives 
per additional true-positive diagnosis. Mean ∆FPRpolyp was significantly higher for patients 
(0.33, 95%CI: 0.27 to 0.39) than professionals (0.17, 95%CI: 0.13 to 0.22. p<0.001). Combined, 
patients and professionals’ ∆FPR values were significantly higher for cancer detection than for 
polyps (0.41 vs. 0.25; p=0.005).  
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Table 17:  False positive rate (FRP) trade-off values and relative weighting for cancer and polyp 
detection scenarios calculated for patients, professionals, and all participants combined  
 
 Tipping point  Relative weighting (W) Average number of 
FP per additional TP 
detection 
 Mean 95%CI Median IQR Mean 95%CI  
Patients        
Polyp 0.33 0.27 to 0.39 0.25 0.05 to 0.55  3.3 2.7 to 3.9 13.2 
Cancer 0.57 0.49 to 0.66 0.70 0.25 to 0.85  5.7 4.9 to 6.6 2850 
Professionals       
Polyp 0.17 0.13 to 0.22  0.15 0.05 to 0.15 1.7 1.3 to 2.2 6.8 
Cancer 0.24 0.19 to 0.31 0.25 0.08 to 0.25  2.4 1.9 to 3.1 1200 
        
Combined        
Polyp 0.25 0.21 to 0.0.30 0.15 0.05 to 0.46 2.5 2.1 to 3.0 10 
Cancer 0.41 0.35 to 0.47 0.25 0.15 to 0.75 4.1 3.5 to 4.7 2050 
 
 
5.3.4 WILLINGNESS-TO-PAY (WTP)  
Median WTP for 0.10 increased sensitivity with maintained specificity was significantly higher 
for cancer than polyps: 201 to 500GBP (IQR 101 to 200GBP to 501 to 1000 GBP) vs. 101 to 200 
GBP (IQR 51 to 100 to 201 to 500 GBP), p<0.001.  
There was no significant difference in WTP between patients and professionals for polyps 
(p=0.97) but patients’ WTP was significantly higher than professionals’ for cancer detection: 
median 201 to 500 GBP (IQR 101 to 200 GBP to 201 to 500GBP) vs median 101 to 200 GBP (IQR 
51 to 100 GBP to 201 to 500 GBP, p=0.036). Moreover, median household income was 
significantly lower for patients than professionals: 20001 to 25000GBP vs >40000GBP; p=0.021 
(Table 18). 
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Table 18:  Patient and professionals’ willingness to pay for a 0.1 increase in sensitivity without any 
reduction in specificity for detection of cancer or clinically significant polyps   
 
WTP/GBP POLYP DETECTION 
 Professionals (72)  Patients (50)  Total (122) 
 N % N % N % 
<50 9 13 8 16 17 14 
51-100 10 14 8 16 18 15 
101-200 15 21 14 28 29 24 
201-500 4 6 10 20 14 11 
501-1000 10 14 4 8 14 11 
>1000 0 0 0 0 0 0 
Declined to answer 24 33 6 12 30 25 
WTP/GBP CANCER DETECTION 
 Professionals (72) Patient (50) Total(122)  
 N % N % n % 
<50 5 7 5 10 10 8 
51-100 3 4 7 14 10 8 
101-200 10 14 12 24 22 18 
201-500 25 35 9 18 23 19 
501-1000 0 0 6 12 17 14 
>1000 8 11 3 6 11 9 
Declined to answer 21 29 8 4 30 25 
 
 
5.4 DISCUSSION 
This study shows that both patients and professionals value gains in diagnostic sensitivity more 
highly than a corresponding loss of specificity, when screening for colorectal cancer and polyps. 
Overall, the relative value ascribed to a more sensitive screening test outweighed reduced 
specificity, with an average of 2050 extra FPs considered worth trading for a single extra TP 
when considering cancer and 10 extra FP for a single extra polyp. Our findings are similar to  
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Figure 17:  Number of additional FP detections patients and professionals would be willing to trade for 
one additional true-positive diagnosis for both polyp and cancer detection scenarios. Individual 
respondent data is presented, patients represented by filled shapes and professionals, by open shapes.  
 
those from a study of mammography that found women willing to trade 500+ false-positive 
mammograms and their consequences in order to diagnose a single additional cancer that 
would otherwise have been missed(238). Although it is known that patients value sensitivity 
above specificity for colorectal cancer screening (239, 240), we could find no data that 
quantified this for a radiological test. 
 
Our interest in this area was stimulated by studies of CAD for CTC, which found that CAD 
increases sensitivity but reduces specificity, sometimes significantly (19, 20, 215, 241). The 
clinical consequences of missed cancer (i.e. potential death) are not equivalent to those for FP 
diagnosis (i.e. unnecessary colonoscopy), and our findings confirm that this belief is held by 
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both patients and professionals. It is therefore important that analysis of research studies take 
account of this asymmetry and this is explored in more detail in the following Chapter. 
 
We elected to use a discrete choice experiment, a relatively novel methodology for establishing 
preferences (242). Traditionally, ranking exercises are used to elicit preferences (243), with test 
attributes considered in isolation. Results are predictable: Patients and professionals favour 
tests that are sensitive, specific, inexpensive, readily available, and non-invasive. This does not 
reflect real-world choices, especially for test characteristics that usually move in opposite 
directions, such as sensitivity and specificity. In contrast, DCE requires respondents to ‘trade’ 
between different test characteristics and are increasingly advocated because they better 
reflect choices necessary in daily practice(224-226, 243-245).  
However, DCEs are complex. To simplify and focus the cognitive task, we compared just two 
attributes, sensitivity and specificity. Change in attributes’ relative weighting between 
scenarios is more important than their absolute level. Thus, we chose a baseline sensitivity of 
85% for cancer detection by CTC, which is likely an underestimate but necessary so that we 
could inflate sensitivity for the new test by 0.10 (e.g. CTC with CAD). In addition, we delivered 
the experiment face-to-face to facilitate participation (excluding 21 medical professionals who 
opted for the online facility). This was beneficial: of those interviewed 99 out of 102 gave 
complete, consistent, responses with only three participants feeling unable to complete the 
task. Likewise, targeting the professional group online facilitated participation with 19 out of 21 
responders providing full responses and the remaining 2 completing the polyp scenario only.  
Face-to-face, interviewer-led surveys can increase generalisability of results by increasing the 
spectrum of respondents. Nevertheless, this methodology could introduce interviewer bias. 
However, we found no significant difference in participants’ responses whether interviewed by 
a psychologist or radiologist nor was there a significant difference in responses obtained face to 
face or accrued online. Moreover, an interview allows responses to be explored in more detail. 
For example, 38% of patients would not trade during the cancer scenario and while DCE 
analysis usually excludes these responses from analysis, they are not necessarily ‘irrational.’ 
Some non-traders used a heuristic (‘rule of thumb’), always choosing the option with the 
highest sensitivity. However, others defended their decision to choose a test with minimal 
specificity stating that an FP would lead to the gold-standard test, and with it, reassurance. 
Moreover, many acknowledged such a test would be unrealistic from a logistic/economic 
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standpoint. These attitudes reflect those of women surveyed regarding false-positive 
mammography (238).  
 
We did identify differences between patients and professionals. Inevitably, demographic and 
socioeconomic characteristics varied. We attempted to account for this via a willingness-to-pay 
assessment, informed by knowledge of respondent’s income. Compared to professionals, 
patients were more inclined to trade sensitivity for specificity for both polyps and cancer. 
Interestingly, despite having approximately half the annual household income, patients 
ascribed monetary value to enhanced sensitivity approximately twice that of professionals. If 
analyses of new diagnostic tests for screening are to account for discrepant weightings 
between sensitivity and sensitivity, the question arises, whose weightings should be used? One 
could argue that healthcare professionals, particularly clinicians, provide the most balanced 
responses, as they are likely to have the best grasp of pros and cons, and to take an informed 
overall perspective. Conversely, there is increasing expectation that patients’ expectations are 
incorporated when developing screening modalities.   
 
Our study has limitations. As we have stated, DCEs can be challenging for participants(246) and 
require motivation, literacy, and numeracy, which may introduce selection bias (231). We 
attempted to counter this via a face-to-face delivery rather than using a postal questionnaire.  
Although we had adequate power, larger and/or different samples may better represent 
different patient and professional groups. Strategies for design and analysis also need further 
investigation(247, 248). Potentially important missing data from non-traders was excluded from 
this DCE analysis. However, a potential strategy to incorporate their responses is described in 
the following Chapter. Common to all hypothetical scenarios, subjects’ actions in real life may 
not mirror those expressed in the DCE. It should be stressed that the weightings we derived are 
specific to colorectal cancer screening.  
 
In summary, via DCE we found that both patients and healthcare professionals consider gains in 
sensitivity more important than corresponding loss of specificity, when considering diagnostic 
tests for colorectal cancer screening. Discrepancy was greatest for cancer detection (vs. polyps) 
and for patients rather than professionals. 
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CHAPTER 6 
6.  INCREMENTAL NET-EFFECT OF COMPUTER AIDED DETECTION (CAD) FOR 
INEXPERIENCED AND EXPERIENCED READERS OF CTC 
 
 
AUTHOR DECLARATION 
Work presented in this Chapter was led by the Author under the supervision of Professor Steve 
Halligan and Professor Stuart Taylor with statistical analysis performed by Dr Susan Mallett and 
Professor Douglas Altman. Research based upon this Chapter’s content is currently under 
consideration for indexed publication: Boone D, Halligan S, Taylor S, Altman DG, Mallett S. 
Assessment of the relative benefit of computer-aided detection (CAD) for interpretation of CTC 
by experienced and inexperienced readers.  
 
 
6.1 INTRODUCTION 
As outlined in Section A (Chapters 1.12.3 and 2.9) of this Thesis, CAD aims to improve the 
diagnostic performance of CTC by using visual prompts to alert radiologists to pathology that 
might otherwise be missed (249, 250)(Figure 18). CAD systems make both TP and FP prompts, 
which are then categorised by the interpreting radiologist. Radiologist categorisations may be 
correct or incorrect. While it has frequently been hypothesised that CAD may diminish the 
need for prior reader experience(34), the two largest studies of CAD published to date have 
used experienced readers alone(20, 21). Very few studies have directly compared experienced 
and inexperienced readers, and those that have done so are limited by their small size and low 
statistical power(22). For example, Mang and colleagues asked two ‘expert’ and two 
‘nonexpert’ observers to interpret 52 patient datasets using CAD in a second-read paradigm, 
finding that CAD was only beneficial for the less experienced readers(251). Research described 
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in this Chapter aimed to quantify the incremental effect of CAD for inexperienced versus 
experienced readers by comparing data across two large multi-reader, multi-case studies of CTC 
using a CAD net-effect analysis incorporating weightings derived from the DCE described in the 
previous Chapter. 
 
Figure 18:  Volume rendered 
endoluminal CTC displaying a computer-
aided-detection (CAD) prompt (small red 
marker) correctly annotating a 5mm 
sessile polyp. 
 
 
 
 
 
 
6.1.1 CAD SOFTWARE OVERVIEW 
 
Several CAD products have secured regulatory approval for routine clinical use in Europe and 
the USA (115). The CAD algorithm utilised for research reported in this thesis, ColonCAD V3.1, 
was developed by MedicSight Plc, Hammersmith, London, UK; the Author gratefully 
acknowledges their support. While early CAD studies required use of dedicated visualisation 
software, CAD products are now generally integrated into proprietary vendor workstations. 
While the algorithms and displays differ, all CAD systems share a common theme; the reader is 
guided to irregularities in the endoluminal surface by visual prompts which must be scrutinised 
to determine if likely to represent genuine colonic pathology.   
 
The performance of CAD products is often described in terms of standalone polyp detection.  
This corresponds to a ‘1st reader’ paradigm (Table 19), whereby the prompts generated by CAD 
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are compared to true positive polyps established, preferably, using a radiological-endoscopic 
ground truth reference standard.  To avoid bias, the dataset upon which the CAD software is 
evaluated should not include cases used for algorithm development. The process of ‘external 
clinical validation’ (222) is described in more detail in Chapter 11 of this Thesis.  
 
A comprehensive description of ColonCAD V3.1 standalone performance has been reported by 
Lawrence et al (162). In summary, CAD was applied retrospectively to a cohort of 3077 patients 
undergoing screening with CTC between March 2006 and December 2008. All participants 
underwent CTC with laxative bowel preparation and faecal tagging. Experienced radiologists 
provided a consensus reference standard for all cases using subsequent colonoscopic findings 
to confirm positive findings; 607 polyps were confirmed in 373 patients. Positive CAD prompts 
were compared to this ‘ground truth.’  
On a per patient basis, CAD sensitivity for polyps ≥6mm was 93.8% (95% CI: 90.9% to 96.1%) 
and for polyps ≥10mm CAD achieved sensitivity of 96.5% (95% CI: 92.0% to 98.8%). On a per-
polyp basis, CAD sensitivities for all polyps was 90.1% (95% CI: 88.0% to 92.8%) and 96.0% (95% 
CI: 91.9% to 98.4%) at 6mm and 10mm thresholds respectively. Moreover, CAD sensitivity for 
advanced neoplasia was 97.0% (95% CI: 92.4% to 99.2%) with 100% (95% CI: 79.4% to 100%) 
sensitivity for cancer. 
However, on a per patient basis, a CAD system can obtain (spurious) high sensitivity, by 
incorrectly assigning a false positive prompt to a true positive case and hence, considerable 
emphasis has been placed on CAD false positive rate (FPR). Using ColonCAD, mean FPR was  9.4 
and median FPR was 6 per patient, illustrating that reader interaction remains essential at 
present, not least to prevent unnecessary colonoscopy in healthy patients.  
Nevertheless, among 373 patients with a positive finding at CT colonography, ColonCAD 
marked an additional 15 endoscopically confirmed polyps ≥6mm (including four large polyps) 
that were missed at initial radiological interpretation. Clearly, the interaction between software 
and radiologist are central to the potential benefit conferred by any CAD product; even highly 
experienced readers will dismiss genuine lesions, correctly annotated by CAD (25). Therefore, 
standalone performance is a limited surrogate marker of performance in clinical practice.  
A more realistic estimate of CAD performance in daily interpretation requires a multireader, 
multicase study where readers evaluate cases both with and without CAD assistance. Two such 
studies have evaluated ColonCAD (referred to hereafter as CAD): The most recent study, (19) 
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required observers to  read 112 CTC examinations (132 polyps in 56 patients) with and without 
CAD assistance. Sixteen experienced radiologists interpreted these datasets on three separate 
occasions either unassisted, using CAD concurrently, or with CAD as a second-reader. CAD 
significantly increased mean per-patient sensitivity both when used as a second-reader (mean 
increase, 7.0%; 95% confidence interval (CI): 4.0 to 9.8%) or when used concurrently (mean 
increase, 4.5; 95% CI: 0.8 to 8.2%). Furthermore, CAD resulted in no significant decrease in per-
patient specificity for these readers.  
The earlier study(215) recruited 10 readers trained in CT but without special expertise in 
colonography to interpret 107 CTC cases (60 patients with 142 polyps), first without CAD and 
then with concurrent CAD after a washout period of 2 months. With CAD, per-patient 
sensitivity increased significantly in 70% of readers, while specificity dropped significantly in 
only one. Polyp detection increased significantly with CAD with, on average, 9.1% more polyps 
detected by each reader (95% CI, 5.2% to 12.8%).  
While these studies varied in design and observer experience, the CAD software and test 
dataset were effectively equivalent. This chapter draws upon the novel analysis methods 
outlined above to compare the net benefit of CAD when applied by inexperienced and 
experienced readers.  
 
 
6.2 METHODS 
6.2.1 DATA SOURCES AND READERS 
We obtained original reader data acquired from two multi-reader, multi-case studies of CAD for 
CTC, published previously by the supervisors of this Thesis (21, 34). Both studies had full ethical 
committee approval for data sharing. The first study investigated 10 radiologist readers with no 
prior experience of CTC who interpreted 107 patient datasets both unaided and when using 
CAD in a concurrent paradigm(34). The second study investigated 16 radiologist readers all of 
whom had prior experience of CTC interpretation (mean 264 cases, range 50 to >1000)(21). 
These readers interpreted 112 patient datasets unaided and with CAD, using both second-read 
and concurrent paradigms (Table 19).  
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6.2.2 DATA CHARACTERISTICS 
118 discrete patient cases were used for the two studies with 102 patient cases common to 
both. We selected reader data from these 102 cases to enable paired comparisons of 
experienced and inexperienced groups without the need for imputation to account for missing 
data. Thus, any differences could be attributed directly to differences in experience rather than 
due to confounding because of different case mix. We calculated the difference between 
novices and experienced readers on a per case basis so allowing ideal data clustering to be 
included in the analysis, generating more appropriate 95% confidence intervals. Cases were a 
mix of symptomatic and asymptomatic subjects aggregated from three USA and two European 
centres. Prone and supine CTC had been performed in each case using multidetector-row 
machines and following full bowel purgation, adhering to published guidelines for data 
acquisition(30, 36).  
 
A reference truth against which the CAD and reader output could be judged was established for 
each case by three experienced readers (none of whom were readers in the studies, and 
including Professors Steve Halligan and Stuart Taylor). A pair read each case with the benefit of 
the original radiological report supplemented with colonoscopic and histological data where 
available, and achieved consensus regarding the case classification and size and location of any 
polyp(21, 34). Ultimately, of the 102 cases, 46 were judged normal and 56 had at least one 
polyp. There were 132 polyps in total: 15 polyps ≥10mm, 41 polyps 6mm to 9mm, 76 polyps 
≤5mm, with 12, 25 and 19 cases where these were the largest polyps respectively. In 37 cases 
the largest polyp was at least 6mm.  
 
6.2.3 READING ENVIRONMENT AND CAD PARADIGM 
For the study of inexperienced readers, readers interpreted all cases in a quiet environment 
without CAD over the course of one week and then repeated the interpretation two months 
later, this time using CAD in a concurrent paradigm(34). For the study of experienced readers, 
cases were read in three batches of one-month each, with a temporal separation of at least 
one-month between batches(21). All cases were read once in each batch, using one of three 
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paradigms (unassisted, concurrent-CAD, second-read CAD; Table 19), with the reading 
paradigm randomised between batches. 
 
 
CAD 
Implementation 
paradigm 
Description 
Unassisted Readers analyse the entire case without CAD, just as in normal daily practice. Where CAD is integrated into 
the vendor workstation it is disabled. 
 
1st reader CAD CAD is activated and presents a list of CAD prompts for review. The reader reviews all CAD prompts 
sequentially accepting lesions he or she considers genuine pathology and rejecting those felt to be spurious. 
Interpretation is restricted to the CAD marks only; an unassisted radiological review of the endoluminal 
surface is not performed. Hence any pathology undetected by CAD is likely to remain undiagnosed; this 
algorithm is not recommended for clinical practice. 
 
2nd reader CAD The reader performs a full, unassisted case review with CAD disabled.  Once analysis is complete, readers 
apply CAD and then review the case again, usually by interrogating sequential CAD candidates rather than 
the entire endoluminal surface. Readers are not permitted to disregard lesions previously considered true 
pathology during their unassisted read, regardless of whether or not they are marked by CAD. This ensures 
CAD acts as a ‘safety net’ and at present, European and US regulatory approval is restricted to this 
paradigm only. 
 
Concurrent CAD CAD is applied from the outset. The reader performs a full review of the case, searching for pathology as 
they would for an unassisted read. CAD-prompted candidate lesions are scrutinised as they appear during 
the full endoluminal review. This is therefore a hybrid of 1st and 2nd reader CAD where the case is read only 
once with the CAD marks visible throughout. According to the available evidence, concurrent reading is less 
effective than the second-read paradigm and its routine use is not recommended at this time. 
 
 
Table 19:  Paradigms for integration of CAD into CTC interpretation. Please note, at present, only 2
nd
 
reader CAD is recommended for routine clinical practice (115) 
Thus unassisted interpretation and concurrent-CAD interpretation of each individual case were 
common to both studies, with a temporal separation between reads of at least one-month. For 
the concurrent paradigm, readers interpreted CAD annotated CTC data simultaneously with un-
annotated data(34). As described above, the same CAD system was used for both studies, so 
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that correctly annotated polyps and FP detections were the same (Colon CAD V 3.1, 
Medicsight, Hammersmith, UK). A proprietary CTC package was used to view CTC data for the 
study of inexperienced readers. For the study of experienced readers, CAD was implemented 
into commercially available workstations (either Viatronix V3D, Stony Brook NY, USA, or Vital 
Images, Minnetonka, Minn, USA).  
Readers were asked to indicate whether they believed a polyp was present at the case-level or 
not. If they believed the case was positive, they were asked to indicate the segmental location 
of all polyps detected and note the CT coordinates. They also estimated the maximum 
diameter of each polyp using software callipers. Responses were made on study datasheets 
collated subsequently by a study coordinator.  
 
6.2.4 STATISTICAL ANALYSIS 
The collated datasheet responses were compared to the reference truth diagnosis for each case 
so that each reader response could be classified as TP, TN, FP, or FN at the case level. Each 
individual polyp detected by readers was also categorised as TP or FP. 
 
CAD NET EFFECT MEASURE 
Our pre-specified analysis was the comparison of the ‘CAD net effect measure’ (the rationale 
for which is explained previously in this Section), defined as follows: 
 
sensitivity + (specificity x [prevalence adjustment] x [1/W]) 
 
 
 sensitivity and specificity are the change in sensitivity and specificity from baseline 
when cases were read with CAD 
 The adjustment for prevalence of abnormality within the dataset (0.5) was defined as 
(1-prevalence/prevalence) where prevalence is a proportion.  
 The weighting value ‘ W’ was based on the discrete choice experiment described in 
Chapter 5, with an adjustment for non-trader missing data explained below.  
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CALCULATING ‘W’ FROM THE RESULTS OF CONJOINT ANALYSIS  
The method for eliciting the relative value patients’ and professionals’ ascribe to TP vs FP 
diagnoses is described in detail in chapter 5. However, as noted, the study had limitations 
regarding missing non-trader data which were overcome as follows: 
The distribution of ‘tipping points’ for polyp detection (i.e. the point at which loss of specificity 
outweighed a 0.10 gain in sensitivity) was determined for all respondents and expressed as the 
number of FPs per additional true positive diagnosis. Cumulative data points were plotted for 
healthcare professionals and patients (Figure 19 and Figure 20 respectively). While the ‘tipping 
point’ for non-traders is unknown it must be higher than the maximum choice they were 
presented (i.e. less than the lowest specificity in any trading scenario). Hence, their responses 
are plotted beyond the maximum tipping point tested (25FP per TP). Hence, the 50% 
cumulative point (median) appropriately estimates the tipping point at which 50% of 
respondents would trade (and 50% would decline, a proportion of whom are non-traders.)  
The median tipping point is adjusted for prevalence (0.25 for polyps; 0.02 for cancer in the DCE: 
Therefore TP/FP ratio is divided by 3 for polyp and 499 for cancer detection scenarios following  
[p/1-p] as described above), ultimately  resulting in a value of Wpolyp of 4.7 (Table 20). 
Table 20: Relative weighting values ‘W’ determined from Patient and Professional groups for polyp and 
cancer detection scenarios tested during the discrete choice experiment (Chapter 5) 
 FP vs TP absolute values Relative weighting W* 
Participants Polyps Cancer Polyps Cancer 
Patients 22 4250 7.33* 8.5 
Professionals 6 1250 2.0* 2.5 
Average at 50% population 14 2750 4.67* 5.5 
 
 
PRIMARY OUTCOME MEASURE 
The primary analysis was a comparison of the CAD net effect measure between inexperienced 
and experienced readers when using a concurrent CAD paradigm, for a per-patient analysis of 
patients with polyps of any size.  
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SECONDARY OUTCOME MEASURES 
The following secondary outcomes were pre-specified for experienced and inexperienced 
readers, and the difference between them: 
 Per-patient sensitivity and specificity when unassisted, when using concurrent CAD, 
and the change when using CAD, for patients with all polyps and restricted to those 
with polyps ≥6mm 
 Per-polyp sensitivity when unassisted, when using CAD, and the change when using 
CAD, for patients with all polyps, polyps ≥6mm, and polyps ≤5mm. 
 The mean number of patients correctly classified as true-positive solely as a 
consequence of false-positive detections.  
 Mean reading time with and without CAD, and the difference between the two. 
 To speculate on the potential gain for inexperienced readers using CAD in a second-
read paradigm by quantifying the difference in accuracy between concurrent and 
second-read CAD paradigms for experienced readers via existing data(21). 
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Figure 19: Ranked trade-off values for Professional respondents from the discrete choice experiment 
Polyp detection scenario (Chapter 5). Note data points beyond the maximum trade-off (25 FP per TP) 
represent missing data from non-traders 
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Figure 20:  Ranked trade-off values for Patient respondents from the discrete choice experiment polyp 
detection scenario (Chapter 5). Note data points beyond the maximum trade-off (25 FP per TP) 
represent missing data from non-traders. 
 
Average estimates were calculated from 2000 bootstrap samples generated by random 
sampling patients and readers, retaining data clustering. Positive and negative patients were 
bootstrapped separately and the same case bootstrapping used for both studies. Readers were 
bootstrapped separately for each study. Differences between novices and experienced readers 
were calculated within each case prior to averaging across all cases. Calculations of the net-
effect for CAD were based on 50% prevalence. Meta-analysis with equal weighting per reader 
was used to obtain an average across all readers. For per-polyp sensitivity bootstrap analysis 
accounted for the clustering of multiple polyps per patient.  
Confidence intervals were calculated by taking the 2.5% and 97.5% percentiles of the 
cumulative distribution of the 2000 estimates. Although underpowered for analysis at the 1cm 
threshold, we calculated the median number of patients detected. Interpretation times for 
experienced readers were based on 15 readers (one had missing data). Sensitivity and 
specificity, and changes in these are expressed as decimals. Results are reported with 95% 
confidence intervals (CI). Differences with confidence intervals not including zero were 
considered to be statistically significant. 
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6.3 RESULTS 
6.3.1 PER-PATIENT ANALYSES 
 
A net benefit for CAD was identified in 83% of cases for both inexperienced and experienced 
readers; detection of patients with polyps increased in 70% and 57% of cases over 10 and 16 
readers respectively.  Per-patient sensitivity and specificity (with 95%CI) for readers when 
unassisted and when using CAD are shown in Table 21.  There was a statistically significant 
mean gain in sensitivity for all polyps of 14.1% for inexperienced readers when using CAD 
(rising from 39.1% to 53.2%). Sensitivity for all polyps was higher for experienced readers but 
the mean gain of 4.6% with CAD was not significant (rising from 57.5% to 62.1%).  
 
Inexperienced readers benefitted by a mean gain in sensitivity approximately 3-times that for 
experienced readers, a significant difference of 9.6% (95%CI:  1.2% to 17.7%). The mean drop in 
specificity of -6.1% with CAD was non-significant for inexperienced readers (falling from 94.1% 
to 88.0%). Likewise, the mean drop in specificity of -2.7% with CAD was non-significant for 
experienced readers (falling from 91.0% to 88.3%). Thus, in a series of 200 patients (100 with 
polyps) inexperienced readers using CAD would correctly identify 14 additional patients with 
polyps on average, at the cost of approximately 6 additional false-positives, whereas 
experienced readers would identify 4 or 5 additional patients with polyps at cost of 2 or 3 
additional false-positives. For our primary outcome, these data gave a significant mean CAD net 
benefit of 12.9 (95%CI:  5.5-20.0) for inexperienced readers, versus a non-significant net effect 
of 4 (95%CI: -0.8 to 8.8) for experienced. Net benefit was significantly greater among 
inexperienced readers than for the experienced group, with a mean difference of 8.9 (95%CI: 
0.5 to 17.1) (Table 21).  
 
With the analyses restricted to patients with polyps ≥6mm there was a significant mean gain in 
sensitivity with CAD of 11.6% for inexperienced readers (rising from 49.5% unassisted to 61.1%) 
compared with a non significant mean gain of 4.2% for experienced readers (rising from 65.9% 
to 70.1%)(Table 21). The fall in specificity with CAD was non-significant for both groups, with a 
mean change of -3.4% for inexperienced readers and -0.8% for experienced readers. 
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Thus, in a series of 200 patients (100 with polyps) inexperienced readers using CAD would 
correctly identify 11 or 12 additional patients with polyps on average, at the cost of 
approximately 3 or 4 additional false-positives, whereas experienced readers would identify 4 
or 5 additional patients with polyps at the cost of 1 additional false-positive.   
Mean net effect was significant for inexperienced readers (10.8, 95% CI: 1.2 to 20.0) but not for 
experienced subjects (4.0, 95%CI:  -2.3 to 10.3) resulting in a non-significant difference 
between groups (6.8, 95%CI:  -3.1 to 16.4) (Table 21). 
 
6.3.2 PER-POLYP ANALYSES 
Per-polyp sensitivity for readers when unassisted and when using CAD are shown in 6.3.4
 Other analyses 
 
On a per patient basis, it is possible to achieve a fortuitous true-positive diagnosis while failing 
to identify a true polyp through erroneously assigning a false-positive polyp. The mean number 
of such patients was 4.3% for both experienced and inexperienced readers when unassisted, 
falling with CAD to 3.9% for experienced readers and rising to 5.0% for inexperienced readers. 
Thus the proportion of such patients is small and the increase in sensitivity found with CAD was 
not due to increased false-positive detections at the per-patient level. 
When unassisted, mean reading time for inexperienced readers was 11.2 min (95%CI 10.7 to 
11.7) compared with 7.9 min (7.4 to 8.2) for experienced readers. When using CAD 
concurrently, this fell to 8.9 (8.3 to 9.4) for inexperienced readers but rose to 8.7 (8.2 to 9.3) for 
experienced readers. 
Table 22. For all polyps there was a significant mean gain in sensitivity with CAD of 9.0% for 
inexperienced readers (rising from 15.4 unassisted to 24.4%) and a mean gain of 4.1% for 
experienced readers (rising from 30.3%  to 34.4%), which was also significant. Restricting 
analysis to polyps ≥6mm the mean gain of 10.0% (rising from 28.5% to 38.5%) for 
inexperienced readers was significant but the mean gain of 3.0% (rising from 51.0% to 54.0%) 
for experienced readers was not. When the analysis was restricted to polyps ≤5mm the mean 
gain in sensitivity with CAD was significant for both groups, 8.3% (rising from 5.9% to 14.2%) 
for inexperienced readers and 4.8% (15.3% rising to 20.1%) for experienced readers. The 
magnitude of benefit with CAD was not significantly different between the two groups. 
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Table 21:  Per-patient results for CAD assistance when used in concurrent mode for interpretation of 
CTC by inexperienced and experienced readers. All comparisons with CAD assistance are minus 
performance when unassisted. Net effect RED; statistical significance denoted by underlined figures. 
 
 Inexperienced readers 
[mean (95%CI)] (%) 
Experienced readers 
[mean (95%CI)] (%) 
Difference Inexperienced – 
Experienced 
[mean (95%CI)] (%) 
CAD net effect measure 
(all polyps) 
12.9 
(5.5 to 20.0) 
4.0 
(-0.8 to 8.8) 
8.9 
(0.5 to 17.1) 
Unassisted sensitivity        
(all polyps) 
39.1 
(30.9 to 47.0) 
57.5 
(49.6 to 65.2) 
-18.5 
(-25.3 to -11.9) 
Unassisted specificity        
(all polyps) 
94.1 
(90.0 to 97.4) 
91.0 
(87.0 to 94.8) 
3.1 
(-1.7 to 7.9) 
Sensitivity with CAD           
(all polyps) 
53.2 
(43.9 to 61.4) 
62.1 
(54.1 to 70.3) 
-8.9 
(-16.6 to -1.9) 
Specificity with CAD           
(all polyps) 
88.0 
(82.2 to 93.3) 
88.3 
(83.8 to 92.4) 
-0.3 
(-5.6 to 5.0) 
Change in sensitivity 
with CAD (all polyps) 
14.1 
(6.8 to 21.4) 
4.6 
(-0.2 to 9.3) 
9.6 
(1.2 to 17.7) 
Change in specificity 
with CAD (all polyps) 
-6.1 
(-12.0 to -0.2) 
-2.7 
(-6.3 to 0.8) 
-3.4 
(-9.6 to 3.0) 
CAD net effect measure 
(polyps ≥6mm)  
10.8 
(1.2 to 20.0) 
4.0 
(-2.3 to 10.3) 
6.8 
(-3.1 to 16.4) 
Unassisted sensitivity 
(polyps ≥6mm) 
49.5 
(40.0 to 58.9) 
65.9 
(56.4 to 74.7) 
-16.4 
(-24.0 to -8.3) 
Unassisted specificity 
(polyps ≥6mm) 
92.6 
(89.0 to 95.5) 
93.5 
(90.5 to 95.9) 
-0.9 
(-4.4 to 2.5) 
Sensitivity with CAD           
(polyps ≥6mm) 
61.1 
(50.0 to 71.1) 
70.1 
(60.5 to 78.7) 
-9.0 
(-18.4 to -0.3) 
Specificity with CAD           
(polyps ≥6mm) 
89.2 
(84.7 to 92.8) 
92.7 
(89.0 to 95.5) 
-3.5 
(-7.4 to 0.2) 
Change in sensitivity 
with CAD (polyps 
≥6mm) 
11.6 
(1.9 to 20.5) 
4.2 
(-2.0 to 10.5) 
7.5 
(-2.6 to 16.8) 
Change in specificity 
with CAD (polyps 
≥6mm) 
-3.4 
(-8.0 to 0.8) 
-0.8 
(-3.4 to 1.7) 
-2.6 
(-7.5 to 2.0) 
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6.3.3 SECOND-READ CAD 
Data for second-read CAD were only available for experienced readers (as this reading 
paradigm was not tested directly in the earlier study of inexperienced readers) and are shown 
in Table 23. There was a significant rise in mean sensitivity of 6.9% for patients with all polyps 
(rising from 57.5% to 64.4%), with a non-significant fall in mean specificity of -2.0% (falling from 
91.0% to 89.0%). Thus in a series of 200 patients (100 with polyps) experienced readers would 
identify 6 or 7 additional patients with polyps on average, at a cost of 2 additional false-
positives. These data gave a significant CAD net benefit of 6.5 (95%CI: 2.2 to 10.9). Mean per-
patient sensitivity for patients with polyps ≥6mm rose significantly by 6.9% also, with a non-
significant fall in specificity of -0.9%.  
 
Second-read CAD was not tested on inexperienced readers but we can infer at least a similar 
impact to that seen in the experienced reader group, with second-read CAD likely to confer 
positive net benefit. Using second-read CAD experienced readers achieved an average 
sensitivity 25% above that when using concurrent CAD (6.9% increase with second read, 4.6% 
increase with concurrent read; Table 21 & Table 23). Furthermore, the reduction in specificity 
for experienced readers was  0.7% less using second-read CAD compared to concurrent reading 
(-2.0 change for second-read versus -2.7 change for concurrent; Table 21 & Table 23).  
Conservative estimates suggest a significant increase in sensitivity for inexperienced readers of 
16.6% (14.1 plus 25%; Table 21) with a potentially significant decrease in specificity of 
approximately -5.5% (-6.1% plus +0. 7%; Table 21).  
Per-polyp sensitivity rose significantly by a mean of 7.2% for all polyps, with significant gains in 
mean sensitivity of 9.1% for polyps ≥6mm and 5.8% for polyps ≤5mm. 
 
 
6.3.4 OTHER ANALYSES 
 
On a per patient basis, it is possible to achieve a fortuitous true-positive diagnosis while failing 
to identify a true polyp through erroneously assigning a false-positive polyp. The mean number 
of such patients was 4.3% for both experienced and inexperienced readers when unassisted, 
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falling with CAD to 3.9% for experienced readers and rising to 5.0% for inexperienced readers. 
Thus the proportion of such patients is small and the increase in sensitivity found with CAD was 
not due to increased false-positive detections at the per-patient level. 
When unassisted, mean reading time for inexperienced readers was 11.2 min (95%CI 10.7 to 
11.7) compared with 7.9 min (7.4 to 8.2) for experienced readers. When using CAD 
concurrently, this fell to 8.9 (8.3 to 9.4) for inexperienced readers but rose to 8.7 (8.2 to 9.3) for 
experienced readers. 
Table 22:  Per-polyp sensitivity for CAD assistance when used in concurrent mode for interpretation of 
CTC by inexperienced and experienced readers. All comparisons with CAD assistance are minus 
performance when unassisted. 
 
 Novice 
readers 
(mean) (%) 
Experienced 
readers 
(mean) (%) 
Difference 
(Novice – 
Experienced) (%) 
Unassisted sensitivity (all polyps) 15.4 
(11.3 to 20.8) 
30.3 
(23.9 to 37.7) 
-14.9 
(-19.6 to -10.5) 
Sensitivity with CAD concurrent (all polyps) 24.4 
(18.8 to 31.3) 
34.4 
(27.4 to 42.5) 
-10.0 
(-14.7 to -5.4) 
Change in sensitivity with CAD (all polyps) 9.0 
(5.1 to 13.2) 
4.1 
(1.0 to 7.5) 
4.9 
(0.3 to 9.5) 
Unassisted sensitivity (polyps ≥6mm) 28.5 
(20.2 to 36.9) 
51.0 
(40.4 to 60.9) 
-22.5 
(-29.9 to -14.7) 
Sensitivity with CAD (polyps ≥6mm) 38.5 
(29.7 to 48.3) 
54.0 
(43.0 to 64.7) 
-15.5 
(-23.0 to -7.6) 
Change in sensitivity with CAD (polyps 
≥6mm) 
10.0 
(3.0 to 17.3) 
3.0 
(-2.1 to 8.7) 
7.0 
(-1.2 to 14.7) 
Unassisted sensitivity (polyps ≤5mm) 5.9 
(3.0 to 10.0) 
15.3 
(10.4 to 21.2) 
-9.3 
(-14.3 to -5.6) 
Sensitivity with CAD (polyps ≤5mm) 14.2 
(8.4 to 21.4) 
20.1 
(13.9 to 28.0) 
-5.9 
(-10.6 to -0.9) 
Change in sensitivity with CAD (polyps 
≤5mm) 
8.3 
(4.1 to 13.6) 
4.8 
(1.5 to 8.7) 
3.5 
(-1.2 to 8.9) 
Table 23:  Effect of CAD assistance when used in second-read mode for interpretation of CTC by 
experienced readers. All comparisons with CAD assistance are minus performance when unassisted. 
Net effect RED; statistical significance denoted by underlined figures. 
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 Per-Patient analysis 
[mean (95%CI)] (%) 
Per-polyp analysis 
(mean) (%) 
CAD net effect measure 
 (all polyps) 
6.5 
(2.2 to 10.9) 
n/a 
Unassisted sensitivity   
(all polyps) 
57.5 
(49.6 to 65.2) 
30.3 
(23.9 to 37.7) 
Unassisted specificity      
   (all polyps) 
91.0 
(87.0 to 94.8) 
n/a 
Sensitivity with CAD  
 (all polyps) 
64.4 
(56.6 to 72.3) 
37.5 
(29.5 to 46.1) 
Specificity with CAD  
 (all polyps) 
89.0 
(84.1 to 93.3) 
n/a 
Change in sensitivity with CAD 
 (all polyps) 
6.9 
(2.8 to 11.2) 
7.2 
(3.9 to 10.6) 
Change in specificity with CAD 
 (all polyps) 
-2.0 
(-6.2 to 1.6) 
n/a 
CAD net effect measure 
 (polyps ≥6mm) 
6.7 
(1.5 to 12.2) 
n/a 
Unassisted sensitivity 
 (polyps ≥6mm) 
65.9 
(56.4 to 74.7) 
51.0 
(40.4 to 60.9) 
Unassisted specificity 
 (polyps ≥6mm) 
93.5 
(90.5 to 95.9) 
n/a 
Sensitivity with CAD            
(polyps ≥6mm) 
72.8 
(63.3 to 81.4) 
60.1 
(48.9 to 70.4) 
Specificity with CAD           
 (polyps ≥6mm) 
92.6 
(89.0 to 95.6) 
n/a 
Change in sensitivity with CAD 
 (polyps ≥6mm) 
6.9 
(1.9 to 12.5) 
9.1 
(3.8 to 13.8) 
Change in specificity with CAD 
 (polyps ≥6mm) 
-0.9 
(-3.7 to 1.8) 
n/a 
Unassisted sensitivity 
(polyps ≤5mm) 
n/a 15.3 
(10.4 to 21.2) 
Sensitivity with CAD 
(polyps ≤5mm) 
n/a 21.1 
(14.3 to 29.7) 
Change in sensitivity with CAD 
(polyps ≤5mm) 
n/a 5.8 
(2.3 to 9.7) 
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6.4 DISCUSSION 
This study aimed to quantify the incremental benefit of CAD for inexperienced versus 
experienced readers; both groups read the same CTC data using a concurrent CAD paradigm. 
Our primary outcome was a weighted combination of sensitivity and specificity for detection of 
patients with polyps of all sizes. We found that inexperienced readers achieved a significant, 
beneficial net-effect when using concurrent CAD but that experienced readers did not. The 
magnitude of net benefit for inexperienced readers using CAD was approximately three-times 
that achieved for experienced readers. This was achieved despite a significant fall in specificity 
with CAD for inexperienced readers (a phenomenon that did not occur with experienced 
readers), confirming that the rise in sensitivity outweighed the corresponding diminished 
specificity. For both inexperienced and experienced readers, the impact of CAD was spread 
across 83% of cases with polyps, indicating that benefit was not limited to a relatively small 
number of pivotal cases and suggesting that our findings are generalisable.  
Our primary outcome was for detection of patients with polyps of all sizes, but secondary 
outcomes for patients with polyps ≥6mm also confirmed CAD continued to confer a significant 
mean net-benefit for inexperienced readers, but not for the experienced group. Per-polyp 
analyses also found that inexperienced readers achieved significant gains in sensitivity when 
CAD-assisted for polyps of all sizes and also when restricted to polyps ≥6mm and ≤5mm. 
Experienced readers also achieved significant gains in sensitivity for the ‘all polyps’ and ‘≤5mm’ 
analyses, mainly due to increased detection of both medium and smaller polyps; statistical 
power was limited for analyses of polyps ≥6mm, which will impact on the ability to identify 
significance. 
Several studies have investigated the effect of CAD-assistance on inexperienced readers of CTC, 
both radiologists(34, 252-254) and technicians(159). However, direct comparisons of 
inexperienced and experienced readers are uncommon, possibly because experienced readers 
are more difficult to recruit to research studies than less experienced individuals (who are 
often trainees and/or those who wish to lean CTC). Mang and colleagues(251) used a second-
reader paradigm, finding that CAD increased the sensitivity of two inexperienced readers to 
levels close to those achieved by two experienced readers. Our findings suggest that while CAD 
improves the diagnostic accuracy of inexperienced readers, in isolation CAD is insufficient to 
compensate for a lack of proper training and experience. For example, CAD assisted per-polyp 
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sensitivity for lesions ≥6mm (considered a threshold for ‘clinical significance’) was just 38.5% 
for inexperienced readers versus 54.0% for experienced readers. Supporting this, a study of 6 
inexperienced readers who had participated in a prior study of CAD for CTC found that a single 
day of focussed clinical training resulted in a significant incremental gain in mean sensitivity 
subsequently (172). Likewise, researchers have also investigated the role of CAD prompting of 
potential polyps to facilitate training inexperienced readers(255).  
 
Our comparison used concurrent CAD because both groups used this paradigm to read the 
same cases. However, we found that second-read CAD (tested only by experienced readers) 
provided a significant net-benefit to experienced readers whereas concurrent CAD did not. This 
suggests the second-read paradigm provides the greatest diagnostic accuracy. Other 
researchers have also found second-read CAD beneficial for experienced readers, using ROC 
AUC as the primary analysis(20). Although second-read CAD was not tested on inexperienced 
readers, it is plausible to expect at least a similar net-benefit to that seen in experienced 
readers; i.e. second-read CAD is likely to be more effective than concurrent CAD. A conservative 
estimate would assume a similar improvement in the inexperienced readers’ diagnostic 
performance between concurrent and second-read paradigms to that observed for 
experienced readers. This assumption suggests that per-patient sensitivity for all polyps would 
increase significantly by approximately 16.6% with a potentially significant decrease in 
specificity of approximately -5.5% 
 
Our primary outcome was based on detection of patients with polyps of all sizes. We chose this 
endpoint because the clinical trajectory for a patient found to have polyps is likely to be 
colonoscopy, and this usually applies irrespective of the number of polyps found as long as one 
crosses the size threshold for referral. We chose not to apply a size threshold for our primary 
outcome because doing so would reduce power (by reducing the number of patient endpoints) 
and there is also disagreement between radiologists and gastroenterologists regarding the 
appropriate diameter threshold for referral to endoscopy(256). Moreover, 3 or more 
diminutive polyps alone may indicate a patient at risk of developing colorectal cancer, 
attracting a higher CRADS score (99) and also prompting colonoscopy. Also, since smaller 
polyps are more difficult to detect than larger polyps, the a priori expectation would be that 
CAD is likely to have most impact on this category.  
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Mean unassisted interpretation time was significantly longer for inexperienced readers, by 
approximately 3 minutes, a finding that did not surprise us since we would expect experienced 
readers to be quicker (although it could be argued that the most accurate interpretations are 
the result of slow, careful inspection of the imaging data). However, the effect of using 
concurrent CAD was different, shortening interpretation time for inexperienced readers (by 
over two minutes) and raising it for experienced readers (by just under a minute). The reasons 
why this happened are unclear but it seems likely that when using CAD concurrently, 
inexperienced readers were paying less attention to un-annotated areas of the colonic lumen 
than they did when unassisted, which suggests an ‘over-reliance’ on CAD prompts. This 
phenomenon was not observed with experienced readers, possibly because they were more 
aware that CAD may be inaccurate, although both groups were told in advance that the CAD 
algorithm made both TP and FP prompts, and that it may miss polyps altogether. 
This study does have limitations. Reading environment differed between groups (inexperienced 
participants read under ‘laboratory’ conditions over a week whereas experienced readers’ 
interpretations occurred over a month, at their place of work). However, the systematic review 
presented in Chapter 4 suggests this is unlikely to have resulted in significant bias. Also, while 
the CAD algorithm was identical for both reader groups (and so TP and FP prompting was 
identical between studies), the reading platform was different: Inexperienced readers used an 
in-house interface whereas experienced readers used commercially-available workstations with 
the CAD algorithm integrated. Our expectation that second-read CAD would lead to an even 
greater benefit for inexperienced readers is based on the direct comparison between the two 
groups using the concurrent paradigm, and the incremental benefit of second-read concurrent 
over concurrent for experienced readers. Although statistically plausible, our estimate remains 
speculative.  
 
In summary, we found that concurrent CAD resulted in a significant beneficial net-effect when 
used by inexperienced readers to identify patients with any size polyp by CTC. The net-effect 
was approximately three-times the magnitude of that observed in experienced readers. 
Experienced readers had a significantly increased net effect with second-read CAD but did not 
benefit significantly from concurrent CAD when used to identify patients with polyps of any 
size. This suggests that second-read CAD would also be more effective than concurrent CAD 
when used by inexperienced readers. 
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CHAPTER 7:  
7.  ESTABLISHING VISUAL SEARCH PATTERNS DURING CTC:  TECHNICAL 
DEVELOPMENT OF EYE TRACKING TECHNOLOGY, PROPOSED METRICS FOR 
ANALYSIS AND PILOT STUDY 
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7.1 INTRODUCTION 
Medical image perception research can provide valuable insight into radiological interpretation. 
There are quantifiable differences in visual search strategy that can be related to reader 
expertise(257-259) and certain search parameters such as saccadic amplitude and the ‘time to 
first hit’ on a target have been used as surrogates for search efficiency and accuracy (260). 
Moreover, eye-tracking can characterise false negative detections into errors of visual search 
vs. those of misclassification as it can establish whether the observer failed to see a missed 
lesion or simply chose to disregard it. This is potentially valuable for directing reader training. 
However, to date, eyetracking has been confined to mammography (258), chest radiography 
(39) and more recently, high-resolution thoracic CT (261). However, the visual task faced by 
radiologists is becoming increasingly complex with cross-sectional imaging acquiring volumetric 
information requiring review of multiple images, usually in several planes, and now with 
moving images in the case of CTC. Continuous interaction with the display is necessary to 
navigate these data, increasing the perceptual and cognitive burden for the reader. CTC 
colonography is a prime example: Colonic navigation to detect mural abnormalities often 
combines endoluminal and multiplanar reconstructions; simultaneous review of the 
complementary prone dataset adds another layer of complexity. Therefore, it is unsurprising 
that interpretation of CTC is difficult and requires considerable training(262). It is know that 
diagnostic performance varies considerably among observers but little is known regarding the 
search strategies used by experienced and inexperienced readers.  
 
The technical challenge posed by recording visual search during CTC is significant; rather than a 
consistent abnormality on a 2D image, the target pathology (e.g. a polyp in an endoluminal 
flythrough) is moving, changing in size and direction, and may remain in the field-of-view for 
only a short period of time. Furthermore, metrics for analysing eyetracking that are well-
established in the 2D literature are unlikely to transfer readily to the 3D domain.  
We aimed to separate perceptual error in CTC into either failure of search (i.e. failure to ‘look’ 
at a lesion), or failure of recognition (i.e. failing to diagnose the lesion despite having looked at 
it). In order to achieve this we aimed to develop eye-tracking applicable to 3D images, notably 
where the target pathology (in contrast to 2D display) is both moving and changing in size.  
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7.2 MATERIALS AND METHODS 
LREC approval was granted to record eye-tracking data from six readers recruited from 
participants at an ESGAR CTC workshop, Stresa, Italy, 2009. All were radiology consultants or 
registrars and gave written informed consent. Participants completed the same questionnaire 
as in Chapter 3 (Appendix B) to establish previous training and experience. None had attended 
a prior CTC course or had experience of eye-tracking. 
 
7.2.1 CASE PREPARATION 
Anonymised CTC datasets were selected from the multicentre CAD studies described in Chapter 
6 (19, 215); both studies had full ethical committee approval for data sharing. Cases included 
both symptomatic and screening patients from four centres. All had undergone CTC according 
to best practice guidelines (30, 36) followed by endoscopy. A consensus reference standard was 
available for each case. 
 
To ensure polyp detection was suitably challenging, collaborating statistician, Dr Susan Mallett, 
selected 20 CTC cases in whom a false-negative or false-positive polyp diagnosis had been 
made by approximately 50% of readers in the prior studies(19, 215). The author reviewed MPR 
images using a proprietary workstation (V3D Colon, Viatronix Inc, Stony Brook, USA) using 
reference standard reports to locate lesions. 11 cases were excluded because the lesion could 
not be demonstrated on either endoluminal projection or because it was within five seconds’ 
navigation of the anorectal junction or caecal pole. A further case was excluded because of 
concurrent true- and false-positive polyps. Ultimately five true-positive cases (6, 8, 11, 12, 
25mm according to reference standard) and two false-positive cases (5, 7mm according to 
study reader) were selected.  
The author produced short (mean 27s; range 24 to 31s) endoluminal fly-through video clips 
(15fps; 384x384 pixel matrix) incorporating each lesion. Automated navigation was recorded at 
75% maximum speed (considered by the author to reflect clinical practice) and edited to 
ensure the lesion became visible between 5 and 25 seconds at a random time-point generated 
using STATA (StataCorp, College Station, TX). Total clip duration, time of lesion appearance, time 
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of disappearance were noted and screenshots of the index lesion captured. One FP case was 
duplicated resulting in 8 video clips in total. 
 
7.2.2 CASE READING 
Eye-tracking was performed by a medical image perception scientist, Dr Peter Phillips, using a 
Tobii X50 eye-tracker located under the screen and Studio capture software (Tobii Technology 
AB, Danderyd, Sweden) hosted on a laptop. Eye-tracker accuracy was 0.5°, approximately 20 
screen pixels at 60cm viewing distance. Tracker angle and orientation were entered as 
parameters in the tracking software.  
All eight video clips were shown on an LCD monitor (Samsung SyncMaster 723N. Resolution 
1280x1024. One pixel=0.264mm). Readers viewed cases in a quiet environment free from 
disturbance; no chin rest or head restraint was used. Readers remained unaware of the study 
hypothesis and prevalence of abnormality – they were merely told that some cases would 
include polyps. Spectacles and contact lenses were worn as normal. A five-point calibration 
routine matched reader gaze to screen location. When viewing the videos, readers were asked 
to identify any potential polyps that they would scrutinise further if encountered in normal 
daily practice, with a mouse click. Following an introductory video (excluded from analysis) test 
cases were shown in two blocks with a different random order for each reader. Eye-tracking 
only took place during playback. Readers could not see their data being recorded. The total 
time to review all cases was approximately 10 minutes. 
 
7.2.3 DATA PREPARATION AND ANALYSIS 
Dr Phillips examined each video frame-by-frame. The size and position of both TP and FP 
polyps were manually outlined using circular regions of interest (ROI), a process overseen by 
the author. ROI coordinates described a circle epicentre and radius from the point of lesion 
appearance to its eventual disappearance from view. Therefore, each video generated a  
equence of circular ROIs, one per frame, encircling the index lesion to provide a representation 
of the size and position of the 3D ROI as viewed on the 2D screen (Figure 21) 
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Figure 21:   Frame-by-frame ROIs for 
the 12mm polyp. Each individual circle 
is the ROI for each individual frame 
(frame rate 15Hz). 
 
 
 
 
 
 
 
 
Eye tracking from each reader/case pair was checked to confirm gaze data were contained 
within the video area. This acted as a secondary check on the initial calibration and monitored 
any drift in reported eye position during recording. Readers’ gaze moved to keep the pathology 
in foveal view, which we termed ‘pursuit’. This involved both fixation and ‘smooth pursuit’ eye 
movements(263) with the result that grouping gaze points using existing fixation methods(264)  
(e.g. in terms of averaged x,y points) was problematic. Therefore, gaze points were grouped 
into pursuits based on the distance to the polyp ROI boundary. This reframed measurements in 
terms of the relationship between gaze and polyp, rather than gaze within the video. For each 
point of gaze data acquired during a visible polyp, the distance from the gaze point to the ROI 
margin was calculated. Points were marked as polyp fixations if within a 50 pixel threshold 
around the polyp ROI boundary. Four or more contiguous region-related fixations were 
considered to constitute pursuit. These data were used to calculate: time to first hit (time from 
first polyp appearance on the screen to the reader’s first fixation within the ROI); cumulative 
dwell time on the ROIs; number of ROI fixations. The time from first hit to mouse click (i.e. 
decision time) was also calculated. A TP detection was registered if gaze intersected a ROI 
threshold and a mouse click was registered at this time. Two types of FN detections were 
identifiable: A perceptual error occurred when no gaze intersected with the moving ROI; a  
classification error occurred when gaze data intersected a ROI but no mouse click was 
registered. All other mouse clicks were considered FPs. 
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7.2.4 STATISTICAL ANALYSIS 
Missing data was interpolated by Dr Mallett using multiple imputation methods(265) adapted 
for missing longitudinal data. Eye pursuits were defined when within 50 pixels from polyp ROI 
boundary for at least 80msec. Allowing for measurement error, the end of each pursuit was 
defined as at least 20msec when the average pursuit distance plus two standard deviations, 
was more than 50 pixels.  Eye metrics were defined as in 
Figure 22 (time to first pursuit corresponding to B-A; overall decision time E-A); cumulative 
dwell being total time within 50 pixel distance from polyp ROI boundary. The number of 
pursuits was averaged across five imputed datasets and rounded to an integer.   
Data were analysed using STATA 11.0 (StataCorp, College Station, TX). 
 
7.3 RESULTS 
Eye-tracking was technically feasible and data were acquired for all readers. Of the 6 readers, 1 
had experience of interpreting less than 10 CTC cases, 3 had interpreted between 11 and 50, 
and 2 had interpreted between 101 to 200 prior to the course. Of the 8 possible positive polyp 
identifications, the highest score (7 identifications) was made by a reader with prior experience 
of 11 to 50 cases; the lowest score (4 identifications) was made by a reader with prior 
experience of 101 to 200 cases. 
 
Perception and recognition errors for each polyp are shown in Table 24. Of the 48 decisions, 16 
(33.3%) were errors: The vast majority (15) of these errors were errors of classification. A 
search error occurred in a single case. Interestingly, the smallest (5mm) and largest (25mm) 
polyps were the most prone to error, suggesting error was not related to polyp diameter alone. 
The single perceptual (search) error occurred in the case with the smallest (5mm) lesion.  
Table 26 shows the number of times each polyp was viewed during its time on screen. There 
was only one search error. The largest polyp (case 3) was viewed by all readers at least twice 
but only indicated with a click by a single reader (Table 27). With the exception of reader 4 
looking at case 2, detection decisions indicated by a mouse click were associated with more 
than one gaze at the polyp. 
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Figure 22:  Schematic time course of identified gaze and mouse events recorded during time of polyp 
visibility (time A to F). In this instance the reader’s gaze first fixes the polyp at time B. Reader gaze 
revisits the polyp twice more (time C and D) between viewing other regions of the colon video.  The 
reader clicks the mouse to indicate suspicion, occurring at time E. The polyp disappears from the field 
of view at time F. The time to first hit is B - A. The overall reader decision time is E - B. The polyp was 
fixed 3 times (B,C,D). 
Table 27 shows the decision time for each detection. The polyp on screen for the shortest time 
(case1, 2.47s) had the shortest decision time of 2.0s for readers who clicked on this polyp (but 
a high average decision time of 81% when expressed as a percentage of polyp visibility). This 
case had the shortest average time to first pursuit time (0.3s) and on average the cumulative 
eye dwell was 52% of the time the polyp was on the screen. 
 
Table 24:  Summary of errors of search and errors of recognition for 6 readers asked to interpret 5 TP 
CTC  and 3 FP CTC  cases. 
 TP polyp cases FP polyp cases 
 1 2 3 4 5 6 7 8 
Polyp diameter (mm) 12 6 25 11 8 7 7 5 
Screen Time (seconds) 2.47 3.40 4.20 8.87 7.27 7.93 7.93 2.93 
Total Errors 1 2 5 1 0 0 2 5 
Search Errors 0 0 0 0 0 0 0 1 
Recognition Errors 1 2 5 1 0 0 2 4 
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Table 25:  Time to first pursuit and cumulative dwell for each polyp, for each reader. Values are 
seconds. A pursuit value of zero indicates that the polyp was seen immediately it became visible on 
the screen. Positive polyp identifications made by the reader are shown in bold. The average time to 
pursuit and dwell time is also shown for each case, expressed as a percentage of the time each polyp 
was visible. NA=missed lesion 
 
Reader TP Cases FP Cases 
 1 2 3 4 5 6 7 8 
1 0.94, 0.08 1.00, 1.80 0.14, 2.35 1.68, 3.97 0.46, 5.58 0.40, 4.13 0.36, 3.47 1.66, 0.52 
2 0.16, 1.76 0, 2.08 0.30, 2.30 3.25, 2.16 0.24, 5.34 0.40, 4.19 2.57, 1.78 1.32, 0.38 
3 0.10, 1.62 2.11, 0.43 0.90, 1.57 1.54, 2.93 0.04, 4.26 0.51, 2.17 0.50, 2.35 1.56, 0.34 
4 0.12, 1.00 0.76, 1.97 0.56, 2.39 0.02, 0.78 1.14, 5.36 0.32, 3.15 0.22, 2.55 2.21, 0.44 
5 0.50, 1.24 0, 2.35 0.56, 1.30 1.89, 0.82 0, 5.52 0, 3.01 0.02, 3.21 0, 0.88 
6 0, 2.07 0, 1.48 0.60, 0.98 0.40, 1.40 0, 3.53 0.46, 4.87 0.46, 4.91 (NA), (NA) 
Mean 
%age  
0.3, 1.29 0.65, 1.69 0.51, 1.81 1.46, 2.01 0.31, 4.93 0.35, 3.62 0.69, 3.04 1.35, 0.43 
12, 52 19, 50 12, 43 16, 23 4, 68 4, 46 9, 38 15, 5 
 
 
 
The polyp on screen for the longest time (case 4, 8.87s) had decision times ranging from 2.10s 
to 7.86s (Table 27). The reader of this case with the shortest decision time (reader 2) saw the 
polyp 3.25s after it had appeared and gazed at the polyp 10 times for a total of 2.16s. The 
longest decision time was made by reader 6, who saw the polyp 0.40s after it had appeared, 
and used 3 gazes with a cumulative dwell of 1.40s (Table 26 and Table 27). One video was 
viewed twice by all readers (polyp 6 and 7). Times to first pursuit and the number of gazes 
were similar within readers, although two of the six readers had decision errors in one viewing 
and not in the other  (Table 27) 
Plotting gaze on the video area (Figure 23) does not show the temporal relationship between 
points. While some clustering of points was apparent, the ordering is unknown.  
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Table 26:  Number of times each polyp was viewed by each reader during its time on screen. View was 
defined by the reader’s gaze crossing the region threshold and remaining within it for a minimum of 4 
points (80ms). Figures in bold denote a positive identification made by the reader. 
Reader TP polyp cases FP polyp cases 
 1 2 3 4 5 6 7 8 
1 1 5 2 5 2 8 7 1 
2 3 7 5 10 7 7 8 2 
3 4 4 3 9 7 7 6 2 
4 2 1 4 2 4 9 5 1 
5 3 2 2 2 6 9 9 2 
6 3 4 2 3 7 10 5 (missed) 
Table 27:  Decision time (s) for each reader for each polyp, with the average overall for each polyp. 
Recognition errors are denoted by a blank cell. The single search error is shown by an asterisk.  
Reader True positive polyp cases FP polyp cases 
 1 2 3 4 5 6 7 8 
1    7.31 4.90 6.09 6.23  
2 1.84 3.13  2.10 3.91 6.16   
3 2.21 1.20  4.73 5.47 6.67 5.73  
4 2.26 1.86 2.86 5.65 4.78 6.42 6.07  
5 1.74 2.35   6.36 6.94  2.15 
6 1.97   7.86 6.01 7.27 6.03 * 
Average decision time (sec)  
Percentage of polyp visibility time 
2.00 
(81%) 
2.14 
(63%) 
2.86 
(68%) 
5.53 
(62%) 
5.24 
(72%) 
6.59 
(83%) 
6.01 
(76%) 
2.15 
(73%) 
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Figure 23:  Distribution of a reader’s gaze in a 25s video case with a 12mm polyp. Each individual dot 
represents a gaze point (sample rate 50Hz).  
 
However, it was possible to visualize the temporal component of the data by plotting x and y 
coordinates as separate lines (Figure 24). Since time was preserved, the polyp centre position and 
maximum extent could be plotted as separate x and y areas. Thus polyps are plotted as areas 
rather than discrete lines or points, each box being 66.7ms wide, the interval of one video 
frame (Figure 24). The extent of the area added due to the distance thresholding is also plotted. 
The calculated distance from the polyp boundary to gaze points is shown in Table 26. Two 
pursuits can be identified. The first is the initial 200ms when the polyp is on screen. The 
reader’s gaze was already in the region where the polyp appeared, and tracked the polyp 
approximately 40 pixels from the polyp boundary. The second pursuit is approximately 16550 
to 17200ms, a duration of 650ms. In this instance the pursuit follows the edge of the polyp as it 
moves and increases in area. 
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Figure 24:  Time course of reader eye gaze and polyp extent for a single reader (reader 5) reading case 8 (5mm polyp). The line 
represents reader gaze position in the Y (top) and Y (bottom) video coordinates. The maximum extent of the polyp in the 
horizontal (X) and vertical (Y) directions for each video frame is shown in green, bounded by the 50 pixel distance threshold 
(grey border).  X and Y extent increases as the polyp approaches the edges of the screen. Both X and Y gaze components must be 
contained within the polyp & threshold region for a minimum of four points to be deemed a pursuit. 
 
Figure 25:  The calculated distance from gaze to the polyp boundary (line), over the same time axis as 
Figure 24. Two dashed lines are shown: the upper line is the 50 pixel distance threshold, the lower line 
represents the boundary of the polyp. A point with a negative distance value indicates that the point is 
within the polyp region.  
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7.4 DISCUSSION 
In order to investigate interpretation of modern 3D medical image displays, we have developed 
a novel method to track visual gaze when pathology is both moving and changing in size. We 
have shown that data collection is feasible and have developed suitable metrics derived from 
plotting gaze and calculating intersections with the region of pathology.   
Polyps were described frame-by-frame by circular ROIs, and individual gaze points were 
grouped into ‘pursuits’ based on distance to the time-appropriate ROI boundary. It is the 
boundary, the edge of the polyp against the background, which contains useful visual 
information. Figure 23 shows a single pursuit where reader gaze maintained a fixed distance to 
the polyp ROI boundary, despite the polyp changing size and position over the lifetime of the 
pursuit; the reader’s attention was focused on the polyp edge rather than the centre. Metrics 
such as time-to-first-hit and number-of-dwells, used in pulmonary nodule (266) and 
mammographic (38) interpretation, have been reinterpreted for gaze pursuits of moving lesions 
with changing size.  
 
Endoluminal navigation requires a visual search strategy that samples ROIs before they move 
out of view. However, competition from other features, perhaps closer to the screen edge and 
therefore larger and more detailed, may mean other ROIs must be revisited later. Readers must 
judge the optimal time to look at a feature, trading size and detail against remaining screen 
time. Gaze tracking demonstrates how readers allocate attention. Our metrics can resolve 
differences in reader visual search behaviour. The example of two readers (2 and 6) of the 
longest case on screen (case 4), shows different approaches to identification: There is marked 
difference in the number of pursuits, but both result in a positive identification. Reader 2 made 
their decision quickly and early, but with multiple gazes (10 – average 216ms), indicating that 
they had to attend to other features during their decision. Reader 6 saw the polyp early but 
attended to other areas for longer, making fewer (but longer) gazes at the polyp (3 – average 
467ms) and not making a decision until the polyp was about to go off screen. Both readers had 
similar experience and identifications (11-to-50 case; 5 of 8 correct identifications). 
 
This study does have limitations: We investigated endoluminal fly-through, but only in 
automatic mode. Readers clicked to indicate interest, but could not stop and inspect as per 
1 4 5  
 
usual daily practice. Also, irregular polyps and those seen in profile were difficult to 
characterise precisely using a single circular ROI. Other boundary descriptions are possible to 
improve boundary accuracy but will require more complex calculations. The 50 pixel distance 
threshold was constant across all polyp sizes. A side-effect of this decision is that distant polyps 
can be called as ‘seen’ too early. A threshold based on a percentage of the polyp region radius 
would have the opposite effect; larger polyps would have a large threshold. Any future 
thresholding technique must be able to account for polyps at both small and large scales. We 
limited our investigation to inexperienced readers; it will be informative to investigate 
differences between experienced readers and between inexperienced and experienced 
readers. 
 
In summary, eye-tracking volumetric data presents unique challenges for recording what is on 
the screen where and when, and synchronising that data with gaze data. The properties of 
volume imaging modalities, particularly that not all scan data is visible simultaneously, 
challenges standard 2D metrics. We have reframed the problem by considering the relationship 
between gaze and lesion, rather than screen/image area. The metrics we developed can 
describe differences in reader gaze behaviour and attention distribution when interpreting an 
automatic CTC fly-through. Perceptual errors can be classified into visual search errors and 
recognition errors. Classification errors are most frequent in inexperienced readers. 
 
The next Section describes development and validation of novel computer algorithms that aim 
to improve lesion classification by providing accurate corresponding endoluminal locations in 
prone and supine CTC datasets. 
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SECTION D:  
DEVELOPMENT AND 
VALIDATION OF A NOVEL 
COMPUTER ALGORITHM TO 
FACILITATE CT 
COLONOGRAPHY 
INTERPRETATION 
 
 
OVERVIEW 
The research discussed thus far reaffirms the observation that CTC interpretation is difficult; 
the results of Chapter 6 suggest some experienced readers may achieve relatively disappointing 
performance even despite CAD assistance. Moreover, while CAD can partially compensate for 
inexperience, many novice readers continue to perform well below satisfactory levels. This is of 
particular concern given the significant number of radiologists interpreting CTC in daily 
European practice with little experienced suggested in Chapter 3. Moreover, increasing 
sensitivity comes at the expense of additional FP detections and while Chapter 5 suggests this 
may be considered of little clinical consequence by patients, it has profound impact on cost-
effectiveness and subsequent implementation. Although sample size is small, our eye-tracking 
research suggested that, among inexperienced observers, most errors were due to suboptimal 
lesion characterisation; facilitating classification of potential pathology should improve reader 
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performance. As discussed at the outset of this Thesis, matching polyps on both the prone and 
supine acquisitions is central to accurate lesion characterisation but is also challenging: The 
gas-filled bowel undergoes significant deformation and movement during the change of 
position(27), complicating polyp matching, prolonging reporting time, and potentially 
engendering error.  Our group has developed a non-rigid computer aided registration 
technique that can match prone and supine endoluminal surface points despite colonic 
deformation, with the aim of facilitating CTC interpretation and hence, improving diagnostic 
performance.  
 
The CASPR (Computer Assisted Supine-Prone Registration) algorithm development described in 
the following Section was led by computer scientists, Mr Holger Roth (Chapter 8) and Mr 
Thomas Hampshire (Chapter 9) under the supervision of Professor David Hawkes, University 
College London. Methodological descriptions, figures and equations have been adapted with 
their kind permission to provide the technical introduction to the Author’s in vitro (Chapter 10) 
and in vivo (Chapter 11) validation of this novel software. 
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CHAPTER 8 
8.  DEVELOPMENT OF A NOVEL COMPUTER ALGORITHM FOR MATCHING PRONE 
AND SUPINE ENDOLUMINAL LOCATIONS DURING CTC INTERPRETATION 
 
 
AUTHOR DECLARATION 
The research presented in this Chapter was published in: Roth HR, McClelland JR, Boone DJ, et 
al. Registration of the endoluminal surfaces of the colon derived from prone and supine CTC. 
Medical Physics, 2011;38:3077-89.(267). Holger Roth led this project under the supervision of 
Professor David Hawkes, and the technical description contained in this Chapter is reproduced 
with their permission. The author’s collaboration involved establishing ethical approval to 
recruit patients for algorithm development, gathering CTC data thus generated, designing and 
performing the clinical validation study, and editing manuscripts. While the author contributed 
to algorithm development, programming and implementation were performed by 
collaborators. 
 
 
8.1 INTRODUCTION 
As described above, interpretation of CTC is difficult and time consuming even for experienced 
readers. Although the technical quality of the CT data has an impact on diagnostic accuracy, 
perceptual error on the part of the reporting radiologist accounts for the majority of missed 
pathology. Retained faecal matter or anatomical structures such as thickened haustral folds can 
closely simulate pathology, and collapsed segments impair visualisation. CTC is therefore 
performed routinely with the patient in both the prone and supine position. This procedure 
redistributes gas and faeces and presents the opportunity for abnormalities masked on one 
acquisition to become visible on the other. Also, potential abnormalities identified on one scan 
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are more likely to represent true polyps if identified in an identical position on the other, since 
polyps (in general) do not move whereas fluid and residue does. Matching identical colonic 
locations between the prone and supine data acquisitions is thus a cornerstone of 
interpretation. Unfortunately however, the colon is tortuous and deformable with the result 
that positional shifts between the prone and supine acquisitions complicate the observer’s task 
of matching corresponding locations. In order to address this, we have developed a novel 
computational method to aided prone-supine image registration, so that corresponding 
locations between the two scans can be identified rapidly by the reader, with the aim of 
reducing interpretation time and increasing diagnostic accuracy.  
 
 
8.2 METHODS 1: ALGORITHM DEVELOPMENT 
8.2.1 SUMMARY OF THE IMAGE REGISTRATION PRINCIPLE 
Establishing a cylindrical representation of the 3D endoluminal colonic surface enables each 
surface point to be described in two dimensions. Therefore, each endoluminal point can be 
described using two indices x  and y , where x  describes the length along the colon and 
y denotes its angular orientation. Nevertheless, the colorectum is not a simple cylinder and 
transforming a complex 3D structure in two dimensions poses considerable geometric 
challenges. In addition, it is necessary to preserve the complex surface information such as 
haustra and, most importantly, mural pathology. Methods have been developed to ‘unwrap’ 
such cylindrical representations known as ‘virtual dissection’ or ‘filet’ views. These visualisation 
techniques have been adopted by several workstation vendors(40) as they enable a rapid 
overview of the colonic surface(268). 
 
One solution for mapping the colonic surface to a cylinder utilises conformal mapping. 
Conformal maps are typically applied to triangulated surface meshes to enable simplified 
representation of the 3D object in 2D space. These methods are based on differential geometry 
and ensure one-to-one mapping of the 3D surface to 2D space while preserving local angles in 
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the triangles of the mesh(269). This, consequently preserves the appearance of local 
structures, e.g. polyps and haustral folds(270). 
The registration algorithm described in this Chapter is based on the following principle:  
A prone endoluminal colonic surface pS  in 
3R  can be transformed using conformal one-to-one 
mapping pf  to a parameterisation pP  in 
2R . Likewise, the supine surface sS  is mapped to the 
supine parameterisation sP  using the mapping function sf . Applying a transformation cylT  it is 
possible to transform the cylindrical representation pP  to  sP . However this transformation 
must be non-rigid in order to account for colonic deformations such as torsion and stretching, 
introduced when the patient changes position from prone to supine(27). Having established 
cylT  then the transformation psT  required to transform between the surfaces pS  and sS  
follows as shown in Figure 26: 
 
 
 
 
Figure 26:  The principle of colon surface registration between prone and supine CTC using a cylindrical 
2D parameterisation. The colour scale indicates the shape index at each coordinate of the surface 
computed from the 3D endoluminal colon surfaces. The hepatic and splenic flexures are marked as 
hfp/s  and sf p/s  respectively (p/s denotes prone/supine). 
 
Therefore, the process can be broken down into a series of discrete stages: firstly, the 3D 
endoluminal surface must be extracted from the colonography data; this is then converted to a 
triangulated mesh. The mesh is converted to a cylinder whilst preserving surface curvature 
information using conformal mapping; the same is performed for the opposing prone 
colonography data. Having achieved two cylindrical surface parameterisations, the freeform 
deformation required to transform between the cylinders is calculated. This then enables the 
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calculation of a corresponding point for any location on either endoluminal surface. These 
steps are considered in greater detail below. 
 
 
 8.2.2 SEGMENTATION OF THE ENDOLUMINAL SURFACE FROM CTC DATA 
The result of the segmentation process should be familiar to anyone who interprets CTC as this 
is the fundamental step in generating the endoluminal fly-through. There are several methods; 
we implemented the technique described by Slabaugh et al(271). Using proprietary software 
(MedicRead 3.0, Medicsight Ltd, Hammersmith, London) high attenuation luminal oral contrast 
is subtracted to provide ‘digitally cleansed’ prone and supine datasets. Next, the inflated 
lumena L  are extracted by identifying gas-density voxels within each dataset. Other gas-
containing structures such as small bowel and the lung bases are often erroneously segmented 
simultaneously, either separately or in continuity with the colonic lumen. Indeed, most 
colonography workstations enable the reader to check the segmentation to ensure it has not 
included terminal ileum. Extracolonic gas is excluded using a combination of shrinking 
(‘eroding’) and re-dilating the lumen. Ultimately, although the process is automated, a final 
manual check is made to ensure accurate segmentation, just as the reader would when 
performing a fly-through in clinical practice. 
 
 
8.2.3 CENTRELINE EXTRACTION 
Another crucial step involved in generating an automated endoluminal flythrough is extraction 
of the central path along the colonic lumen - the centreline. The centreline can be extracted 
with the method described by Deschamps et al(272) based on evolving a wave front through 
the colon using the fast marching method(273). This is illustrated in Figure 27 using a synthetic 
colonic image. Other methods such as Sadleir’s (274) could be used providing they guarantee 
the extraction of a topologically correct centreline. 
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Figure 27:  Centreline extraction using the fast marching method on a synthetic image: a map of the 
distance to the endoluminal surface (left) is used as a speed function F(x). After wave propagation 
through the colon (right), the centreline path can be extracted by following the steepest gradient of 
the wave function (colour coded from blue to red).  
 
The path should run from the anorectal junction to the tip of the caecal pole and extraction 
requires a defined start- and end-point. Usually, the most caudal point in the colonic lumen is 
selected as this corresponds to the patient's anorectal junction in both projections. The caecal 
endpoint can be identified from the most caudal luminal point to the right of the abdomino-
pelvic volume. These positions tend to be relatively fixed due to their retroperitoneal or sub 
peritoneal locations; good point correspondence improves similarity between the prone and 
supine rectal and caecal surface areas when conformally mapping to a cylinder as described 
below (8.2.8) 
 
8.2.4 TOPOLOGICAL CORRECTION 
The colonic lumen L  is now represented as a single 3-dimensional structure with a start and a 
finish. However, topological errors occur due to reconstruction artefacts, image noise, or 
attempted subtraction of inhomogeneously tagged fluid (secondary to suboptimal faecal 
tagging). In particular, this occurs at flexures or haustra where the thin-walled colon folds back 
upon itself, resulting in surface connections known as ‘handles’ (270) (Figure 28).  The 
centreline is used to remove these handles by adapting a topology correction method used for 
the extraction of topologically correct thickness measurements of the human brain(275).  
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Figure 28:  Left: Enlarged view of handles and an erroneous connection caused by limitation of the 
segmentation quality, resulting in incorrect topology. Right: the same surface region after topological 
correction. Comparison of the highlighted surface areas shows that the handles are now removed and 
the endoluminal surface is of genus zero. 
 
 
8.2.5 COLONIC SURFACE EXTRACTION 
Having performed topological correction of the luminal volumes ( corrL ), it follows the surfaces 
extracted from the gas-tissue interface of these volumes are also topologically correct (i.e. of 
genus zero). Therefore, the endoluminal colonic surfaces S  are modelled as triangulated 
meshes on the surfaces of corr
L
using the ‘marching cubes’ algorithm (276) with subsequent 
smoothing using the method described by Taubin(277). This facilitates convergence to a 2D 
parameterisation as described below. Furthermore, the mesh is decimated using a quadric 
edge collapsing method(278)  to reduce complexity and shorten computation time. We 
automatically detected any resulting self-intersecting faces and vertices using the utilities 
available in the open source software Meshlab(279) (http://meshlab.sourceforge.net/).  
This procedure results in a simply connected genus-zero surface S  of the colonic lumen corrL . 
On average, the resulting surface meshes for cases described in this  Chapter had around 
60,000 faces with typical edge lengths of 3.3 (  1.3) mm. 
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8.2.6 CYLINDRICAL REPRESENTATION OF THE ENDOLUMINAL COLONIC SURFACE VIA DISCRETE RICCI FLOW 
As described above, the endoluminal colon surfaces S  can be modelled as piecewise-linear 
meshes composed of vertices iv  that are connected using triangular faces. Those surfaces S  
can be transformed using a conformal mapping method. One such method to parameterise 
arbitrary discrete surfaces was introduced by Hamilton (280) for Riemannian geometry based 
on Ricci flow. Ricci flow deforms the surface proportionally to its local Gaussian curvature 
similar to a heat diffusion process until it converges towards a desired Gaussian curvature. It 
can be formulated for discrete surfaces such as triangulated meshes(281). Rather than mapping 
the surface to a rectangle as with other methods(282), the Ricci flow does not require a 
boundary. Many other conformal mapping methods require the definition of a boundary along 
the surface in order to enable a mapping of this boundary from 3D to 2D(269). This typically 
requires selecting an arbitrary path (often the shortest path) where the surface can be sliced 
open. This path is then mapped onto the boundary of a rectangle in 2D which constrains how 
all other vertices are mapped to 2D. When computing parameterisations using Ricci flow, there 
is no requirement to define such a boundary which is advantageous. Qiu et al(283) were the 
first to apply Ricci flow to a colonic surface using volume rendering for the purpose of 
visualisation; we implement a modification of their approach. 
 
The original genus-zero surface S  has to be converted to a surface SD  of genus-one for the 
purpose of cylindrical endoluminal surface parameterisation (281). This involves converting a 
spheroid surface to a torus-like surface. Therefore, we create holes in the surface mesh by 
removing vertices and connected triangular faces closest to the previously selected caecal and 
rectal points. The remaining surface is doubled, inverted the remaining surface to create the 
torus. The resulting surface SD  serves then as input to the Ricci flow algorithm. 
 
8.2.7 EMBEDDING INTO TWO-DIMENSIONAL SPACE 
Following Ricci flow convergence, the surface mesh has its local Gaussian curvatures iK  
tending to zero everywhere and hence, can be embedded into two-dimensional space 2R , 
using the edge lengths of each triangle to iteratively add remaining triangular faces, similar to 
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the method described by Jin et al (281). When the errors in the planar embedding are small 
enough, the Ricci flow can be stopped resulting in a continuous 2D parameterisation P . 
 
 
8.2.8 GENERATING CYLINDRICAL IMAGES 
The 2D mesh P  represents a regular cylinder and can be re-sampled between 0  and 360  to 
generate rectangular raster images I   for use in an intensity-based cylindrical registration 
(Figure 29). Here, the horizontal dimension x  corresponds to a distance along the colon from 
caecum to rectum and the vertical dimension y  to the angular position around the 
circumference of the colon.  
 
 
 
 
Figure 29:  Sampling the unfolded mesh to generate rectangular raster-images I suitable for image 
registration. Each band represents a shifted copy of the planar embedded meshes P which are sampled 
between the horizontal lines to cover a full 360
o
 of endoluminal colon surfaces S. 
 
Each pixel comprising the raster image I has an intensity value assigned to it in order to drive a 
non-rigid cylindrical registration. These values are estimated from the local surface shape index 
( SI ) computed on each vertex iv  of a given triangle on the 3D surface mesh S . The shape 
index SI  is a normalised shape descriptor based on local curvature (Figure 30) (284) that can 
describe the local colonic structures such as haustra, folds and polyps. Consequently, it has 
been successfully integrated into colon CAD algorithms  (285)  
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Figure 30:  The shape index (SI)  is a normalised shape measurement to describe local surface 
structures(285). 
 
 
Sampling this curvature intensity information onto the parameterisation P  results in ‘heat 
map’ raster-images I  for supine and prone endoluminal colon surfaces as shown in Figure 31 
(top, middle). The top and bottom edges of the images I  correspond to the same line along 
the endoluminal surface S , running from caecum to rectum. Thus, these images I  represent 
the endoluminal colonic surface as cylinders. Corresponding features, like haustral folds or the 
teniae coli are clearly visible in Figure 31. By using this curvature data to drive an intensity-
based registration method, the cylindrical images can be non-rigidly aligned to provide full 
spatial correspondence between the prone and supine endoluminal surfaces pS  and sS  as 
follows. 
 
 
Figure 31:  Supine (top), prone (middle) and deformed supine deformed to match prone (bottom) 
raster images where each pixel has the value of the corresponding shape index computed on the 
endoluminal colonic surface. The x-axis is the position along the colon, while the y-axis is its 
circumferential location. The x-positions for the detected hepatic and splenic flexures are marked as 
xhepatic and xsplenic. The location of a polyp is marked before (top) and after registration (middle, 
bottom).  
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8.2.9 ESTABLISHING SPATIAL CORRESPONDENCE BETWEEN PRONE AND SUPINE DATASETS 
The complex 3D endoluminal prone and supine colonography surfaces have now been 
simplified to 2D cylindrical representations. However, the anatomical structures remain 
misaligned due to torsion and linear deformations that take place between CT acquisitions. 
Consequently non-rigid image registration can be employed to align these local anatomical 
structures based upon their surface curvature information described above. To provide 
reproducible points from which to initialise the registration algorithm, corresponding hepatic 
flexure ( sp/hf ) and splenic flexure ( sp/sf ) surface points are identified in both datasets. Flexure 
detection is based on the local maxima of the centreline z-coordinate, i.e. the two most cranial 
points on the luminal volume must represent the splenic and hepatic flexures. The hepatic 
flexure is easily identified as it is closest to the caecum. The corresponding x -positions for the 
hepatic and splenic flexures are extrapolated by linear scaling onto the surface 
parameterisations, marked as hepaticx  and splenicx  in Figure 31.  These flexure positions are used 
to initialise non-rigid deformation. 
 
 
8.2.10 FREE-FORM DEFORMATION AND NON-RIGID IMAGE REGISTRATION 
As described previously, the cylindrical representations are used to generate shape index raster 
images pI  and sI , where each pixel corresponds to a voxel position on the endoluminal 
colonic surface in 3D. Alignment between pI  and sI  is established using a cylindrical non-rigid 
B-spline registration method, based upon free-form deformation developed by Rueckert et al 
(286) with fast implementation provided by Modat et al(287) using the open-source software 
package NiftyReg (http://sourceforge.net/projects/niftyreg). Displacement along the x -axis 
(along the centreline) at the colonic ends is avoided by fixing the x -displacement of the first 
and last points ensuring the rectum and caecum remain aligned yet allowing for colonic 
torsion. When optimising B-spline registration parameters, we examined a sub-set of available 
cases visually for haustral fold alignment and for polyp alignment following registration. 
Registration itself follows a coarse-to-fine approach, first registering to the largest 
deformations and then resolving the smaller differences between both images where pI is the 
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target and sI  is the source. The image resolutions are doubled until reaching 4096   256 
( yx nn  ) pixels. The cylindrical B-spline registration results in a continuous transformation 
around the entire endoluminal colon surface and allows the mapping  x

cylT  between pP  and 
sP  in cylindrical space. From this 2D mapping it is straightforward to determine the full 3D 
mapping psT  between pS  and sS  using pf  and sf  as shown previously in Figure 26. Figure 32 
illustrates the registration result obtained by applying a B-spline deformation field to a colonic 
segment. 
 
 
 
Figure 32:  Deformation field on a Section of the colon at the final, highest resolution step. The 
deformation field has been used to deform a regular B-spline grid and been overlaid on top of the 
deformed supine (red) and target (cyan) cylindrical images.  
  
 
8.2.11 DEALING WITH COLONIC UNDER-DISTENSION 
Despite optimal CTC technique (mechanical CO2 insufflation, spasmolysis etc.)(30) , segments 
of colonic collapse occur, particularly when the patient changes position from supine to 
prone(288). Furthermore, residual colonic fluid due to suboptimal bowel preparation can 
occlude the colonic lumen. This situation is encountered commonly in daily practice; data from 
the ACRIN CTC trial (16) suggest collapse and distension affect approximately 50% of 
colonography cases (288).  Consequently, the segmentation process described above (p151) 
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will extract a discontinuous luminal volume and hence multiple segments for endoluminal 
surface extraction. Many vendor workstations allow the radiologist to manually select the 
order in which these disjointed colonic segments lie along the centreline.  
 
Figure 33 illustrates one such patient with distal colonic collapse (or luminal occlusion by fluid 
residue) in the supine dataset.  
 
 
 
Figure 33:   A case where the descending colon is collapsed in the supine position (marked, right 
image) but fully distended in the prone (left). 
 
It follows that any registration method relying upon the distance along the centreline will be 
hindered by a discontinuous colonic lumen unless the length of the ‘missing’ segment can be 
calculated and interpolated. Furthermore, even if algorithms are developed to estimate the 
length of the collapsed segment, complex biomechanical models are required to calculate the 
potential length of this region when fully distended. Nonetheless, some centreline-based 
methods appear to overcome local colonic collapse to register with reasonable accuracy (289-
291). However, centreline algorithms provide only a 1D correspondence from which to begin 
searching for pathology; the focus of this Chapter is providing 3D, voxel-level correspondence. 
At the time of writing, only Suh et al. (292) have published 3D registration results in cases with 
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luminal collapse; they report limited accuracy. This subject is discussed in further detail in 
Chapter 11. 
The algorithm version validated later in this Chapter relied upon manual delineation of 
collapsed segments (Figure 34). Subsequent algorithm development and integration into a 
feature-based initialisation has overcome this limitation and is the focus of Chapter 9.  
 
   
 
 
Figure 34:  Cylindrical representation as raster images of the collapsed supine (top), prone (middle) 
and deformed supine (bottom) endoluminal colon surface. The length of the collapsed segment (solid 
black bar) is interpolated manually in this version of the algorithm. Note the accuracy of polyp 
alignment (white arrows) is unaffected by the luminal discontinuity in this instance.  
  
 
8.3 METHODS: VALIDATION 
Ethical permission was obtained to utilise anonymised CTC data acquired as part of routine day-
to-day clinical practice at University College Hospital, London. CTC had been performed in 
accordance with consensus recommendations(30) and any abnormality subsequently validated 
via optical colonoscopy. Initially, to ensure spatial correspondence could be achieved across 
complete endoluminal surfaces, we selected 24 patients with optimal colonic cleansing and 
distension. While cases with minimal colonic residue were included, cases with homogenous 
faecal tagging were preferred; digital cleansing enabled continuous segmentation around the 
full colonic lumen as described above (p151). Cases were chosen with a widespread 
distribution of polyps to enable assessment of registration over the entire endoluminal surface. 
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The datasets were subdivided into 12 development sets and 12 validation sets by random 
permutation. During development, difficulty with visual identification of corresponding 
features in cylindrical image representations was noted for some cases. Further examination 
revealed this was due to either large differences in colonic distension between the prone and 
supine data or to insufficient fluid tagging, causing endoluminal surface artefacts. Large 
differences in distension can lead to dissimilarity of surface features (such as distorted haustral 
folds) and this can also influence conformal mapping. For example, Figure 35 and Figure 36 
show such a case with marked differences in cylindrical representations, resulting from 
differing distension. Visual inspection of the surface representations led to exclusion of 4 
development datasets with marked differences in local distension. Moreover, 4 validation set 
cases were excluded on the same grounds resulting in a total of 8 data sets with continuous 
colonic segmentations for validation. 
 
 
 
Figure 35:  Marked distension discrepancy changes the shape index of the cylindrical representations 
in supine (top) and prone (bottom). 3D renderings are shown below 
   
Figure 36:  Differing distension in prone and supine acquisitions causes dissimilar local features in the 
cylindrical images. 
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A further 5 cases with local colonic collapse were selected for validation providing the 3D 
endoluminal surfaces S  were judged visually to have sufficiently similar distension in the non-
collapsed regions. This selection process resulted in a total of 13 cases (8 fully connected sets 
and 5 with local colonic collapse)for validation using polyps and haustral fold reference points 
as described in the following paragraphs. 
 
8.3.1 VALIDATION USING POLYP REFERENCE POINTS 
The author preformed a directed search for polyps in both prone and supine CTC scans using 
multi-planar reformats and endoscopy reference data. Coordinates describing the endoluminal 
surface location of polyps were derived by modifying the approach of Yushkevich (293): Using a 
segmentation tool for medical images, ITK-SNAP (www.itksnap.org), the author manually 
circumscribed each polyp, frame-by-frame, on both acquisitions providing corresponding prone 
and supine endoluminal surface coordinates to test the algorithm Figure 37.  
 
 
 
Figure 37:  Delineating 3D polyp volumes using ITK-snap, a tool for segmentation of medical images. 
Note the 3cm caecal mass is overlaid by a red mask. Such volumes can be mapped onto the cylindrical 
representations to test algorithm registration accuracy. 
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The author manually labelled polyp masks in the prone and supine data by visual inspection of 
the unfolded cylindrical representations. Prior to registration, polyps were masked in the 2D 
cylindrical images I as shown in Figure 38 thus preventing polyps’ surface features from 
influencing the results. 
 
 
.  
Figure 38:  Masking polyps to ensure they do not influence subsequent registration: polyps in unfolded 
view (left). Masked polyps (right) to be ignored in registration. The centre of mass c  which is used as a 
reference point is marked (white cross) 
 
To calculate registration accuracy, a single point correspondence ),( yxc was chosen at the 
centre of each polyp on the 2D representations. These points lie on the surfaces pS  and sS  
respectively and approximate closely to the polyp apex (Figure 38, right). Each 2D reference 
point ),( yxc  corresponds to a 3D point ),,( zyxci  on the endoluminal surface S . Therefore, 
each polyp reference point sc  on the supine endoluminal surface sS  was transformed using the 
3D mapping function psT  to find the corresponding point  sps cT  on corresponding prone 
endoluminal surface pS . The 3D Euclidean distance to pc , on surface pS is the gross 3D 
registration error. 
 
All 8 datasets used to refine the algorithm had clearly corresponding features in both prone 
and supine 2D representations, as shown in Figure 31. By using a ‘heatmap’ approach to 
display surface curvature intensity (shape index) information, folds and polyps are readily 
conspicuous as yellow-red areas whereas relatively featureless intervening haustration is 
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shown as blue-green. Likewise, following cylindrical B-spline registration, the corresponding 
features are well aligned (Figure 31, bottom). The registration results are shown in Figure 39 
and Figure 40  
 
 
 
Figure 39:  Overlay of masked out polyps before (left) and after (right) B-spline registration. The prone 
image is coloured red with a yellow polyp mask, and the supine is coloured cyan with a blue polyp 
mask. After establishing spatial correspondence, aligned features display gray and the overlapping 
region of polyp masks in green. 
  
 
Figure 40:  Polyp localisation after registration using the prone (left) and supine (right) virtual 
endoscopic views. The black dot shows the resulting correspondence in the 2D (bottom) and 3D (top) 
renderings. 
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Having optimised the registration parameters using the development patient data, the 
algorithm was locked for further tuning during this validation phase. 
 
Table 28 shows the results of assessing the registrations using the polyps from all 13 validations 
sets. The error after simply mapping the endoluminal surfaces to cylinders is the Polyp 
Parameterisation Error ( PPE ) and the error following B-spline registration is denoted Polyp 
Registration Error ( PRE ). The  PPE  results confirm that cylindrical parameterisation in 
isolation is insufficient to align the datasets with precision; non-rigid B-spline registration is 
required for accurate alignment. Indeed, following full surface registration, the PRE achieved 
a mean error of 5.7mm (SD 3.4mm) across all validation polyps; all 13 polyps were well aligned. 
This result suggests the registration algorithm could successfully direct the radiologist to a 
mural location close to the true corresponding endoluminal point, even in the case of local 
colonic collapse. Reassuringly, the mean registration error (PRE) over 9 polyp correspondences 
following registration of the 8 development cases was 6.6 mm(SD 4.2mm) and therefore 
slightly higher than mean error in the validation set, to which the algorithm was naive. 
 
 
8.3.2 VALIDATION OF SPATIAL CORRESPONDENCE USING ANATOMICAL LANDMARKS 
Polyps can provide reliable corresponding point coordinates with which to test registration 
accuracy. Indeed, the apex of a small, sessile polyp likely provides the most robust landmark in 
vivo. However, pedunculated polyps can undergo considerable deformation(294) and faecal 
residue can complicate the observer task and reduce the accuracy of the reference standard. 
Moreover, most patients have few (if any) polyps and these tend to reside within the distal 
colorectum (295). Over 200 CTC cases were reviewed to select the data required for the 
validation study described above and hence, in order to increase sample size, an extensive 
database would need to be examined. This is explored in greater detail in later in this Thesis 
(Chapter 11). However, all colonography datasets have alternative, surface features such as 
haustral folds and flexures which can provide paired matching points over the entire 
endoluminal surface. The algorithm designer, computer scientist Holger Roth, identified 
haustral folds in both the prone and supine acquisitions of each validation dataset using a 
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graph-cut method developed by fellow computer scientist Tom Hampshire (outlined in Chapter 
9). Using cylindrical representations to identify regions of likely correspondence and 
endoluminal reconstructions for confirmation, the author manually matched an average of 90 
pairs of matched haustral folds for each of the validation datasets described above. This 
provided a total of 1175 matched folds pairs over all 13 prone and supine colonography 
studies. The central point of each corresponding fold was calculated and used as a reference 
point for assessing the registration.  
 
Table 28:  Registration error in mm for 13 polyps in the 13, paired colonography datasets used for 
validation (the first 8 from optimally distended cases and the following 5 from patients with local 
colonic collapse. The Polyp Parameterisation Error (PPE) gives the error in aligning the polyps after 
cylindrical parameterisation but before registration, the Polyp Registration Error (PRE) gives the error 
after surface registration. 
 
  Patient   Polyp location   Collapsed 
location in prone  
 Collapsed 
location in supine  
  PPE (mm)    PRE (mm) 
 9 (optimal)  AC   none   none   32.4   3.0 
10 (optimal)  Caecum   none   none   13.7   6.0 
11 (optimal)  Caecum   none   none   30.2   3.1 
12 (optimal)  Caecum   none   none   41.9   2.4 
13 (optimal)  DC   none   none   15.7   6.8 
14 (optimal)  AC   none   none   11.8   4.6 
15 (optimal)  DC   none   none   23.9   3.6 
16 (optimal)  AC   none   none   18.5   11.1 
 17 (collapsed)  Caecum   none   1 x DC   24.8   9.4 
18 (collapsed)  AC   none   1 x SC   62.6   3.9 
19 (collapsed)  Rectum   1 x DC   1 x DC   55.9   6.0 
20 (collapsed)  Caecum   3 x (DC, SC)   none   13.3   12.4 
21 (collapsed)  AC   1 x DC   1 x DC   39.0   1.5 
 Mean (mm)         29.5   5.7 
  SD (mm)        16.4   3.4 
1 6 7  
 
The distribution of folds is shown in Figure 41; the relative paucity of reference points in the 
left hemicolon is partly due to the anatomical frequency (the rectum and sigmoid are relatively 
devoid of hausta compared to the ascending and transverse) and also influenced by the 
increasing complexity of the observer task. 
 
 
Figure 41:  Distributions of reference points along the centreline from caecum to rectum for un-
collapsed and collapsed cases. 
 
Fold Registration Error ( FRE  ) was calculated using the process described for establishing 
( PRE ) but using the haustral fold centres as reference points rather than polyp apices. Using 
this large set of reference points, the FRE was 7.7 (  7.4) mm for a total of 1175 points 
distributed over all 13 validation patients. In comparison, using only the cylindrical 
parameterisation in isolation (without B-spline registration) returns a Fold Parameterisation 
Error ( FPE  ) of 23.4 (  12.3) mm. In Figure 42, the distributions of  FRE  for un-collapsed 
and collapsed cases are displayed for comparison. The majority of points (95%) lie below an 
error of 22.8 mm, with a maximum error of 44.1 mm. However, the FRE  is slightly higher for 
the 5 collapsed cases with 9.7 (  8.7) mm as opposed to the 8 un-collapsed cases with  FRE  
of 6.6 (  6.3) mm (Figure 42). 
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Figure 42:  Normalised histograms of the Fold Registration Error (FRE) distributions in mm using 
reference points spread over the endoluminal colon surface for un-collapsed and collapsed cases. 
 
The nature of the registration method ensures that any haustral fold is almost invariably 
aligned with a haustral fold in the corresponding dataset. However, as the registration errors 
outlined above confirm, alignment is not always to the correct, corresponding fold. However, 
82% of all 1175 reference points were assigned correctly and 15% were misaligned by just one 
fold. Furthermore, apparent misregistration is likely partly due to an imperfect reference 
standard; the author can attest that the observer task was challenging and prone to reader 
error. Avoiding this verification bias was the motivation for the porcine phantom experiment 
described later in Chapter 10. 
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8.4 DISCUSSION 
This Chapter describes the development and preliminary validation of a novel algorithm for 
registering prone and supine CTC data to calculate corresponding endoluminal surfaces 
locations. Implementing conformal mapping to convert the complex, convoluted 3-dimensional 
colonic surface onto a cylindrical parameterisation, while preserving the surface curvature 
information (via the Ricci Flow) simplifies prone-supine surface registration from a 3D to a 2D 
task. Moreover, the addition of freeform deformation of these cylindrical parameterisations 
using B-spline registration results in considerable improvements in point matching accuracy as 
illustrated above. This process can establish accurate correspondence between the 2D 
cylindrical parameterisations, and hence provide spatial correspondence over the full 3D 
endoluminal surface despite the deformations and torsion that occurs during patient 
repositioning; while overall colonic configuration undergoes large deformation the shape of 
individual surface structures remains sufficiently similar to enable surface alignment.   
During algorithm development 8 of the 24 ‘optimally distended’ cases contained extensive 
regions where the surfaces structures differed markedly between the prone and supine 
acquisitions. This was due to large differences in colonic distension or inhomogeneous fluid 
tagging (precluding successful digital cleansing and leaving an air fluid level within the lumen). 
The generalisability of the registration results is limited considerably by exclusion of these cases 
as it is likely a large proportion of colonography is similarly distended in routine practice. 
However, other methods presented in the literature that aim to generate 3D surface 
correspondence (including feature based methods(282) and voxel based methods(43, 292)) are 
also likely to encounter similar difficulties with cases where the surface features differ between 
the two datasets. Nevertheless, the proportion of such cases observed in this study suggests 
that such cases are not infrequent, and methods that can address these cases must be 
developed to achieve maximum clinical benefit. This is the focus of the next Chapter. 
 
A further consideration for clinically effective CTC registration is the relatively high prevalence 
of cases containing at least one region of complete colonic collapse (or occlusion with retained, 
untagged fluid). Preliminary results using 5 cases with collapse in at least one dataset achieved 
promising results. Moreover, the data suggest the algorithm can overcome multiple collapses in 
both views. Some centreline-based registration methods claim to handle regions of local 
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collapse, but these only give approximate correspondence based on the shape of the centreline 
and are unable to provide 3D correspondence over the endoluminal surface. At the time of 
writing, only one other research group has published 3D surface correspondence in collapsed 
cases(292), with limited accuracy. Moreover, their validation cases each contained at least one 
fully distended series. 
 
This algorithm does rely upon high quality CTC surface data for accurate registration. Therefore, 
pre-processing steps involving segmentation and topological correction were necessary to 
extract suitable surfaces. Moreover, despite improved technical implementation of CTC over 
recent years, poor cleansing, insufficient tagging and local under-distension remain common 
problems in routine clinical practice (288) and this is likely to hinder the transferability of 
registration performance described in this Chapter. Chapter 11 describes a more extensive 
clinical validation study following integration of an additional algorithm described in Chapter 9.  
 
During the preliminary validation phase, the algorithm required significant manual interaction. 
In particular, providing colonic start- and end-points, correcting colonic segmentation, 
excluding the insufflation catheter and performing a visual inspection of segmentation quality. 
These steps have subsequently been automated as described in the following Chapters but it is 
possible that human interaction contributed to the registration performance presented in this 
Chapter. For example, when spanning collapsed segments, the interpolated segment was 
estimated following visual inspection of the 2D parameterisations.    
 
Another limitation that could inhibit clinical implementation of this algorithm is the duration 
taken to process each case. For surface meshes of the size used in this study (approximately 
60000 triangular faces), single processor implementation of the Ricci flow conformal mapping 
currently takes several hours to achieve sufficient convergence. However, this is reminiscent of 
early CAD systems, which had to process overnight yet now take only minutes. GPU-based 
implementation(283) would reduce processing time considerably. Alternatively, other 
conformal mapping methods could be used, e.g. (296), which require less computation time; 
obtaining rapid cylindrical parameterisation was not the focus of this study. There have been a 
number of alternative conformal mapping techniques presented in the literature (269, 270, 
296), any of which could prove more suitable but this remains the subject of future research to 
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produce appropriate parameterisations in a clinically feasible time frame. In contrast to the 
cylindrical parameterisation, the cylindrical B-spline registration provides a result within a few 
minutes, which is fast enough to be clinically useful. Nonetheless, the results confirm there 
remains a need for robust initialisation, superior to calculating flexure locations from local 
maxima. This provides the focus of the next Chapter. 
 
In conclusion, this Chapter describes a novel technique for aligning prone and supine CTC. The 
method comprises conformal mapping of CT endoluminal surface features onto a cylindrical 
surface, followed by a non-rigid registration of these features. This enables dense 
correspondence throughout the extracted colonic surface with promising registration results 
for polyp detection and for matching corresponding haustral folds on a limited sample of 
colonography datasets. The following Chapters continue to build upon this with the 
development of a haustral fold based initialisation algorithm (Chapter 10), testing and 
optimisation using a porcine phantom (Chapter 9) and finally, clinical validation (Chapter 11) 
using a large, publically available CTC archive.  
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CHAPTER 9: 
9.  AUTOMATED PRONE TO SUPINE HAUSTRAL FOLD MATCHING USING A MARKOV 
RANDOM FIELD MODEL 
 
AUTHOR DECLARATION 
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the manuscript. The author contributed clinical guidance during algorithm development; 
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9.1 INTRODUCTION 
The results presented in Chapter 8 demonstrate that surface correspondence between prone 
and supine CTC datasets can be achieved using a combination of conformal endoluminal 
surface mapping onto a cylindrical parameterisation followed by non-rigid registration. 
Moreover, preliminary validation showed promising performance. However, the study was not 
without limitations, not least the requirement for manual interaction which precludes efficient 
integration into clinical practice and may influence registration results. Furthermore, while the 
algorithm showed potential for overcoming regions of luminal collapse (Figure 43), cases with 
differing distension were excluded from the analysis, which also limits the generalisability of 
the results. 
The focus of this Chapter is the design, development and initial validation of a separate 
registration algorithm to identify and match corresponding haustral folds between CTC 
datasets. The motivation is to provide robust, automated initialisation of the surface-matching 
algorithm described in the preceding Chapter to facilitate implementation and enable 
registration in a more heterogeneous sample of CTC studies. 
Voxel based registration methods rely predominantly on surface feature similarities such as the 
morphology of haustral fold complexes, flexures and other conspicuous mural structures. 
Consequently they can be susceptible to misregistration of long, continuous sections due to 
the similarities of (non-corresponding) neighbouring features. 
This was noted during haustral fold-based validation described in Chapter 8: Short colonic 
sections were misaligned by one or two haustral folds. Despite contributing little to gross 
registration error, this could be relevant in clinical practice, particularly as pathology can be 
concealed behind a fold. Moreover, in cases with luminal collapse such as those encountered 
frequently in daily practice(288), registration error can be influenced by the manual interaction 
required to bridge regions of missing data (Figure 43). During Chapter 8, surface 
parameterisations were initially aligned by visual inspection and consequently, corresponding 
surface points generally aligned to within approximately 20mm of each other, even prior to 
1 7 4  
 
 
Figure 43:  External 3D rendered view of prone (left) and supine (right) datasets. The dotted line 
indicates  luminal collapse. The surface parameterisation (bottom) shows the conformally mapped 
prone and supine surfaces around the sigmoid with a colour-coded ‘heat map’ representing shape 
index intensity. Red areas indicate regions of collapse (Black lines show detected fold 
correspondences). Note that the length of missing data was manually determined following visual 
inspection of the surface features;  interpolation with equivalent lengths would likely stress the non-
rigid registration process. 
 
performing non-rigid registration. This degree of user interaction would not be appropriate in 
clinical use and does not reflect how the algorithm would perform if fully automated. Although 
relatively fixed colonic locations such as the flexures, caecum and anorectal junction can help 
provide gross alignment between the datasets, simply extracting local maxima and minima can 
result in differing anatomical landmarks. However, this issue is not unique to our registration 
algorithm; other methods involving conformal mapping of the colonic surface have recently 
been described which share similar limitations. For example, Zeng et al combined conformal 
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mapping with feature matching to register prone and supine surfaces(282) but rather than a 
cylindrical parameterisation, they mapped the endoluminal surfaces onto five pairs of 
rectangles. However, this method required accurate manual delineation of five matching 
segments in the prone and supine datasets, which is difficult to achieve particularly in cases 
with colonic collapse. Furthermore, this problem is not specific to complex 3D registration 
techniques: Luminal collapse and differential distension detrimental to polyp registration along 
the colonic centreline (298). Considerable research has attempted to improve centreline 
registration accuracy, particularly in suboptimally prepared cases (43, 290, 291, 299-302). For 
example, endoluminal positions can be expressed relative to overall centreline length 
(‘normalised distance along the colonic centreline NDACC’)(290, 302) to adjust for shrinking or 
stretching between acquisitions. Additionally, automated detection of anatomical reference 
points (e.g. flexures or rectum) and path geometry can be used to improve registration (292, 
303, 304). Alternative voxel-based methods can provide a further means of deforming the 
centreline (43) yet these also rely, to an extent, upon optimal colonic preparation; a scenario 
which occurs infrequently in daily practice (83).  
 
Fukano et al. proposed an alternative registration method based on haustral fold 
matching(305). An algorithm was used to extract relative fold positions along the centreline 
and used for surface matching. This method involved automatic identification of a set of 
landmark coordinates to guide registration and hence, the attraction of this technique is the 
requirement for minimal manual intervention. However, initial validation results were 
disappointing with correct registration of only 65.1% of large folds and 13.3% of small folds. 
Consequently, it is doubtful that, in its current implementation, this method would provide 
significant gains initialising the surface matching algorithm described in Chapter 8. 
Nevertheless, while the morphology and location of haustral folds may vary (Figure 44), their 
position relative to one another remains consistent and as such, haustral fold registration is 
inherently resistant to varying luminal distension and colonic collapse. We aimed to develop 
and validate a novel algorithm for generating fold-based correspondences between the prone 
and supine CT data to provide an initialisation for voxel-level surface registration algorithms in 
cases with luminal collapse or differing distension. 
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Figure 44:  Endoluminal CTC showing morphologically disparate corresponding folds in the prone (left) 
and supine (right). The complexity of the observer task and thus the likely imperfect reference 
standard results from uncertainty matching folds such as these where there are no other contributory 
surface features (such as diverticula). 
 
 
9.2 METHODS: ALGORITHM DEVELOPMENT 
9.2.1 CTC SAMPLE SELECTION 
Separate development and validation CTC datasets were selected from the collection accrued 
during development of the algorithm described in Chapter 8. Cleansing and insufflation had 
been performed in all cases according to best-practice recommendations(30). Ethical approval 
was obtained to use these patient data to develop the additional algorithm. As previously 
described, all patients provided informed consent; data were anonymised. In total, all 13 
validation cases were retained to test this new algorithm. A random selection of 5 development 
cases was selected to tune algorithm parameters. 
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9.2.2 ALGORITHM DESCRIPTION  
Unlike previous methods (282, 305), which have attempted to match corresponding folds based 
on spatial location and size alone, we aimed for this algorithm to incorporate endoluminal 
visual renderings in addition to local geometric information. The proposed matching problem is 
modelled using a Markov Random Field (MRF) and the maximum a posteriori labelling solution 
is estimated to provide correspondence.  
 
9.2.3 ENDOLUMINAL SURFACE PREPARATION 
The procedure for digital cleansing, colonic segmentation, topological correction and extraction 
of the endoluminal surface from prone and supine CTC data is described previously in Section 
8.3. Multifaceted triangulated surfaces meshes (approximately 60000 faces), were again 
constructed using Lorensens’s ‘marching cubes’ algorithm(276). However, the present 
algorithm has no requirement for 2D surface parameterisation (for example, by implementing 
the Ricci flow conformal mapping algorithm) and can be performed in 3D space. This avoids 
introducing similar limitations to those described in the preceding Chapter. 
 
9.2.4 GRAPH CUT HAUSTRAL FOLD SEGMENTATION  
As haustral folds are elongated, mural protrusions, they can be identified by examining surface 
curvature measurements from an endoluminal surface reconstruction. Maximum ( 1k ) and 
minimum ( 2k ) values of the normal curvature at any point are known as the principal 
curvatures. At the centre of a fold,  0>>1k  and 02 k . Therefore, the metric  
||||= 21 kkM   can classify each vertex on the endoluminal mesh as belonging to a fold, or 
otherwise. The   parameter penalises the metric against curvature in any direction other than 
in the maximum, to separate the folds at the teniae coli. Thereafter, the surface mesh is 
considered as a graph, with the vertices comprising the nodes and triangles edges defining the 
graph edges. A graph cut segmentation(306) is thus performed differentiating folds from non-
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folds over the entire endoluminal surface (Figure 45). The centre of each fold is calculated and 
used to label each fold location.  
 
 
 
Figure 45:  External (a) and internal (b) endoluminal reconstructions showing haustral folds following 
segmentation. Note the colour-coded surface curvature intensity.  
 
9.2.5 MARKOV RANDOM FIELD MODELLING 
Having established the 3D location of each fold it is possible to employ a Markov Random Field 
model to ascertain their relationship to one-another. Technical description of this complex 
artificial intelligence technique is beyond the scope of this Thesis; interested readers are 
advised to refer to the detailed explanation provided by Hampshire et al (297). Nevertheless, in 
brief, prone and supine haustral folds (detected using the methods described above) are 
uniquely labelled and the vector between each is computed. By generating endoluminal 
surface renderings with the ‘virtual camera’ directed at the midpoint of each haustral fold, 
surface curvature intensity images can be constructed. The resulting images are then compared 
using a similarity metric (sum-of-squared-differences). By applying the MRF, the maximum a 
posteriori (MAP) estimate of the optimum fold labelling is computed. In addition, a matrix can 
be constructed (unary cost matrix) from which the likely neighbours for each haustral fold can 
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be determined (i.e. the probability that folds neighbour one-another) to drive registration. 
Development datasets were used to optimise algorithm parameters and no training took place 
using validation data 
 
9. 3 METHODS: VALIDATION  
9.3.1. VALIDATION USING HAUSTRAL FOLD MATCHING 
The validation dataset used to test haustral fold matching accuracy consisted of the same cases 
used for validation in Section 8.3, with 13 patient cases, 5 of which contained at least one 
region of luminal discontinuity, either due to suboptimal distension or excess retained fluid. 
Likewise, the process by which the author manually identified corresponding haustral fold pairs 
is described in detail in Section 8.3.2. Consequently, coordinates for 1175 matching fold pairs 
were recorded over 13 datasets, 5 of which contained at least one region of local colonic 
collapse in one or both acquisitions. To assess the degree of intra-observer variability, after a 
period of three months, the author repeated the matching exercise using a random selection of 
three colonography datasets. Fold matching accuracy was assessed by comparing the 
correspondences generated by the algorithm with the reference standard points provided by 
the author.  
9.3.2. IMPROVING ACCURACY OF THE SURFACE REGISTRATION ALGORITHM BY FOLD BASED INITIALISATION 
The results of this fold matching algorithm provided automated initialisation for the surface-
based registration technique described in Chapter 8. The fold positions identified by this 
algorithm are mapped onto the surface parameterisations described previously to enable 
linear scaling between haustral folds in the direction of the centreline. This step is performed 
prior to B-spline registration and effectively automates the alignment which previously 
performed manually (potentially introducing bias). Using this enhanced initialisation, the 
surface registration is compared to polyp and fold-based reference points in an identical 
manner to that described in Section 8.3 providing 3D Euclidean registration error that can be 
compared in using a Related Samples Wilcoxon Signed Rank Test to those reported previously 
in Chapter 8. 
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9.4 RESULTS 
9.4.1 HAUSTRAL FOLD MATCHING ACCURACY 
Table 29 shows fold-labelling accuracy across all 13 datasets compared against the observer-
identified reference standard. Corresponding matches occurred in 83.1% of cases with at least 
one region of colonic discontinuity and 88.5% of optimally distended cases. Nonetheless, 
accuracy was much higher in some cases than others. For example, fold matching was 
disproportionately low in patients 1 and 10. Interrogation of these datasets suggests this may 
be due to markedly differing distension distorting the neighbourhood relationships between 
folds. For example, good distension around a flexure will cause quite distant folds to align more 
closely in 3D space. Likewise, while the similar performance in collapsed and optimal cases is 
promising for dealing with missing data, the proportion of correctly labelled folds closely 
parallels the ability of the algorithm extract folds, which in turn relies upon colonic preparation.  
 
 
 
Table 29:  Initial validation using observer-identified haustral fold correspondences  
 Validation cases without colonic collapse   Cases with colonic collapse  
 Case   1   2   3   4   5   6   7   8  Total   9   10   11   12   13  Total 
 RS Points   74   104   112   88   86   112   107   91   774   65   107   66   83   80   401  
Labelled   66   97   106   84   82   92   99   88   714   62   101   63   77   51   354  
Correct   49   90   98   70   74   76   91   84   632   50   78   53   74   39   294  
Incorrect   17   7   8   14   8   16   8   4   82   12   23   10   3   12   60  
Label(%) 89.2  93.3  94.6  95.5  95.3  82.1  92.5  96.7   92.2  95.4  94.4  95.5  92.8  63.8   88.3  
Correct(%) 74.2  92.8  92.5  83.3  90.2  82.6  91.9  95.5   88.5  80.6  77.2  84.1  96.1  76.5   83.1  
RS = Reference Standard; Labelled = folds segmented by graph-cut methods; label %=proportion of correctly labelled folds  
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9.4.2 INITIALISATION OF THE SURFACE BASED REGISTRATION METHOD 
The results for cases with and without colonic collapse are shown in Table 30 using the same 
reference standard as for the previous experiment. Initialisation significantly improved 
registration in cases with colonic collapse, decreasing mean error from 9.7mm (SD 8.7mm) to 
7.7mm (SD 7.1mm) (p=0.009). However in cases with optimal colonic distension, the mean 
error was unchanged at 6.6mm (p=0.317). This suggests that the fold matching algorithm 
enhances surface-based registration in cases of poor insufflation but cannot improve upon the 
surface-based registration in well prepared data.  
 
Table 30:  Surface registration initialisation with non-collapsed cases. The number of Reference 
Standard (RS) points are shown. Error 1 and 2 show the error of the surface-based registration without 
and with using points as an initialisation. 
  Without colonic collapse   With colonic collapse  
 Case   1   2   3   4   5   6   7   8  Total   9   10   11   12   13  Total  
 RS Points   74   104  112   88   86  112  107   91   774   65   107   66   83   80   401  
Error 1 (mm)  11.5   8.6   5.3  5.7  5.5   5.2   5.8  6.7   6.6  12.2   6.5  7.8  13.5   9.6   9.7  
Error 2 (mm)  11.5   7.2   5.5  5.7  5.8   5.5   6.1  6.9   6.6   7.9   5.8  7.8   8.7   9.1   7.7  
Difference( 
mm) 
0.0   1.4   0.2  0.0  0.3   0.3   0.3  0.2   0.0   -4.3   0.7   0   -4.8   0.5   -2  
 
 
9.5 CONCLUSION 
The initial motivation behind developing this fold-matching algorithm was to align folds 
detected at colonoscopy with those extracted from CTC data (research which remains ongoing). 
However, it was apparent that this algorithm, although unable to provide dense, voxel-level 
surface correspondence, could overcome some of the limitations inherent in the surface 
matching software described in Chapter 8 and that applying the algorithms together could 
improve registration. Indeed, applying this method to initialise the surface-based registration 
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technique appears to reduce registration error. However, the main limitation of this study 
stems from the author’s imperfect reference standard; repeated observations performed on 
three random validation sets showed intra-observer agreement of 85.3%. Moreover, the when 
the fold matching exercise was recently repeated by collaborators Dr Andrew Plumb and Dr 
Emma Helbren (307) resulting inter-observer agreement was 87.8 % and 80% compared to 
repeated fold matching in consensus with the algorithm designer, Tom Hampshire. It is difficult 
to conceive a more reliable in vivo reference standard and hence a reliable ground truth is 
required. An in vitro study using a colonic phantom is likely to be required and this is the focus 
of the following Chapter.  
1 8 3  
 
CHAPTER 10 
10.  DEVELOPMENT OF A PORCINE COLONIC PHANTOM FOR OPTIMISATION OF PRONE-
SUPINE REGISTRATION ALGORITHMS 
 
 
 
AUTHOR DECLARATION 
The research presented in this Chapter is under consideration for indexed publication: Boone D, 
Roth HR, Hampshire T, et al. CTC: Construction of a deformable porcine colonic phantom for 
development of computer assisted diagnosis algorithms. The author led this project with 
significant collaboration from co-authors Roth, Hampshire and McClelland under the joint 
supervision of Professor Steve Halligan and Professor David Hawkes. The author obtained, 
excised, and prepared the porcine specimen, supervised the CTC acquisition, and collated the 
data. Algorithm implementation and registration analysis were performed by collaborators. 
 
 
10.1  INTRODUCTION 
The preceding two Chapters describe two separate algorithms for registration: Voxel-level 
registration via cylindrical conformal mapping followed by free-form deformation (Chapter8) 
and haustral fold based registration using a Markov Random Field Model (Chapter 9). Both 
offer different approaches that contribute to overcoming the same clinical problem – the need 
for accurate, automated prone-supine registration. Consequently, applying both algorithms in 
combination could improve registration performance. However, as discussed in the previous 
two Chapters, validation has relied upon an imperfect gold standard due to the complexity of 
the observer’s interpretative task. In Chapter 8, the author performed an initial validation using 
manually matched points on the colonic surface using a combination of polyps, colonic 
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diverticula and folds. The task was technically challenging and blinded repeat matching 
(following a period of washout) revealed an intra-observer error of 8.2mm (SD 12.5 mm). Not 
only does this reinforce the difficulties encountered in clinical practice when attempting to find 
matching endoluminal locations, it also suggests the algorithms’ true performance could have 
been underestimated due to verification bias. Moreover, lack of a suitable reference standard 
for testing both algorithms hinders accurate assessment of the incremental benefit of applying 
the algorithms in combination. A colonic phantom containing fixed reproducible landmarks 
would facilitate matching of anatomical locations despite colonic deformation and provide a 
robust ‘ground truth’ against which to test both algorithms. This enabled development of a 
combined registration algorithm prior to formal clinical validation in patients (Chapter 11) 
 
While a human specimen would be preferable, panproctocolectomy is usually carried out for 
severe colitis, cancer or multiple polyposis syndromes – all of which render the specimen 
potentially unsuitable for our purposes. Porcine colon is readily available and morphologically 
similar to human colon, albeit with less haustration, and some ethical issues are avoided. For 
this reason it is used extensively in optical colonoscopy training(308) and CTC research(309, 
310). However, specific to this phantom experiment, the specimen must be constrained in such 
a way that the haustral fold pattern is not disrupted. Distension reduces mural thickness (which 
is of the order of 1-4mm) so to provide suitable CT contrast resolution, the specimen is 
generally immersed in fluid of similar attenuation value to abdominal tissue. However, the 
insufflated colon is buoyant; previous phantom studies have overcome this by submerging the 
specimen under bags of normal saline(309). However, this inevitably deforms colonic 
morphology and distorts haustral configuration. Ideally, therefore, the porcine colonic phantom 
should conform naturally with minimal extrinsic deformation. 
 
 The aim of the study therefore was to construct a porcine colonic phantom labelled with 
radiopaque markers along its length, and to image it in a variety of orientations to simulate in-
vivo colonic deformation that takes place during prone to supine repositioning. Furthermore, 
the colon must be constrained such that the haustral pattern remains consistent.  
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10.2 MATERIALS AND METHODS 
10.2.1 SPECIMEN PREPARATION 
Porcine bowel was obtained (Humphries’ Slaughterhouse, Brentwood, Essex) from a pig 
previously slaughtered for human consumption (Figure 46).  
 
Figure 46:  Unprepared porcine intestinal specimen from an 
animal slaughtered for human consumption. The colonic 
specimen remains distended due to (extensive) retained 
residue at this stage. Note the haustral fold pattern is not 
dissimilar to human colon. 
 
 
 
The author excised the colon, washed, trimmed and sutured the specimen (Figure 47). The 
distal end was sutured using a purse-string around the rectal insufflation catheter (Trimline DC; 
E-Z-Em, Westbury, NY) and the proximal end  closed with continuous blanket sutures using 2/0 
Vicryl (Ethicon Endo-Surgery, Cincinnati, Ohio) (Figure 48).  
 
 
Figure 47:  Excised, cleansed colonic specimen with short residual terminal ileum  
Figure 48:  Specimen sutured at each end with indwelling insufflation catheter in situ 
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Wound closure clips (3M™ Precise™) were placed evenly along the serosal surface of specimen 
to act as radiopaque markers for the subsequent registrations (Figure 49). 
 
Figure 49:  The colonic specimen is distended with 
water via the insufflation catheter to enable 
placement of radiopaque markers. Although not 
placed endoluminally, the colonic wall is sub-
millimetre thickness at this degree of distension. 
 
 
 
 
Having tested the colonic anastamotic integrity by insufflation to 40mmHg underwater (Figure 
50), the specimen was placed inside an acrylic 60 denier stocking, into which loops of suture 
material were attached via radiopaque plastic hooks, orientated to approximate in vivo colonic 
configuration . In particular, the flexures, rectum and caecum were relatively immobile with 
respect to the transverse colon. The prepared colon was placed inside a 500 x300x300mm 
sealable plastic crate and transferred to the CT scanning suite (Figure 51). 
 
  
Figure 50:  Colonic specimen distended at 40mmHg to test integrity 
Figure 51:  Colonic specimen placed within its artificial ‘mesentery’  
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The crate was filled with 20 L of 0.9% saline to which 60 ml of diatrizoate meglumine containing 
370 mg of iodine per millilitre has been added (Gastrografin; Schering Health Care, Burgess Hill, 
West Sussex, England), resulting in an average attenuation value of approximately 40 HU, 
similar to that of human abdominal tissue(66). The specimen was inflated with CO2 via an 
automated insufflator (MediCO2lon, Medicsight Plc), until sufficiently distended (Figure 52). 
 
Figure 52:  The buoyant insufflated colonic 
specimen, suspended via the ‘artificial mesentery’ 
has minimal haustral deformation. The ‘mesenteric 
attachments’ can be adjusted to simulate the 
deformation during positional change from prone to 
supine. 
 
10.2.2 IMAGING 
Multi-detector CT was be performed by Heena Patel and Elaine Atkins using a SOMATOM 
Sensation 64 machine (Siemens, Germany), with routine CTC acquisition parameters; 0.6mm 
collimation, 120KV, 150mAs, pitch 0.75, reconstruction thickness 1mm with 50% slice overlap. 
After the initial scan, the specimen was deformed by adjusting the position of its ‘mesenteric 
attachments’ (sutures attached to the base of the crate) to simulate prone to supine 
repositioning and rescanned using identical parameters.   
 
10.2.3 IMAGE ANALYSIS 
Images were transferred to a 3D CTC workstation, MedicRead™ 3.0 (Medicsight Plc, 
Hammersmith, London, UK) and segmentation performed for endoluminal review (Figure 53). 
Using multiplanar reformats, the radiopaque markers were identified and 3D coordinates 
recorded serially from the rectum to the caecum for each colonography dataset. Computer 
scientists, Holger Roth and Tom Hampshire applied the algorithms to all five datasets, providing 
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ten individual permutations with which to test the algorithm. 3D error for each point 
correspondence was calculated following surface registration (Chapter 8), first in isolation and 
then following haustral fold-based initialisation (Chapter 9). The radiopaque markers were 
masked to avoid influencing the registration process. 
 
Figure 53:  CTC of porcine phantom. Note the 
relatively sparse haustral folds but the overall 
similarity with less densely haustrated human 
colonic segments such as rectum and sigmoid. 
 
 
 
 
 
 
 
10.2.4 STATISTICAL ANALYSIS 
Mean registration error followed a parametric distribution; a paired t-test statistic was used to 
compare error before and after feature-based initialisation.  
 
 
10.3 RESULTS 
Overall, 5 porcine CTC datasets with differing deformation were obtained, enabling 10 separate 
comparisons, each with coordinates for 12 radiopaque markers (Figure 54 and Figure 55). In 
each case, the algorithm was able to register the endoluminal surface, resulting in 120 paired 
point correspondences with which to test registration accuracy. 
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Figure 54:  Porcine colonography acquisitions A through to E (left to right). While haustral fold 
morphology remains similar, there is considerable deformation within the mid-transverse colon and 
differential distension at the rectal and caecal ends. Performing registrations between each dataset 
provided 10 permutations with which to test the algorithm. 
 
Following registration without fold-based initialisation, mean 3D registration error (standard 
deviation; SD) over all 120 points was 24.7mm (36.8mm), with a median error of 5mm (range 
0.4 to 146.2mm). Individual registration results are displayed in (Table 31). 
 
 
Table 31: Gross registration error for endoluminal surface registration algorithm (Chapter 8) applied to 
of porcine colonic phantom CTC data without feature-based initialisation algorithm (Chapter 9) 
Combination: A to B A to C A to D A to E B to C B to D B to E C to D C to E D to E 
Mean 56.00 4.57 9.44 8.82 17.50 56.70 59.10 16.18 14.35 4.11 
SD 47.64 2.98 15.13 15.18 33.12 46.67 50.34 20.56 21.93 3.75 
Median 63.36 4.17 3.31 2.59 4.20 65.26 62.93 7.99 4.71 2.38 
Min 2.52 0.86 0.50 0.45 0.53 1.77 1.12 0.73 2.37 1.01 
Max 146.18 11.57 48.51 42.00 98.07 122.24 142.69 57.65 62.89 12.01 
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Figure 55:  Surface rendered CTC of porcine colonic phantom showing distribution of radiopaque 
markers and correspondence error vectors following registration of endoluminal surfaces A to C. 
 
 
Following fold based initialisation, there was a significant reduction in mean Euclidean 3D 
registration error to 4.9mm (SD 4.0mm) with a median error of 3.7mm (range 0.12 to 23.0mm) 
(p=0.024) (Table 32). In particular, the highest mean pre-initialisation error (greater than 2 
standard deviations from the mean) obtained when registering endoluminal surface B (A to B, 
B to D and B to E) reduced to within 1 SD of the mean following initialisation (Figure 56). 
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Table 32:  Comparison of registration error with and without feature-based initialisation when 
registering porcine colonic phantom CTC datasets. 
Combination Registration error without fold-based initialisation 
(mm) 
Registration error with fold-based initialisation 
(mm) 
A to B 56.00 4.61 
A to C 4.57 4.96 
A to D 9.44 4.63 
A to E 8.82 2.73 
B to C 17.50 4.01 
B to D 56.70 4.58 
B to E 59.10 4.28 
C to D 16.18 8.24 
C to E 14.35 6.59 
D to E 4.11 4.48 
   
Mean* 24.68 4.91 
SD 36.77 4.03 
Median 5.13 3.72 
Range 0.45 to 146.18 0.12 to 23.03 
*Significant reduction in registration error when fold-based registration algorithm is used to initialise 
voxel-level surface registration (p=0.024) 
 
Figure 56:  Comparison of registration error with and without feature-based initialisation when 
registering porcine colonic phantom CTC datasets. The marked increase in error when registering 
surface B is likely due to artefact introduced during deformation. 
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10.4 DISCUSSION 
Porcine phantom experiments have featured in CTC research since the 1990’s (66, 309-312). 
Indeed, many technical acquisition parameters used in current clinical practice stem from the 
early phantom studies described in Chapter 1. Nevertheless, this study posed unique 
challenges, not least the requirement to maintain submersion of the insufflated colonic 
specimen while minimising extrinsic haustral distortion. To the author’s knowledge, this is the 
first description of a technique to constrain the in vitro colonic specimen yet facilitating the 
realistic deformations required for testing prone-supine registration.  
 
This colonic phantom study provided an objective ‘ground truth’ reference standard which 
cannot be replicated in vivo and hence, should provide the most reliable estimate of algorithm 
performance. However, the registration error of 24.7mm (SD 36.8mm) is disappointing when 
compared to the mean polyp registration error of 5.1mm (SD 2.9mm) reported in Chapter 8. 
However, this discrepancy is not surprising in retrospect because the endoluminal surface 
algorithm relies upon strong surface features to drive the B-spline non-rigid transformation and 
these are relatively sparse in the porcine colon as compared to the human colon. Nevertheless, 
there was a significant improvement in registration accuracy when the fold-based registration 
algorithm was used for initialisation. Although these results may not necessarily be reflected in 
vivo, they are promising, particularly for improving registration in similarly featureless colonic 
segments such as the left colon in many patients. 
 
This study is not without limitations. The deformations applied to the phantom likely were not 
as marked as those encountered in vivo during prone-supine repositioning. In particular, the 
specimen was constrained such that colonic torsion was minimised. However, more extensive 
deformations attempting to stress the registration algorithm were degraded by haustral 
distortion due to the buoyancy of the insufflated specimen. An alternative solution to 
submerging the gas-filled colon in water would be to fill the colonic specimen with water, 
surrounded by room air. After inverting the image the gas/fluid contrast would allow 
colonographic segmentation. 
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In summary, by constraining a submerged porcine colonic specimen via an ‘artificial mesentery,’ 
it is possible to construct a phantom suitable for assessing the accuracy of prone-supine 
registration. Surface registration results were disappointing due to the relative paucity of 
haustral folds in porcine colon but were satisfactory following integration of haustral fold-based 
initialisation. It is likely that combining the registration algorithms described in Chapters 8 and 
9 will enhance registration accuracy in vivo but this remains unquantified; clinical validation 
using a representative sample of CTC datasets is required to infer the utility of these algorithms 
in daily practice. This is the subject of the next Chapter. 
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CHAPTER 11:  
11.  COMPUTER ASSISTED SUPINE-PRONE REGISTRATION (CASPR): EXTERNAL 
CLINICAL VALIDATION  
 
 
AUTHOR DECLARATION 
The research presented in this Chapter was led and submitted for publication by the author:   
Boone D, Halligan S, Roth H, et al. CT Colonography: External Clinical Validation of an Algorithm 
for Computer Assisted Prone-Supine Registration. Radiology. 2013 Sep; 268(3):752-60. 
The author obtained ethical approval, collated CTC data, constructed the reference standard, 
manually circumscribed polyp volumes, and performed the clinical validation experiment with 
collaborator Dr Emma Helbren. Algorithm programming and implementation were performed 
by Holger Roth and Thomas Hampshire under the supervision of Professor David Hawkes. The 
author compiled the manuscript under the supervision of Professor Steve Halligan and 
Professor Stuart Taylor. 
 
 
11.1 INTRODUCTION 
As described thus far in this Section, we have developed and performed preliminary validation 
of two separate registration algorithms and used a porcine phantom to combine them into 
computer-assisted supine-prone registration software (CASPR) to indicate corresponding points 
on the endoluminal surface of prone and supine acquisitions. The initialisation step (Chapter 9) 
compares patterns of neighbouring haustral folds to establish landmark-based correspondence; 
full 3D spatial correspondence is achieved by mapping the endoluminal surfaces to cylindrical 
representations followed by non-rigid registration (Chapter 8). Having demonstrated technical 
feasibility using optimised cases and a porcine phantom (Chapter 10), clinical validation is now 
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required using patient examinations representative of daily clinical practice. While no 
equivalent 3D surface registration algorithm is available for direct comparison to CASPR, 
centreline registration methods are widely incorporated into vendor workstations(40). The 
‘normalised distance along the colonic centreline’ (NDACC) proposed by Summers et al (290) 
corrects for discrepancies in centreline registration by expressing the distance relative to the 
overall centreline length and is relatively well researched (289-291, 301, 302). Although the 
exact mechanism of centreline registration in proprietary workstations is not publicised, it is 
likely that they are based on this technique. In order to avoid bias, validation should use data 
from centres that have not contributed cases for algorithm development (‘external validation’) 
to ensure prior exposure to the test data or similar does not influence results (215) (313). 
Therefore, the aim of this  Chapter is to describe external validation of a CASPR for CTC and to 
compare to this to the well-described NDACC (290) registration method. 
 
 
11.2 METHODS AND MATERIALS 
11.2.1 CASE CHARACTERISTICS AND SELECTION 
Cases were obtained from the National CT Colonography Trial (ACRIN 6664) (16) via the 
National Cancer Institute’s National Biomedical Imaging Archive (NBIA) 
(https://imaging.nci.nih.gov/ncia/). The CASPR algorithm was naive to these data. The ACRIN 
6664 trial protocol (http://www.acrin.org/TabID/151/Default.aspx) has been described 
previously. In brief, 2604 asymptomatic adults scheduled for colonoscopy were recruited from 
15 USA centres (16). All patients underwent CTC with full catharsis, carbon dioxide insufflation 
and faecal tagging followed by same-day colonoscopy. The archive comprises 825 CTC cases 
randomly selected from the trial (‘CT Colonography’ collection at The Cancer Imaging Archive: 
http://cancerimagingarchive.net/). Of these, 35 have at least one polyp ≥10mm. A further 68 
contain ≥1 polyp 6-9mm (one case is duplicated). Reference data (diameter, segment, axial 
slice) are available for 62 cases (29 where the largest polyp ≥10mm and 33 where the largest 
polyp measured 6-9mm) (https://wiki.cancerimagingarchive.net/x/DQE2). Datasets were 
downloaded and transferred to a CTC workstation (MedicRead 3.0, Medicsight Plc, London, 
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UK). The author used these reference data to locate polyps in prone and supine datasets. To 
maintain an external reference standard, cases were included only if pathology was identified 
at the axial location in the accompanying spreadsheet; no attempt was made to search for 
polyps using segmental location alone. Cases were selected if ≥1matched polyp ≥6mm was 
visible in both prone and supine acquisitions (Table 33). Three cases were excluded due to 
incomplete CT data, 5 where polyps were submerged in untagged fluid, and 3 where polyps 
were obscured by complete luminal collapse. Where cases contained multiple polyps, each 
individual polyp was subject to the above criteria: A further 3 polyps ≥10mm and 14 polyps 6-
9mm were thus included. Hence, the validation sample (Appendix B) was 51 patients with 68 
polyps (31 ≥10mm; 37, 6-9mm).  
Table 33:  Case and polyp selection criteria used to provide a validation sample from the publically 
available ACRIN CTC study dataset 
  Case Exclusion criteria Polyp exclusion criteria Total 
cases 
included 
Additional polyps 
suitable for 
inclusion in cases 
with multiple 
polyps** 
Total 
polyps 
Included 
to test 
algorithm 
Total cases 
available on 
archive 
External 
radiologic 
reference 
data missing 
or 
inconsistent 
Incomplete 
CTC dataset 
Polyp 
concealed in 
either prone 
or supine 
view by 
untagged 
residue 
Polyp 
concealed in 
either prone 
or supine 
view by 
luminal 
collapse 
 6-
9mm 
≥10mm   
At least 
one 
polyp, 
the 
largest 
of which 
is 6-
9mm 
68 35  2 3  2 26 11 0 37 
At least 
one 
polyp 
10mm 
or larger 
35 6  1 2  1 25 3 3 31 
Total 103 41  3 5  3 51 14 3 68 
 
For each study (including those excluded), the author recorded a subjective impression of 
distension and residue (Table 34), employing an established score used previously for the 
ACRIN CTC database (288). Cases were deemed ‘poorly prepared’ if >50% residual fluid was 
present in one or more colonic segments, and ‘collapsed’ if ≥1 region of complete luminal 
occlusion was present in either acquisition(125).  
1 9 7  
 
Table 34:  Proportion of validation cases with inadequate distension or excess colonic residue 
compared to those in the overall ACRIN CTC study sample  
 
 Total Cases with 
polyps 
≥6mm  
Number of cases with 
excess colonic residue/ 
n(%) 
Polyp-positive cases with at 
least one collapsed segment/ 
n(%) 
ACRIN CTC study sample undergoing full 
cathartic bowel preparation 
2525 825 1313 (52%)* Unavailable 
Publicly available subset of ACRIN study 
with polyps ≥6mm undergoing full bowel 
preparation 
547 103 295(54%) 50 (49%) 
Validation sample 51 51 32 (63%)** 37(73%) 
*After Hara et al (288)  
** Applying criteria described by Hara et al on the publicly available data  
 
No case was excluded on this basis however; rather, these data were collected to assess the 
generalisability of our sample (Table 34) and to perform pre-specified subgroup analysis (Table 
35). Per-polyp segmental location was also recorded (Table 36). 
 
Table 35:  Summary of gross 3D error across all polyps in validation sample. Subgroup analysis of 
registration error in cases with poor luminal distension and/ or cleansing and comparison with NDACC 
  Algorithm Registration error (mm) NDAAC      
error (mm) 
 Polyp 
size 
(mm) 
Polyp in dataset 
with at least 
one luminal 
collapse (n=37) 
Polyp in dataset 
without luminal 
collapse (n=31) 
Polyp in 
dataset with 
excess colonic 
residue* 
(n=38) 
Polyp in 
dataset with 
low colonic 
residue (n=30) 
Overall gross 
registration 
error (n=68) 
Overall gross 
registration 
error (n=68) 
Mean 12.0 21.8 17.7** 23.4 15.5*** 19.9 27.4 
S.D. 9.2 19.5 21.6 21.3 18.7 20.4 15.1 
Range 6 to 55 1.2 to 85.8 1.0 to 76.9 1.0 to 85.8  1.1 to 76.9 1.0 to 85.8 4.1 to 92.0 
Median 8 17.0 8.2 19.2 8.4 12.3 23.5**** 
 
*Excess colonic residue defined as >50% luminal fluid in one or more colonic segments 
**No Significant difference in 3D (p=0.066) registration error in cases with one or more areas of complete luminal collapse. 
***No significant difference in 3D registration error in poorly cleansed cases compared to well prepared cases (p=0.060)  
****Overall, algorithm registration error over all 68 polyps is significantly smaller compared to NDACC (p=0.001)  
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Table 36:  Per segment distribution of polyps in the validation sample compared to the overall ACRIN 
CTC dataset and mean registration error per colonic segment 
 
 Total polyps ≥6mm in  
ACRIN CTC Study 
sample 
Polyps ≥6mm  included 
in this validation 
Sample 
CASPR Mean gross 
registration error per 
colonic segment  
NDACC Mean gross 
registration error per 
colonic segment  
 n     (%) n   (%) 3D error/mm* 3D error/mm** 
Rectum 90  (16) 14 (21) 19.2 24.3 
Sigmoid 147(27) 15(22) 22.2 30.8 
Descending 58  (11) 11 (16) 18.1 31.0 
Transverse 95  (17) 7   (10) 25.5 32.7 
Ascending 97  (18) 13 (19) 21.7 25.9 
Caecum 60  (11) 8   (12) 11.7 19.1 
Total 547 68 19.9 27.4*** 
 
*No significant change in algorithm 3D registration error due to polyp position per colonic segment (p=0.76 , Kruskal-Wallis 
statistic).  
**NDACC 3D error is calculated as the smallest vector from a centreline point tangential to the true polyp location.  
***Algorithm total mean registration error significantly smaller than NDACC (p=0.001)  
 
11.2.2 RECORDING 3D  POLYP LOCATIONS 
For each polyp, 3D endoluminal location was recorded using ITK-SNAP (www.itksnap.org) (293) 
using the method described in Chapter 8. The author manually circumscribed each polyp on 
both acquisitions, thereby providing corresponding prone and supine endoluminal surface 
coordinates with which to test the algorithm.  
 
11.2.3 ALGORITHM DEVELOPMENT AND IMPLEMENTATION  
After development described previously in this Section, the algorithm was locked; no ACRIN 
data were used for algorithm development. 3D endoluminal visualisation software designed by 
Tom Hampshire was used to test the algorithm. The tool displayed 120-degree 3D endoluminal 
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colonography and via mouse-clicking a location in one dataset, automatically updated the 
opposing endoluminal view to a point calculated to be at the corresponding location in the 
opposing dataset, generated by either CASPR or NDACC depending on the methods chosen. 
The reference-standard polyp locations were confirmed by overlaying colour ‘masks’ onto the 
endoluminal surface. In practice, a ‘registration prompt’ (Figure 57) indicated the 
corresponding voxel location. However, this was deactivated when comparing against the 
NDACC method to minimise bias. 
 
11.2.4 ASSESSMENT OF CLINICAL UTILITY 
Scores to estimate potential clinical benefit during multiplanar (Table 37) or primary 
endoluminal review (Table 38) were developed by Professor Halligan and Professor Taylor.  
 For endoluminal interpretation, we considered registration ‘successful’ if the polyp 
became visible in the opposing dataset within the regular (1200) field of view without 
any need for further navigation (Figure 57). 
 Matching was considered ‘partially successful’ if the polyp became visible following 
mouse-driven rotation around the endoluminal ‘camera position’ provided by the 
algorithm (Figure 58).  
 Registration was considered ‘unsuccessful’ if any navigation back or forth along the 
colonic centreline was required in order to bring the polyp into the standard field-of-
view (Figure 60).  
 
For multiplanar assessment, registration was ‘successful’ if the polyp was within ±15mm in any 
plane and ‘partially successful’ if the polyp was visible within ±30mm; >30mm navigation was 
‘unsuccessful’. Note was made of any polyp marked directly (i.e. the prompt was on the polyp 
surface rather than the surrounding endoluminal surface) with the registration prompt using 
either display. 
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Figure 57:  (left) Example of polyp conspicuity score of 5 (‘direct hit’). Using a standard 120 degree 3D 
rendered endoluminal view, following automated registration, the prompt intersects with the true 
polyp location. Left: The registration prompt (black dot) marks the polyp location indicated by the 
observer in the supine dataset. Note the dot partially obscures this 6mm polyp. 
(Right) Following automated registration, the algorithm centres the prone 3D field of view to point 
towards the endoluminal coordinates calculated by the algorithm. Note the registration prompt (black 
dot) just intersects with the base of this sessile polyp. 
 
Figure 58:  (Left) Example of polyp conspicuity score of 4 (‘near miss’). Using a standard 120 degree 3D 
rendered endoluminal view, following registration, the polyp is visible without navigation but the 
prompt fails to intersect with the polyp. Left: The registration prompt (black dot) marks the polyp 
location indicated by the observer in the prone dataset. Note the dot partially obscures this 6mm 
polyp. (Right) Following automated registration, the algorithm centres the supine 3D field of view to 
point towards the endoluminal coordinates calculated by the algorithm. Note the registration prompt 
(black dot) fails to indicate the polyp (arrow) due to slight misregistration but the polyp is clearly 
visible in the field of view without recourse to mouse-driven navigation. The gross 3D error in this case 
was 17mm but registration was considered ‘successful’ according to pre-specified criteria. 
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Figure 59:  (Left) Example of polyp conspicuity score of 2 or 3 (‘partially successful’). Using a standard 
120 degree 3D rendered endoluminal view, following registration, the polyp is visible following 
mouse-driven rotation but without navigation along the lumen. The registration prompt (black dot) 
marks the location indicated by the observer in the prone dataset. The polyp is a 6mm sessile polyp on 
a bulky fold which is partially obscured by the marker (black dot). Note the faecal residue on an 
adjacent fold.  (Right) Following automated registration, the algorithm centres the supine 3D field of 
view to point towards the endoluminal coordinates calculated by the algorithm but due to 
misregistration, points the observer toward the adjacent cluster of faecal residue (indicated by black 
dot). The actual polyp (not shown) was ‘behind’ the endoluminal camera position and required 
mouse-driven rotation to locate.  
 
Figure 60:  (Left) Example of polyp conspicuity score of 1 (‘registration failure’). Using a standard 120 degree 3D 
rendered endoluminal view, following registration, the polyp is not visible following mouse-driven rotation; 
navigation along the lumen is required.  (left). The registration prompt (black dot) marks the polyp location 
indicated by the observer in the prone dataset. Fig 4b (right). Following automated registration, the algorithm 
aligns the supine 3D field of view to point towards the endoluminal coordinates calculated by the algorithm but 
the polyp is not visible as it is obscured by fold. Moreover, mouse-driven rotation around the endoluminal 
starting position fails to bring the 
polyp into view. (Right) Although only a few mm navigation along the centreline is required to find the polyp 
(arrow), this was considered registration failure by pre-specified criteria.  
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11.2.5 TESTING ALGORITHM PERFORMANCE 
Polyp conspicuity following registration was assessed separately by the author and also by 
collaborator Dr Emma Helbren, with technical assistance from Holger Roth. Roth loaded each 
patient case into the display software, located the polyp using reference data, and selected 
either CASPR or NDACC according to a randomisation table. The ‘registration prompt’ was 
disabled to prevent unblinding observers to the method under test. Having identified and 
clicked the polyp in either the prone or supine dataset (again, randomly allocated), the 
software automatically updated the opposing display to align the ‘virtual endoscope’ either at 
the anticipated mural location generated by CASPR or along the centreline (NDACC), depending 
on the registration method under investigation. The radiologist observer then attempted to 
locate the target polyp, using mouse driven navigation, where necessary and then grading its 
conspicuity using the pre-specified score (Table 38). The process was repeated for all polyps, 
prone to supine and then supine to prone, using both registration methods. Roth collated 
responses and where the registration algorithm scored a ‘successful’ result, the author re-
examined cases with the ‘registration prompt’ activated to assess its proximity to the polyp.  
 
Multiplanar conspicuity was assessed using the polyp reference volumes delineated above. For 
each polyp, corresponding paired mural coordinates (CASPR) or endoluminal locations (NDACC) 
were calculated. Starting with these point correspondences the minimum axial, coronal or 
sagittal navigation required to locate the polyp in the opposing dataset was determined for 
both methods. Results were scored according to pre-specified criteria (Table 37). Polyps with 
overlapping volumes following registration were examined for registration prompt accuracy. 
The distance between points on the centreline closest to the polyp apex and algorithm-
generated surface correspondence was measured to simulate (1D) registration error along the 
centreline. Finally, the gross 3D registration error was calculated from the vector between the 
polyp apex and the corresponding mural coordinates (CASPR) or the closest position on the 
centreline (NDACC), following the approach described by Wang et al (304)  
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11.2.6 STATISTICAL ANALYSIS 
Polyp location was assumed to be non-parametric; p-values less than 0.05 were considered 
statistically significant. Pairwise Wilcoxon-Signed Rank tests were used to compare the 
algorithm’s results (multiplanar, 1D, and Euclidean 3D registration error, multiplanar and 3D 
polyp conspicuity scores) to those generated from NDACC. McNemar tests were used to 
compare 'successful' conspicuity scores between CASPR and NDACC. Subgroup analysis was 
performed to compare distributions of registration error in cases with differing bowel 
preparation and endoluminal collapse. The segmental distribution of polyps ≥6mm in both the 
validation sample and the entire ACRIN CTC dataset were also compared. Comparisons used 
the Kruskal-Wallis statistical test when comparing per-segment polyp distribution and 
segmental collapse. The Mann-Witney-U statistical test was used to compare error 
distributions in cases with differing colonic cleansing.  
 
 
11.3 RESULTS 
Overall, 51 patient cases containing 68 polyps were included. In 100% cases, the algorithm was 
able to register the endoluminal surface, providing 68 paired point correspondences with 
which to test the algorithm. 
 
11.3.1 VALIDATION SAMPLE CHARACTERISTICS  
The segmental distribution of polyps in the validation sample (n=68) (Table 36) were compared 
to polyps ≥6mm (n=547) from the entire ACRIN CTC study (16)  (n=2525) to investigate the 
likely generalizability of our results. By adopting the criteria proposed by Hara et al (288), 53% 
of validation cases (n=27) had excess residual fluid compared to 52% (1313) of the total CTC 
studies from the same trial. 49% (25) had at least one region of complete luminal collapse 
(Table 34) similar to the 48% (50) observed in the total, 103, positive cases in the publicly 
available database.  
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11.3.2 REGISTRATION PERFORMANCE: GROSS 3D AND 1D ERROR (TABLE 36) 
Overall mean 3D registration error (Standard Deviation; SD) over all 68 polyps was 19.9mm 
(20.4mm), with a median error of 12.3mm (range 1.0mm to 85.8mm). 3D registration accuracy 
did not vary significantly when comparing differing colonic segments (p=0.76) (Table 35), or 
varying distension (p=0.066). Furthermore, the difference in registration accuracy was not 
significant among cases with excess residual fluid (23.4mm, n=38) compared to well-cleansed 
cases (15.5mm; n=30) (p=0.06) (Table 35). In comparison, mean Euclidean 3D registration error 
was significantly greater using NDACC: 27.4mm (SD 15.1mm) (p =0.001). Likewise, although the 
algorithm’s simulated 1D centreline error (mean 17.6mm) was not significantly less than for 
NDACC (mean 20.8mm) over the entire colon, when considering the most mobile sigmoid, 
transverse and descending colonic segments (27), mean error was significantly less than for 
NDACC (19.3mm vs 26.9mm; p=0.047). 
 
11.3.3 COMPARATIVE PERFORMANCE, MULTIPLANAR CONSPICUITY (TABLE 37)(FIGURE 61) 
Using a multiplanar approach, CASPR generated 48 (70.6%) ‘successful’ matches. Moreover, 43 
(63.2%) polyps were marked directly with the registration prompt. 13.2% were ‘partially 
successful’ and 16.5% polyp matching tasks failed according to our pre-specified criteria. In 
comparison, using NDACC, 23.5% polyp matching tasks were ‘successful’ and 58.8% ‘partially 
successful.’ Consequently, NDACC generated significantly fewer successful matches (p<0.001)  
 
11.3.4 COMPARATIVE PERFORMANCE: OBSERVER GRADED POLYP CONSPICUITY (TABLE 38)(FIGURE 62) 
Ease of polyp visualisation following registration was assessed from prone to supine and vice 
versa in all 51 cases; 68 corresponding polyp-pairs generated 136 individual polyp matching 
tasks. Using a 3D endoluminal approach (Fig 6)(Table 38), following registration using CASPR, 
two observers, the author and Dr Helbren graded 82% overall (83.1% and 80.9% respectively) 
polyp matches as ‘successful’ and 8.8% (both 8.8%) ‘partially successful’ according to pre-
specified criteria. Moreover, review of the successful cases confirmed 64.8% (68.4% and  61.1% 
respectively) of the total polyp matches were marked directly with the registration prompt. 
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Overall, 9.2% failed (8.1% and 10.3% respectively). In contrast, using NDACC, 47.5% polyp 
matches were assessed as successful (39% and 56% respectively), 36.5% (44.9% and 28.0% 
respectively) were partially successful and 16.2% (16.2% and 16.2% respectively) failed. NDACC 
registration had significantly greater failure (p<0.001). 
 
 
Table 37:  Multiplanar review clinical utility score: Description of pre-specified polyp conspicuity 
criteria and registration success following surface matching algorithm or NDACC registration. 
 Polyp conspicuity score   Definition  Registration 
‘success’ 
Number and percentage of polyps 
registered (n=68) 
   Registration 
algorithm 
NDACC 
   Number % Number % 
5 Polyp masks overlap - polyp visible 
on opposing MPR following 
registration without navigation 
(dotted line) 
 43 63.2 0 0 
4 Polyp visible after ±15mm scrolling in 
any MPR axis 
 5 7.4 16 23.5 
  TOTAL 
SUCCESSFUL 
48 70.4 16 23.5 
3 Polyp not visible within ±15mm of 
MPR navigation prompt but visible 
after ±20mm 
 0 0 23 33.8 
2 Polyp not within ±20mm of MPR 
navigation  but visible after ±30mm  
 9 13.2 17 25 
  TOTAL PARTIALLY 
SUCCESSFULL 
9 13.2 40 58.8 
1 Polyp not visible despite ±30mm of 
navigation on each MPR display  
 11 16.2 12 17.6 
  TOTAL 
UNSUCESSFUL 
11 16.2 12 17.6 
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Table 38:  3D endoluminal clinical utility score: Description of pre-specified polyp conspicuity criteria 
and registration success following surface matching algorithm or NDACC registration. 
Polyp 
conspicuity 
score (Fig 
example) 
Definition Registration 
‘success’ 
Number and percentage of polyps registered (n=68) assessed from prone to 
supine and vice versa resulting in 136 individual polyp matching events 
   Observer 1 Observer 2 Combined 
   Registratio
n algorithm  
NDACC* Registration 
algorithm  
NDACC* Registration 
algorithm  
NDACC* 
Three dimensional  N % N % N % N % % % 
5 (Fig 1) Polyp 
marked 
directly by 
registration 
prompt** 
Successful 93 68 N/
A 
N/
A 
83 61 N/
A 
N/
A 
64.5 N/A 
4 (Fig 2) Polyp 
visible 
immediatel
y in field of 
view 
Successful 20 15 53 39 27 20 76 56 17.5 47.5 
  TOTAL 
SUCCESSFUL 
113 83 53 39 110 81 76 56 82 47.5 
3 (Fig 3) Polyp 
detected 
with ±90 
deg 
rotation 
Partially 
Successful 
9 7 40 29 10 7 27 20 7 24.5 
2 (Fig 3) Polyp 
visible 
within 360 
deg 
rotation 
Partially 
Successful 
3 2 21 15 2 1 11 8 1.5 11.5 
  TOTAL 
PARTIALLY 
SUCCESSFUL 
12 9 61 45 12 9 38 2
8 
9 36.5 
1 (Fig 4) Polyp not 
visible 
without 
navigation 
along the 
colonic 
centerline  
TOTAL 
UNSUCCESSFUL 
11 8 22 16 14 10 22 1
6 
9 16 
* Standard 120 degree field of view used for all endoluminal reconstruction 
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Figure 61:   Conspicuity of polyps at multiplanar review following automated colonic registration using 
either the prone-supine registration algorithm or NDACC. Pre-specified criteria are outlined in table 
37. Note the proportion of ‘successful’ polyp matches enclosed within the dotted line represents those 
marked directly by the algorithm’s registration prompt.   
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Figure 62:  3D error. Conspicuity of polyps at endoluminal review following automated colonic 
registration using either the prone-supine registration algorithm or NDACC. Pre-specified criteria are 
outlined in table 38. Note the proportion of ‘successful’ polyp matches enclosed within the dotted line 
represents those marked directly by the algorithm’s registration prompt. 
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11.4 DISCUSSION 
 
Computer-assisted registration for CTC is not new; once methods to compute the luminal 
centreline were developed (314), they were rapidly incorporated into vendor workstations (40) 
to provide approximate corresponding endoluminal locations between prone and supine  
acquisitions. However, luminal collapse and residual fluid are encountered regularly in daily 
practice and impair centreline matching of corresponding endoluminal locations (298). 
Therefore, algorithms have been designed to overcome this. For example, expressing the 
endoluminal position relative to total centreline length (NDACC) has been shown to improve 
upon regular centreline matching (290, 302). Likewise, anatomical reference points (e.g. 
flexures or rectum) can be used to shrink or stretch centreline geometry to improve 
registration (292, 303, 304) often with promising results. However, despite correcting for 
colonic torsion using teniae coli to improve upon existing 2D centreline methods (315), Huang 
et al achieved a registration error of ±61mm. This probably reflects the use of a representative 
sample (14) with similar selection criteria to the present study; their results are likely more 
generalisable than those using optimized datasets (42, 298, 316). Therefore, the 3D error 
(20.4mm) presented in this study compares favourably.  
Furthermore, centreline studies usually assess registration accuracy by linear distance 
measurements (42, 298, 316), the significance of which does not transfer readily to clinical 
practice. In contrast, De Vries et al(289) attempted to estimate clinical utility by testing 
endoluminal polyp visibility following registration using 32 representative datasets obtained 
from an unrelated observer study. They found that 70% of polyps were visible following 
registration using an ‘unfolded cube’ visualisation, which is much larger than a standard 
120degree field-of-view(317). Using a comparable endoluminal field of view, the current 
algorithm would reveal 91% polyps, over half of which would be marked directly with a 
registration prompt. Moreover, while we chose a standard 1200 viewing angle to provide the 
most generalisable reflection of how the technology could perform in everyday practice, 
increasingly, vendor platforms are offering ultra-wide (>1500) rendering as standard. Future 
research should evaluate CASPR performance when applied to wider viewing angles and 
potentially alternative display methods such fillet views.  
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While this study compared CASPR to NDACC matching due the lack of an equivalent technology 
against which to gauge performance, this was somewhat artificial. In particular, indicating a 
specific location on the endoluminal surface provides the observer with considerably more 
information than simply providing a position from which to search; centreline methods 
inherently cannot provide a 3D mural location. In addition to outperforming NDACC using both 
standalone and observer measures, following registration 64.7% of polyps would have been 
correctly marked with the CASPR ‘registration prompt’ providing a further clinical advantage 
over centreline registration. However, to avoid unblinding the observer to the registration 
algorithm under test, this function had to be disabled during the observer study. Therefore, the 
clinical impact of an endoluminal prompt on diagnostic performance and reading time remains 
untested and is the subject of future research.  
 
Other algorithms have been developed to provide 3D endoluminal surface correspondence: 
Suh et al modified a centreline based rigid registration (aided by automated anatomical 
landmark detection) to initialise a voxel based non-rigid deformation intended to provide true 
3D correspondence(43). They reported a registration error of 13.8mm (SD 6.2 mm) when 
aligning 24 polyps in 21 patients but all cases were optimally distended. A subsequent study of 
four cases with colonic collapse saw mean error increase to 30.1 mm(292). Moreover, each 
collapsed segment was matched with a fully distended segment on the opposing acquisition so 
that missing data could be interpolated; it is our experience that, luminal collapse is often 
present in the same segment in both datasets. Fukano et al(305) attempted surface 
correspondence via matching haustral folds and reported 65.1% of ‘large’ folds matched 
correctly. When developing our own haustral-fold-based initialisation (Chapter 9) we found 
that colonic torsion induced errors in both registration and reference standard observations. 
Nevertheless, our method achieved fold-matching accuracy of 83.1% and 88.5% with and 
without local colonic collapse, irrespective of fold size. Recently, Zeng (282) used automated 
feature detection to create five colonic segments, subsequently mapping each endoluminal 
surface to a rectangle. They found an average 3D error of 5.65 mm for 20 paired polyps within 
optimally distended colons but no data for collapse were presented. 
At the time of writing, all previous attempts at endoluminal surface registration require manual 
initiation and delineation of fixed colonic landmarks. The present algorithm is essentially 
automated; the reader reviews the proposed colonic segmentation, excludes small bowel, and 
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confirms the sequence of colonic segments, defining start and end points, just as when 
generating a 3D flythrough. We used external validation (i.e. validation used cases from 
hospitals uninvolved with algorithm development), to obtain a generalisable estimate of 
algorithm performance in normal practice. Our study sample closely paralleled the ACRIN CTC 
study data with respect to bowel preparation quality and distension. Our registration method 
compares favourably with centreline based methods and surface-based registration, especially 
considering the heterogeneity of the sample.  
 
Our study has limitations. Cases were excluded from validation where there was an incomplete 
external radiologic reference standard or where polyp locations could not be confirmed, 
despite accounting for inconsistencies in axial slice numbering between vendor platforms. 
However, both the distribution of polyps and the proportion of cases with ‘poor’ bowel 
preparation in our sample parallels the ACRIN data overall (16, 288). We excluded cases with 
absent or incomplete faecal tagging because the algorithm relies on matching surface features 
and digitally cleansing is necessary to achieve this in the presence of significant residual fluid. 
However, as described in Section A, optimisation of both colonic preparation and digital are the 
subject of considerable research. Although alternative displays (e.g. ‘filet’ or ‘unfolded cube’) 
would have increased successful registrations according to our pre-specified criteria, we believe 
standard endoluminal display is most generalisable. In addition to prone and supine 
acquisitions, current implementation guidelines recommend an additional decubitus series in 
selected patients; registration of decubitus datasets is the subject of future research. The polyp 
conspicuity scales we developed may not reflect utility in normal practice although we did base 
the scale on a priori discussions of clinical benefit. We plan studies of clinical utility in everyday 
practice. Although it is intuitive that accurate endoluminal registration will facilitate and 
shorten interpretation, this needs quantification as does any effect on sensitivity/specificity. It 
is possible that observers using automated matching could incorrectly reject TP polyps if 
incorrectly registered just as those using CAD may incorrectly reject false-negative polyps (25). 
Moreover, just as CAD only has regulatory approval as a ‘second reader’ (20, 21), it is unclear 
how a registration algorithm such as CASPR should integrate into clinical interpretation.  
  
In summary, we have tested a computer-assisted prone-supine registration algorithm (CASPR) 
on a representative subset of CTC data from a large multicenter trial, with successful results. 
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The ability to rapidly and automatically match potential polyp locations between acquisitions is 
likely to facilitate CTC interpretation. 
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SECTION E: 
CONCLUSIONS AND 
RECOMMENDATIONS FOR 
FUTURE RESEARCH 
 
 
OVERVIEW 
This Thesis describes multidisciplinary, collaborative research intended to facilitate colorectal 
cancer and precursor polyp diagnosis with CTC. The research comprising each Chapter has 
been published or is under consideration. The studies described explore diverse themes and 
methodology, none of which would have been possible without input from an equally diverse 
group of academics; statisticians, computer scientists, radiologists, clinical psychologists, and 
health economists, to whom I am indebted. While the research is presented from a clinical 
perspective, their contributions, often from a different standpoint, permeate this Thesis and I 
have aspired to provide a contribution to colorectal cancer research that amounts to more than 
the sum of its parts. This Chapter concludes the Thesis with a discussion of the results 
presented and proposes areas in need of further research. 
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CHAPTER 12 
12.  DISCUSSION, CONCLUSIONS AND SUMMARY 
 
 
12.1 DISCUSSION OF RESULTS 
The opening pages of this Thesis outlined the research questions and hypotheses tested over 
the ensuing research studies. These are now revisited and the pertinent findings discussed: 
 
 
WHAT IS THE RATIONALE FOR CURRENT CTC IMPLEMENTATION?  
Section A of this Thesis provides a review of CTC research from its inception to present day. The 
trajectory from an experimental modality in specialised academic centres to widespread 
implementation in daily practice was driven by a number of landmark publications and in the 
UK by research seeking an alternative to BaE. Early research was instrumental in optimising 
technical parameters and subsequently, by performing CTC according to consensus guidelines, 
multicentre studies demonstrated promising diagnostic accuracy in asymptomatic (14, 16)and 
high risk screening populations(128). Recently, the SIGGAR RCT(10, 133) has confirmed that 
CTC is significantly more accurate than BaE which has consequently been abandoned for 
colorectal cancer screening purposes in the UK(318).  
 
In addition, the literature to date confirm that adverse events during CTC are uncommon(155) 
and that patient acceptability is good when compared to the alternatives (88). Bowel 
preparation ‘tagging’ regimens aimed at improving specificity continue to show considerable 
promise(319) and recent RCT data suggest that reduced-laxative CTC could significantly 
enhance uptake for colorectal cancer screening(154). Furthermore, evidence is mounting that 
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impressive stand-alone detection rates for CAD translate into improved diagnostic accuracy for 
radiologists (20, 21). 
However, opinions remain divided on some issues. While the American Cancer Society, the US 
Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology(143) 
endorse CTC, CMS(131) declined coverage, citing a lack of evidence for improved diagnostic 
accuracy compared to existing alternatives. While this decision was not well received by the 
radiological community (132, 149, 320), it is important to understand how such a decision 
might come about: There remains a paucity of published level 1 evidence of benefit and, even 
then, concerns exist regarding the transferability of the available research into daily practice.  
 
In addition, controversy continues to surround the potential impact of incidental extracolonic 
detections, who should interpret CTC, and whether the technique is ultimately cost-effective.  
While a relatively extensive synopsis of the published literature was discussed, narrative 
reviews are inherently limited and the evidence described is, by no means, exhaustive. 
Nevertheless, there appears to be a promising recent trend towards well-designed 
collaborative research studies which may go some way to addressing these issues. 
 
 
WHAT IS THE LEVEL OF CTC EXPERIENCE AND TRAINING AMONG EUROPEAN RADIOLOGISTS? 
The survey described in this Thesis illustrates that many participants at CTC workshops had 
little formal training or experience. While it would be reasonable to argue that attendees at 
educational symposia are unrepresentative of those reporting CTC in clinical practice 
unsupervised, we found that the majority (86%) were nonetheless doing exactly this.  
The majority of these (76%) had interpreted fewer than 50 cases, which is commonly believed 
to be the absolute minimum level of experience recommended for independent reporting; 49% 
had reported less than 10 individual cases. The level of CTC training among those interpreting 
CTC independently also gave cause for concern: Only a small proportion (8%) had any formal 
training prior to the workshop and 54% had none whatsoever. These data imply that 
radiologists are interpreting specialised examinations in daily practice of which they have little 
prior experience. The consequence is that the test characteristics suggested by large clinical 
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trials and metaanalysis, often performed in centres with experienced practitioners, are 
presently unlikely generalisable to daily European practice. However, it was promising to note 
that most respondents were performing the CTC examination (i.e. acquiring the medical image 
data) in accordance with published European guidelines.  
This survey obtained a good (73%) response rate suggesting the results are likely to be 
representative of those attending ESGAR workshops. However, the germane limitation is that 
the level of experience and training of those not undergoing training remain unquantified and 
this should be the subject of future research. 
This survey was performed during a period of escalating demand for CTC across the UK 
corresponding to introduction of the NHS BCSP and publication of guidelines recommending 
CTC in lieu of BaE(318). Abstracted data from a recent survey of UK practice has shown a 
significant increase in the volume of CTC performed since 2004 (170). Hence, there are clinical 
and political imperatives for radiologists to interpret CTC in daily practice, some of whom, like 
many of those surveyed above, will be insufficiently prepared for the task. Specific 
accreditation for interpretation is likely to be rejected on pragmatic grounds at present. 
Therefore, ongoing audit of departments and individuals is suggested to determine if adequate 
performance can be demonstrated and sustained in clinical practice. 
 
 
TO WHAT EXTENT DOES RESEARCH METHODOLOGY BIAS STUDIES OF DIAGNOSTIC TEST ACCURACY? 
Despite employing a complex, comprehensive search strategy, the systematic review outlined 
in Chapter 4 failed to identify a sufficient volume of quality research with which to perform the 
planned metaanalysis. Therefore, point estimates around the potential sources of bias 
discussed remain unquantified. However, this finding, in itself, confirms the author’s suspicions 
that several issues central to the design of studies of diagnostic test accuracy have been 
insufficiently researched to date.  
Further research in this area is important so that sources of bias can be identified, quantified if 
present, and so inform study methodology. For example, peer-review of the research described 
in Chapter 11 stated that insufficient washout had been allowed to minimise observer recall 
bias, prolonging study publication by several months since the study had to be repeated. This 
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attitude is not unexpected since such a source of bias is widely assumed to exist. However, 
Chapter 4’s systematic review concluded that there is no evidence that such ‘memory effects’ 
exist (albeit on the basis of few studies) and, even ignoring this fact, there is no available 
evidence regarding what constitutes a suitable washout interval between repeated 
interpretations of the same data.  
Similar concerns exist when manipulating sample prevalence. The argument that reader 
performance for datasets with enriched prevalence will not resemble performance in clinical 
practice was not borne out either; our systematic review found the opposite, albeit again on 
the basis of very little available data. However, the studies which did manipulate prevalence did 
not do so beyond 28% yet prevalence is regularly enriched to at least 50% in other studies 
reviewed in this Thesis. Therefore, future research is needed to determine whether bias 
resulting from altered prevalence, observers’ knowledge of prevalence, and the effects of recall 
bias exist and, if so, to quantify the magnitude of any such bias. This should be enabled across 
several imaging technologies and diseases, and particularly in the context of screening.  
Avoidance of bias in studies of diagnostic imaging tests often requires research to take place in 
controlled, ‘laboratory’ conditions and while it has been postulated that this may give rise to 
spuriously elevated diagnostic test performance, we found what little research exists suggests 
the converse is true: Diagnostic performance achieved in daily practice may exceed that in 
research studies. While this issue also remains insufficiently researched, available data are 
reassuring.  
In summary, at present the available evidence is insufficient to demonstrate a measurable bias 
arising from the methodological strategies considered in our systematic review. Nevertheless, 
overall research is limited and moreover, none deals specifically with CT colonography. Hence, 
further research is necessary to ensure methodology employed in diagnostic test research does 
not impair transferability into daily practice.  
 
 
WHAT IS THE RELATIVE VALUE OF TRUE VS. FALSE POSITIVE DIAGNOSIS WHEN SCREENING USING CTC? 
Any diagnostic test can perform with high sensitivity providing little regard is given to the 
consequences of FP detections; in an extreme example, all tests could simply be considered 
2 1 8  
 
positive. However, given the personal and economic impact of reduced specificity, there is 
clearly a point at which reduced specificity renders a test result unhelpful and meaningless. 
While acknowledging that there is a trade-off between improved sensitivity in the face of 
diminished specificity, we believe that numerically equivalent trade-offs are not necessarily 
clinically equivalent, although regarded as such by analyses such as ROC AUC. We believe a 
metric that combines both sensitivity and specificity while allowing each to be weighted 
differently (and so enable the researcher to adjust this weighting) is necessary to compare 
existing tests with newer, potentially enhanced alternatives in a fair and equitable manner. 
However, the degree to which patients and/or health professionals value gains in sensitivity 
over and above a corresponding fall in specificity was unknown at the outset of this Thesis. We 
employed a ‘probability equivalence’ discrete choice analysis to address this research question, 
which requires respondents to make trade-offs. This avoided some limitations inherent to 
certainty-equivalence methods such as determining values for utilities (248) with the aim of 
replicating realistic decision-making.  
 
We found that when considering colorectal cancer screening, both patients and healthcare 
professionals believed gains in diagnostic sensitivity to be more important than equivalent 
losses in specificity. Overall, we found patients and healthcare professionals combined were 
willing to accept an additional 2050 false-positive diagnoses of cancer by CTC in order to avoid 
a single missed tumour. Gains in sensitivity were considered less important for diagnosis of 
polyps but were still valued over and above corresponding loss of specificity: Overall, patients 
and healthcare professionals were willing to accept an additional 10 false-positive diagnoses of 
polyps by CTC in order to avoid a single missed lesion. Moreover, we found patients valued 
gains in sensitivity significantly more than do healthcare professionals, a finding that applied to 
both polyps and cancers. Despite having lower average annual household income than 
healthcare professionals, patients were willing to pay more for a test that raised sensitivity 
without diminishing specificity.  
 
We found that several of our participants refused to trade, a phenomenon  commonly 
attributed to heuristic bias – i.e. the cognitive challenge is too high and hence a ‘rule of thumb’ 
is applied to simplify the problem. Such responses were exhibited by over 25% of participants 
in our DCE, suggesting that this attitude cannot simply be dismissed as ‘irrational.’ Further 
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research is needed to understand these responses more fully. Evidence is accumulating that 
incorporating patient preferences into design of screening tests can improve uptake(321) and 
future studies should elaborate upon the methods described here and extend them to other 
diagnostic scenarios. 
 
 
CAN A NOVEL WEIGHTED STATISTICAL ANALYSIS BE APPLIED TO STUDIES OF CAD FOR CTC? 
The study outlined in Chapter 6 demonstrated it is possible to apply a weighted net-effect 
analysis to provide a combined measure of diagnostic performance that incorporates 
consideration (and control) of the discrepant clinical consequences of different types of 
diagnostic misclassifications. This overcomes some limitations inherent in using ROC AUC 
methods (24) and allowed meaningful cross-study comparison between readers of varying 
experience.  
Using a CAD net-effect measure that favoured sensitivity over specificity (with the weighting 
based on data from our discrete choice experiment), the research outlined in Chapter 6 
demonstrated that despite generating more FP detections among inexperienced readers, the 
increase in sensitivity achieved with CAD was likely to be perceived by patients and health care 
professionals as clinically beneficial overall.  The beneficial net-effect of CAD was approximately 
3-times higher for inexperienced vs. experienced readers suggesting that relative novices 
benefit considerably more from CAD than their experienced counterparts.  
Reflecting upon the results of multicentre trials described in Section A, it is interesting to note 
the relatively poor performance of the experienced readers in this study. While one might 
expect inexperienced readers to perform sub-optimally, experienced readers had a mean 
sensitivity for patients with polyps (without CAD assistance) of only 57.5% (95%CI 49.6 to 
65.2%). These results are discrepant from those obtained by either the DoD or ACRIN II studies 
but part of this will be explained by the fact that this research did not employ a diameter 
threshold for detection. CTC test data were collated from multiple centres prior to 2006 and 
one could also argue that technical differences in CT data acquisition are partly responsible 
(e.g. not all studies had oral faecal tagging and some US studies used PEG preparation). In any 
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event, the unassisted reader performance reinforces that marked heterogeneity exists across 
CTC observer studies, and hence, generalisability must be interpreted with a degree of caution. 
While the assisted performance of inexperienced readers in this study was disappointing, the 
crucial finding is that CAD increases sensitivity significantly, and while this may come at the 
cost of additional FP diagnoses, the net-effect is beneficial. In contrast to previous studies that 
have used weightings derived from expert opinion, we used weightings derived from our 
discrete choice experiment that are likely to better reflect the thresholds adopted by health 
care workers and patients in daily practice. Future research should extend this analysis into 
other areas of radiology and diagnostic test evaluation where novel techniques are compared 
against existing methods, to ensure potentially useful technology is appropriately appraised. 
 
 
IS IT POSSIBLE TO MEASURE VISUAL SEARCH STRATEGY DURING CTC INTERPRETATION? 
The author believes research described in this Thesis constitutes a paradigm shift for medical 
image perception research. We have developed a method to apply eye-tracking methodology 
to complex 3D volumetric renderings where the target pathology is both moving and changing 
in size simultaneously. We have also developed metrics that can be used to compare visual 
search patterns between different observers; we have had to quantify ‘pursuit’ during which 
readers scrutinise a moving lesion. Moreover, while during 2D eye-tracking, a lapse in visual 
search merely prolongs “time-to-first hit”, during CTC, missing data during the short interval for 
which lesions were visible complicates analysis further. Overcoming this issue required 
development of multiple imputation methods.  While our studies have demonstrated 
feasibility, much further research is required to understand the diagnostic consequences of 
differing visual search patterns between observers. In particular, work is ongoing to compare 
search in novice vs. experienced observers and to ascertain the effect of visual CAD prompts 
upon gaze patterns. 
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CAN AN AUTOMATED PRONE-SUPINE REGISTRATION ALGORITHM ACCURATELY MATCH CORRESPONDING 
ENDOLUMINAL SURFACE LOCATIONS?  
The final Section of this Thesis encompasses the development, in vitro and, in vivo validation of 
a novel software algorithm that aims to facilitate colorectal neoplasia characterisation by 
automatically aligning corresponding endoluminal surface locations across prone and supine 
datasets.  
The collaborative research described in Chapter 8 demonstrated that using geometric 
parameterisation to transform the complex 3D colonic structure into a cylindrical 
representation can simplify the prone-supine registration task. Preliminary validation achieved 
a polyp matching accuracy of 5.7mm using a selection of optimally-prepared datasets that 
compared favourably with alternative published methods. However, the study was limited by 
an imperfect reference standard and non-generalisable CTC data. Moreover, manual 
initialisation, particularly to span regions of colonic under-distension, limited clinical utility.  
Chapter 9 presented an alternative, artificial intelligence (MRF) method of registering CTC 
datasets, this time concentrating on the distribution of haustral folds. This achieved fold 
matching accuracy of 96.0% and 96.1% in cases with and without colonic collapse. Moreover, 
this algorithm significantly improved the surface matching algorithm described in Chapter 8 by 
initialisation, reducing mean registration error to 6.0mm (p < 0.001), across 1743 reference 
points in 17 CTC datasets. Again, while these data were promising, the author’s manual fold 
locations constituted an imperfect reference standard. To overcome this limitation, a porcine 
phantom was constructed as described in Chapter 10.  
While porcine phantoms are well described in the CTC literature, prone-supine registration 
research brings unique challenges. For example, simply depressing the specimen using bags of 
saline (as performed previously by other authors) distorted the colonic specimen rendering it 
unusable for feature-based registration. We therefore developed a novel method of 
constraining the phantom which allowed for relatively realistic deformations without undue 
morphological distortion. This experiment enabled further development of software 
parameters to combine both methods into a single computer assisted supine-prone registration 
algorithm (CASPR). This required validation using a generalisable test dataset. Therefore, 
Chapter 11 describes clinical validation of CASPR to match polyps across prone and supine 
datasets from a publically available subset of the ACRIN CTC study. While no equivalent 
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registration method was available against which to test this algorithm, variations upon the 
available registration technology (NDACC) are incorporated into vendor workstations and 
hence comparison was made using this: Using an endoluminal display CASPR provided 82% 
‘successful’ polyp matches according to our predefined criteria compared to 48% for NDACC 
(p<0.001). Likewise, using a multiplanar approach, 71% polyp matching tasks were successful 
compared to 24% for MPR (p<0.001). 
Our clinical validation suggested that the algorithm could provide radiologists with accurate 
endoluminal surface correspondence, which improves considerably upon currently available 
technology (that simply provides a comparable position along the colonic centreline). While 
our results are promising, the question remains as to how this algorithm might influence 
interpretation in daily practice, both in terms of interpretation time and diagnostic accuracy, 
and this is the subject of ongoing research. Moreover, this Section demonstrates that while CTC 
data display has improved considerably since Vining’s original description in 1994, there is still 
potential for continued improvement. Future research will explore the optimal reading 
paradigm for integration of CASPR into clinical practice and will also examine how the 
identification (or not) of corresponding endoluminal surface features could enhance the 
sensitivity and specificity of CAD algorithms. 
 
 
12.2 FUTURE PERSPECTIVES 
Timely diagnosis of cancer and precursor polyps remains an international healthcare priority 
with screening programmes established throughout European countries (322).  
However, despite considerable research into patient preferences and targeted media 
campaigns, uptake of whole-colon screening tests remains worryingly low; bowel preparation 
and concerns regarding invasive testing are often implicated{Power, 2009 #596}. Moreover, 
endoscopy may not be achievable or desirable in a significant number of patients. Therefore, a 
suitable radiological alternative in the form of optimally performed CTC is necessary. 
However, CTC is a relatively novel technique, performance of which continues to evolve; 
dissemination of CTC from research centres into daily practice took place rapidly, often before 
imaging departments and interpreting radiologists were fully prepared.  While a large volume 
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of CTC literature exists, this Thesis raises doubts regarding fundamentals of study methodology 
and diagnostic performance in daily practice. The studies cited in support of widespread CTC 
implementation are not generalisable due to discrepant levels of training and experience, 
particularly in non-academic environments.  Therefore, it is the author’s opinion that the most 
important development that can take place over the next few years will be to introduce formal 
training, assessment and accreditation for those reporting CTC to ensure adequate 
performance in daily practice. 
 
While this may appear to be a rather humble expectation, a recent study of UK CTC practice 
(323) confirms that many centres offering CTC for the NHS bowel cancer screening programme 
(BCSP), currently fail to practice according to consensus guidelines. Moreover, while there 
remains no formal UK CTC accreditation, examinations continue to be interpreted by 
radiologists with little training or experience. Promisingly, procedures have already been 
introduced to rectify this: Recently published guidance (324) specifies criteria for performing 
and reporting CTC as well as stipulating minimum levels of experience for reporting BCSP 
examinations. Moreover, the requirement for ongoing audit, if nationally collated and analysed 
could provide far better insight into routine clinical CTC interpretation than any laboratory-
based research study. In addition, the guidance suggests those reporting CTC will soon need to 
demonstrate competence via a formal assessment. 
 
However, at present very little is understood regarding radiology training and expertise in 
general, not least for CTC. The minimum level of experience remains unquantified and the 
mechanism to test performance is yet to be established. For example, the disappointing results 
obtained by experienced readers detailed in chapter 6, suggests that threshold sensitivity for 
detecting clinically significant polyps of only 70% would classify the majority of these (expert) 
radiologists unfit to interpret CTC. Furthermore, it remains unclear as to what extent observer 
performance in laboratory conditions would reflect their practice in a busy clinical 
environment. Moreover, the relative clinical value of sensitivity and specificity would also have 
to been considered for an assessment to have practical relevance.  Nonetheless, the author 
speculates that within five years, systems of quality assurance akin to those employed in breast 
radiology will be routine practice for CTC in the UK and much of Europe. Moreover, this is likely 
to be extended to other branches of radiology: Radiologists will need to provide evidence of 
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their audited results and depending on how stringent the level of accreditation, it is almost 
inevitable that a degree of centralisation will have to take place.  
 
While the diagnostic performance of experienced radiologists described previously is of 
concern, it is important to note that many of the validation cases used during the studies 
analysed in Chapter 6 were conducted almost 10 years ago. While examinations were 
performed according to consensus guidelines at the time, one should not underestimate the 
impact of optimally performed CTC. Improved faecal tagging, routine use of mechanical CO2 
insufflators and training of CTC technicians to take ownership of examinations and ensure high 
quality acquisitions are relatively recent developments contributing to accurate polyp 
detection. Furthermore, these developments have not taken place at the expense of patient 
acceptability. It is likely that as researchers refine reduced laxative preparations, the use of 
harsh purgatives will diminish in the near future. Moreover, it remains the ultimate goal of 
many researchers to perform CTC avoiding laxatives altogether. While at present, this seems 
infeasible, developments in CT technology such as multiple energy sources may increase the 
contrast between stool and the endoluminal surface sufficiently to cleanse untagged or 
minimally labelled stool. This would represent a paradigm shift in practice and it is hoped that 
such theoretical technical developments will soon become reality. Likewise, new CT scanners 
are likely to reduce radiation exposure in addition to improving image resolution, 
simultaneously improving patient safety and diagnostic performance. 
 
As reinforced throughout this Thesis, it is the Author’s opinion that CTC should not be 
considered an alternative to colonoscopy; unlike endoscopy, CTC has no therapeutic role. 
Conversely, it seems highly improbable that future colonoscopy research will negate the 
necessity for bowel cleansing or reduce the test’s invasive nature. In this respect, the two 
techniques should be considered complementary. Nevertheless, this view is not universally 
accepted, particularly outside Europe.  The author predicts the colonoscopy vs CTC ‘turf battle’ 
will not only continue, but as CTC technique is refined, the debate is likely to intensify. While 
this may seem uncomfortable on the surface, competition between protagonists of each 
technique, has unquestionably driven forward high quality research in both fields in the past, 
and is likely to continue to do so in years to come, benefiting individual patients and colorectal 
cancer research in general. 
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Nevertheless, the author believes that the future of CTC lies in collaborative research. Not only 
will CTC continue to occupy a niche alongside colonoscopy but ultimately, it is hoped that 
technological developments will enable true integration of CTC and colonoscopy. It is the 
author’s view that the ultimate goal of CTC research at present is CT-guided colonoscopic 
polypectomy. In a few years it is possible that patients will undergo CTC as a first line 
investigation to stratify risk and then, where positive findings are detected, colonoscopy can be 
carried out a purely therapeutic procedure, freeing endoscopic resources and streamlining 
patient care. However, to succeed, this will require optimal CTC implementation in routine 
practice, continued technological developments in image registration and, above all, 
cooperation between all interested parties. 
 
It is my sincere hope that the themes explored in this Thesis continue to be developed and 
researched over future years. Not only are several sources of bias poorly understood and 
incompletely researched, in many cases they appear to be completely unknown to researchers 
designing new studies. Furthermore, there remains considerable scope for improving human-
computer interaction, not only for CTC but for radiology in general. CAD algorithms are likely to 
improve, as too are the ways in which the observer implements the software. For example, one 
research group has recently described a novel reading paradigm where CAD acts as a first 
reader(325) yet despite promising results, it is likely that extensive validation will be necessary 
before this reading technique can be considered safe enough to gain regulatory approval.  
Likewise, new technology such as CASPR will need refinement before integration into 
workstations for routine use is permitted. Ultimately, the author envisages the combination of 
CASPR and CAD into a single entity whereby the endoluminal surface information assimilated 
by CAD could improve CASPR accuracy while incorporating accurate prone-supine 
correspondence into CAD would improve polyp detection and dismissal of false positives.  
Providing computer processing power continues to progress at its current pace, it is likely that 
fully automated CTC interpretation will be theoretically achievable within a few years (whether 
or not radiologists consider this desirable). Nonetheless, for the foreseeable future, human 
interaction will remain mandatory for interpretation of investigations performed in clinical 
practice.  
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However, at present our knowledge of the relationships between training, experience, 
expertise and competence across all radiological subspecialties is very limited. The author 
considers that exploring why some radiologists outperform others is central to optimising 
training and that eye-tracking technology likely holds the key to this complex subject. However, 
it is important to stress that our understanding of visual search, beyond plain radiographic 
interpretation, remains in its infancy and the small volume of research presented in this Thesis 
belies the extensive collaboration required between eye-tracking scientists, radiologists and 
statisticians to arrive at what is essentially the very first step on a long path.   
Unfortunately, methodology and medical image perception, while potentially of immense 
value, seem to be considered relatively peripheral to cancer research; the direct clinical impact 
is not readily appreciated. Consequently, it may be difficult to secure funding when intense 
competition exists for limited resources. It is the author’s hope that collaboration with 
scientists working across disciplines continues to develop in the future, enabling such crucial 
research to be nested into larger, diagnostic performance studies.  
Moreover, while research presented in this Thesis relates to gastrointestinal radiology, it is 
anticipated that some of the issues raised and method developed may disseminate into a wider 
radiological context. 
 
 
12.3 CONCLUSION 
In summary, I believe CTC, optimally implemented, has the potential to improve diagnosis of 
colorectal neoplasia and have described research that aims to facilitate this. The current level 
of CTC training and experience are of concern and the generalisability of the evidence base is 
often questionable. However, my research into observer study design, conjoint analysis and 
representative statistical analyses should translate into improved methodology and I am 
hopeful that studies of CAD and computer assisted registration described in this Thesis will 
ultimately improve diagnostic performance. 
 
Dr Darren Boone. 30th October 2013 
2 2 7  
 
APPENDIX A:  
PUBLICATIONS ARISING FROM THIS THESIS 
 
 
BOOK CHAPTERS 
Boone D, Halligan S, Taylor SA (2013). CTC Background and Development. In: Cash, B. (Ed.), 
Colorectal Cancer Screening and Computerized Tomographic Colonography: A Comprehensive 
Overview (pp 41-58). New York, USA: Springer 
 
Boone D, Taylor SA, Halligan S. (2013). Rectal cancer. In:  E. Neri, L. Faggioni, C. Bartolozzi.(Eds.), 
CT Colonography Atlas (pp 133-150). Berlin Heidelberg. Springer-Verlag 
 
INVITED REVIEWS AND EDITORIALS 
 
Boone D, Taylor SA, Halligan S. Evidence Review and Status Update on Computed Tomography 
Colonography. Curr Gastroenterol Rep. 2011;13(5):486-94 
 
ORIGINAL ARTICLES 
 
Boone D, Halligan S, Zhu S, Yoa G, Bell N, Ghanouni A, et al. CT Colonography: Discrete choice 
experiment of patients' and healthcare professionals’ preferences to FP diagnosis during 
colorectal cancer screening. (Under consideration for indexed publication). 
 
Boone D, Halligan S, Taylor S, Altman DG, Mallett S. Assessment of the relative benefit of 
computer-aided detection (CAD) for interpretation of CTC by experienced and inexperienced 
readers. (Under consideration for indexed publication). 
 
2 2 8  
 
Plumb A, Boone D, Fitzke H, Helbren E, Mallett S. Detection of extracolonic pathology by CTC 
colonography: A discrete choice experiment of perceived benefits versus harms. (Under 
consideration for indexed publication) 
 
Ghanouni A, Halligan S, Boone D, Taylor SA, Plumb AO,et al. Sensitivity and specificity of CT 
colonography for pre-cancerous polyps vs. burden of bowel preparation: Quantifying patients’ 
preferences via a discrete choice experiment (Under consideration for indexed publication) 
 
Helbren E, Halligan S, Phillips P, Boone D, Fanshawe T, Taylor SA, Manning D, Gale A, Altman 
DG, Mallett S. Towards a framework for analysis of eye-tracking studies in the 3D environment: 
A study of visual search by experienced readers of endoluminal CT Colonography. (Under 
consideration for indexed publication) 
 
Boone D, Halligan S, Roth H, Hampshire T, Helbren E, Slabaugh G, et al. CT Colonography: 
External Clinical Validation of an Algorithm for Computer Assisted Prone-Supine Registration 
Radiology. 2013 Sep; 268(3):752-60. 
 
Phillips P, Boone D, Mallett S, Taylor SA, Altman DG, Manning D, et al. Method for tracking eye 
gaze during interpretation of endoluminal 3D CT colonography: technical description and 
proposed metrics for analysis. Radiology 2013;267(3):924-31. 
 
Ghanouni A, Halligan S, Taylor SA, Boone D, Plumb A, Wardle J, et al. Evaluating patients' 
preferences for type of bowel preparation prior to screening CT colonography: Convenience 
and comfort versus sensitivity and specificity. Clin Radiol 2013. 
 
Ghanouni A, Smith SG, Halligan S, Plumb A, Boone D, Yao GL, et al. Public preferences for 
colorectal cancer screening tests: a review of conjoint analysis studies. Expert Rev Med Devices 
2013;10(4):489-99. 
 
Ghanouni A, Smith SG, Halligan S, Taylor SA, Plumb A, Boone D, et al. An interview study 
analysing patients' experiences and perceptions of non-laxative or full-laxative preparation with 
faecal tagging prior to CT colonography. Clin Radiol 2013;68(5):472-8. 
2 2 9  
 
Hampshire T, Roth HR, Helbren E, Plumb A, Boone D, Slabaugh G, et al. Endoluminal surface 
registration for CT colonography using haustral fold matching. Med Image Anal 2013;17(8):946-
58. 
 
Boone D, Halligan S, Mallett S, Taylor SA, Altman DG. Systematic review: bias in imaging studies 
- the effect of manipulating clinical context, recall bias and reporting intensity. Eur Radiol 
2012;22(3):495-505. 
 
Ghanouni A, Smith SG, Halligan S, Plumb A, Boone D, Magee MS, et al. Public perceptions and 
preferences for CT colonography or colonoscopy in colorectal cancer screening. Patient Educ 
Couns 2012;89(1):116-21. 
 
 
Boone D, Halligan S, Frost R, Kay C, Laghi A, Lefere P, et al. CT Colonography: Who attends 
training? A survey of participants at educational workshops. Clin Radiol 2011; 66(6):510-6. 
 
Ghanouni A, Smith S, Halligan S, Taylor S, Plumb A, Boone D, et al. Exploring patients’ 
experiences and perceptions of either non-laxative or full-laxative preparation with fecal 
tagging prior to CTC: An interview study. Clinical Radiology 2012; (In press). 
 
Roth HR, McClelland JR, Boone DJ, Modat M, Cardoso MJ, Hampshire TE, et al. Registration of 
the endoluminal surfaces of the colon derived from prone and supine CT colonography. 
Medical Physics 2011;38(6):3077-89. 
 
Taylor SA, Robinson C, Boone D, Honeyfield L, Halligan S. Polyp characteristics correctly 
annotated by computer-aided detection software but ignored by reporting radiologists during 
CT colonography. Radiology 2009;253(3):715-23. 
 
 
 
 
 
 
2 3 0  
 
PEER REVIEWED WORKSHOP PROCEEDINGS 
Roth H, Boone D, Halligan S, Hampshire T, Slabaugh G, McQuillan J, et al. External Clinical 
Validation of Prone and Supine CT Colonography Registration, Abdominal Imaging. 
Computational and Clinical Applications, Lecture Notes in Computer Science, 7601, 10-19, Oct 
2012. 
 
Hampshire T, Roth H, Boone D, Slabaugh G, Halligan S, Hawkes D, Prone to Supine CT 
Colonography: Registration Using a Landmark and Intensity Composite Method, Abdominal 
Imaging. Computational and Clinical Applications, Lecture Notes in Computer Science, 7601, 1-
9, Oct 2012. 
 
Roth H, Hampshire T, McClelland J, Hu M, Boone D, Slabaugh G, Halligan S, Hawkes D, Inverse 
consistency error in the registration of prone and supine images in CT colonography, MICCAI 
Workshop on Computational and Clinical Applications in Abdominal Imaging 2011, Lecture 
Notes in Computer Science, 7029, 1-7, 2012. 
 
 
PEER-REVIEWED CONFERENCE PROCEEDINGS 
 
Roth H, McClelland J, Modat M, Hampshire T, Boone D, Hu M, Ourselin S, Halligan S, Hawkes D, 
CT colonography: inverse-consistent symmetric registration of prone and supine inner colon 
surfaces, SPIE Medical Imaging 2013. 
 
Hampshire T, Roth H, Hu M, Boone D, Slabaugh G, Punwani S, Halligan S, Hawkes D, Automatic 
prone to supine haustral fold matching in CT colonography using a Markov random field 
model, 14th International Conference on Medical Image Computing and Computer Assisted 
Intervention (MICCAI), Oct 2011. 
 
2 3 1  
 
Hampshire T, Roth H, Hu M, Boone D, Slabaugh G, Punwani S, et al. Automatic prone to supine 
haustral fold matching in CT colonography using a Markov random field model. Med Image 
Comput Comput Assist Interv. 2011;14(Pt 1):508-15. 
 
Roth H, McClelland J, Modat M, Boone D, Hu MX, Ourselin S, et al. Establishing Spatial 
Correspondence between the Inner Colon Surfaces from Prone and Supine CT Colonography. 
Ed: Jiang T, Navab N, Pluim JPW, Viergever MA. Medical Image Computing and Computer-
Assisted Intervention - MICCAI 2010, Pt Iii, 2010:497-504. 
 
Roth H, McClelland J, Boone D, Hu M, Ourselin S, Slabaugh G, Halligan S, Hawkes D, Conformal 
Mapping of the Inner Colon Surface to a Cylinder for the Application of Prone to Supine 
Registration, 14th conference on Medical Image Understanding and Analysis (MIUA), Jul 2010. 
 
Roth H, McClelland J, Modat M, Boone D, Hu M, et al. Establishing spatial correspondence 
between the inner colon surfaces from prone and supine ct colonography. Medical Image 
Computing and Computer-Assisted Intervention 2010; 497-50 
 
 
ABSTRACTS 
 
Plumb AO, Halligan S, Boone D, Helbren E, Zhu S. True- and false-positive diagnosis of 
extracolonic cancers by CT colonography: discrete choice experiment. Insights Imaging. 2013 
June; 4(Suppl 2): 467–518. 
 
Hampshire TE, Roth HR, Helbren E, Plumb A, Boone D, Slabaugh, Halligan S, Hawkes DJ. CT 
colonography: Accurate registration of prone and supine endoluminal surfaces of the colon. 
Insights into imaging, 2013;4(suppl 1):S328-9  
 
Boone D, Halligan S, Bell N, et al. How do patients and doctors weight the relative importance 
of false-positive and false-negative diagnoses of cancer by CT colonography: discrete choice 
experiment. Insights into Imaging. 2012;3 (suppl 2):455-503. 
2 3 2  
 
Boone D, Halligan S, Mallett S, et al. Computer-aided detection (CAD) for CT colonography: 
Incremental benefit for inexperienced over experienced readers. Insights into Imaging. 
2012;3(Suppl. 2). 
 
 
Roth H, McClelland J, Modat M, Hampshire T, Boone D, et al. Inverse-consistent symmetric 
registration of inner colon surfaces derived from prone and supine CT colonography, AAPM 
2012 
 
Hampshire T, Roth H, Hu M, Boone D et al. Automatic prone to supine haustral fold matching in 
CT colonography using a Markov random field model. Med Image Comput Comput Assist 
Interv. 2011;14(Pt 1):508-15. 
 
Ye X, Roth H, Hampshire T, Boone D et al. Computer-aided Detection for CT Colonography: 
False-Positive Reduction Using Surface-based Prone-Supine Registration. Radiological Society of 
North America  2011;2011. 
 
Boone D, Roth H, Hampshire T, et al. CT Colonography: Development and Validation of a Novel 
Registration Algorithm to Align Prone and Supine Scans. Radiological Society of North America. 
2011. 
 
Boone D, Halligan S, Mallett S, Taylor S, Altman DG. Systematic review: the effect of 
manipulating clinical context on studies of diagnostic test accuracy. Insights into Imaging. 
2011;2(Suppl. 2). 
 
Boone D, Roth H, Hampshire T, et al. CT colonography: development and validation of a novel 
registration algorithm to align prone and supine scans. Insights into Imaging. 2011;2 (Suppl. 1 - 
ECR Book of abstracts). 
 
Boone D, Halligan S, Phillips P, et al. CT colonography: Comparison of visual search patterns in 
experienced and novice readers. Insights into Imaging. 2011;2(Suppl. 1 - ECR book of abstracts). 
 
2 3 3  
 
Boone D, Roth H, Halligan S, et al. CT colonography: development and validation of a novel 
registration algorithm to align prone and supine scans. Insights into Imaging. ESGAR 
2011;2(Suppl.2 - ESGAR books of abstracts). 
 
Boone D, Halligan S, Phillips P, et al. CT colonography: Comparison of visual search patterns in 
experienced and novice readers. Insights into Imaging. ECR 2011;2(Suppl. 2 - ESGAR book of 
abstracts). 
 
Phillips, P., Boone, D., Mallett, S., Taylor, S., Manning, D., Gale, A., Halligan, S., Altman, D. Eye 
Tracking The Interpretation Of Endoluminal Fly-Through In CT Colonography. Medical Image 
Perception Society XIV, Dublin, Ireland. August 2011. 
 
Roth H, McClelland J, Boone D, et al. Conformal Mapping of the Inner Colon Surface to a 
Cylinder for the Application of Prone to Supine Registration. Med Image Comput Comput Assist 
Interv 2010. 
 
Roth H, McClelland J, Modat M, Boone D et al. Establishing spatial correspondence between 
the inner colon surfaces from prone and supine CT colonography. Med Image Comput Comput 
Assist Interv. 2010;13(Pt 3):497-504. 
 
Boone D, Frost R, Kay C, et al. CTC: who attends for training? a survey of participants attending 
the ESGAR CTC workshops. European Radiology. 2010;20(Suppl. 1):8. 
 
Boone D, Phillips P, Mallett S, et al. Recording of visual search pattern during interpretation of 
CTC: feasibility study and pilot data. European Radiology. 2010;20(Suppl 1):9. 
 
Mallett S, Boone D, Phillips P, et al. Statistical design and preliminary analysis of eye tracking 
studies to investigate diagnostic performance in CT colonography. Methods for Evaluating 
Medical Tests and Biomarkers: Second International Symposium. 2010. 
 
 
 
2 3 4  
 
APPENDIX B:  
ESGAR WORKSHOP QUESTIONNAIRE 
 
Dear Dr. ….. 
  
Thank you very much for your registration for the (WORKSHOP NUMBER) ESGAR CT-Colonography Workshop that takes place in 
(WORKSHOP LOCATION) next week.  
The ESGAR CTC  Committee is evaluating some statistical data of our participants for research purposes. Therefore, may I kindly ask 
you on their behalf, to complete a pre-survey (by using the link below)?  
The results will also allow the faculty to be prepared for the correct target group. The compilation of this survey should not take 
you longer than 5 minutes. 
  
WEB-LINK  
   
We wish you a nice trip to (WORKSHOP LOCATION). 
 Kind regards,  
  
The ESGAR Office 
On behalf of the CTC  Committee 
  
1. Are you (please tick the single response that best describes you): 
Medical: Trainee radiologist 
 Medical: Staff radiologist with a subspecialty interest in GI radiology 
 Medical: Staff radiologist with a subspecialty interest in CT scanning 
 Medical: Staff radiologist with a general interest 
 Medical: Non-radiologist (e.g. gastroenterologist) 
 Non-medical (e.g. radiographic technician) 
 
2. Are you working in (HOST COUNTRY)? 
 Yes 
 No 
 
3. Have you had any hands-on experience of CTC interpretation before this workshop? Please tick all that apply. 
 None whatsoever 
 I have sat in when others have interpreted cases at my local hospital 
 I have interpreted some cases myself 
 I have previously been to a colonography workshop 
 I have previously interpreted some educational colonography datasets 
 
4. If you have interpreted some cases yourself, what is your experience to date?  
 Fewer than 10 cases 
 Fewer than 50 cases 
 Fewer than 100 cases 
 100 cases or more 
 300 cases or more 
 
5. How do you practice (or intend to practice) CTC?  
(Please tick all that apply at this point in time). 
Public hospital practice; symptomatic patients. 
Private hospital practice; symptomatic patients 
Private hospital practice; asymptomatic patients (i.e. screening) 
I don’t intend to practice – I’m just curious. 
6. Is CTC being performed at the local hospital(s) in which you work? Please tick all that apply. 
 No. 
 Yes, in the public hospital 
 Yes, in the private hospital 
7. If CTC is being performed at the local hospital(s) in which you work, how is the patients’ colon usually prepared? Please tick 
all that apply. 
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 Full bowel preparation in most cases 
 A reduced preparation used in most cases 
 Full bowel preparation in younger patients, reduced in older 
8. If CTC is being performed at the local hospital(s) in which you work, do you use faecal tagging (i.e. positive contrast) to label 
residual stool? Please tick all that apply. 
 Yes, in most patients 
 No, in most patients 
9. If CTC is being performed at the local hospitals in which you work, what gas do you most often use to insufflate the colon? 
 Room air 
 Carbon dioxide 
10. If CTC is being performed at the local hospitals in which you work, do you usually administer a spasmolytic routinely (eg 
Buscopan, glucagon) 
 Yes 
 No 
11. If CTC is being performed at the local hospitals in which you work, how are the cases most often interpreted?  
 A primary 2D read alone 
A primary 2D read with 3D for problem areas 
 A primary 3D read (includes ‘virtual disSection’ etc) 
 
12. What sort of CT machine are you using (or intend to use) for CTC? Please tick all that apply at your local hospital(s). 
 Helical single slice 
 4-detector row 
8-detector row 
16-detector row 
32-detector row 
40-detector row 
64-detector row 
 
13. Do you have dedicated CTC interpretation software available at your local hospital(s)? If so, please state which: 
 (FREE TEXT BOX) 
 
14. What do you think will be the present or future role of CTC in the following clinical situations that pertain to the colon?  
Please tick all responses that apply to you. 
 Detecting colon cancers in symptomatic patients of all ages. 
Detecting colon cancers, but mostly restricted to elderly symptomatic patients. 
Screening for colorectal cancer & polyps in patients of all relevant ages 
Screening for colorectal cancer & polyps, but mostly restricted to elderly attendees. 
15. It is well-established that CTC can detect pathology outside the colon. On balance overall, do you think that this attribute is:  
(please tick all that apply): 
 A good thing in symptomatic patients. 
 A bad thing in symptomatic patients. 
A good thing in asymptomatic patients (ie screenees). 
A bad thing in asymptomatic patients (ie screenees) 
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APPENDIX C:  
ACRIN CTC TRIAL CASES USED FOR VALIDATION 
ACRIN code Slice# 
polyp 
Supine 
Slice
# 
polyp 
Pron
e 
Poly
p  
Size 
Polyp 
Location 
Disten
sion 
Prone 
Disten
sion 
Supine 
Residu
e 
Prone 
Residue 
Supine 
CASPR 
3D 
error 
(mm) 
NDAC 
3D 
error 
to 
polyp 
(mm) 
CASPR 
1D 
error 
along 
center 
line 
(mm) 
NDAC 
1D  
error 
along  
cente
r linel 
(mm) 
1.3.6.1.4.1.9328.50.4.0007 350 281 6 DC Good Poor Poor Poor 1.8 14.7 1.2 5.1 
1.3.6.1.4.1.9328.50.4.0007 307 351 6 R Good Good Good Good 1.1 17.3 0.6 5.0 
1.3.6.1.4.1.9328.50.4.0080 222 213 6 DC Good Good Good Poor 11.0 12.2 9.3 10.4 
1.3.6.1.4.1.9328.50.4.0080 286 304 8 DC Good Good Good Good 1.2 17.5 0.4 7.4 
1.3.6.1.4.1.9328.50.4.0154 399 405 7 S Good Poor Good Good 10.0 20.3 6.2 4.3 
1.3.6.1.4.1.9328.50.4.0490 120 183 6 TC Good Good Poor Poor 39.9 35.2 16.5 72.6 
1.3.6.1.4.1.9328.50.4.0490 258 157 6 TC Good Good Poor Poor 32.1 34.2 11.7 32.2 
1.3.6.1.4.1.9328.50.4.0490 302 305 6 AC Good Good Good Good 8.6 15.3 1.8 0.6 
1.3.6.1.4.1.9328.50.4.0495 369 387 8 S Good Good Good Good 1.2 19.8 1.0 13.4 
1.3.6.1.4.1.9328.50.4.0651 352 354 7 S Good Poor Good Good 3.4 11.0 3.9 8.8 
1.3.6.1.4.1.9328.50.4.0699 394 416 7 C Poor Good Good Good 3.5 13.1 7.1 4.2 
CTC-1050546075 412/463 439/5
00 
6 DC Good Good Poor Good 4.7 16.7 0.0 5.2 
CTC-1050546075 412/463 439/5
00 
8 S Good Good Good Poor 7.5 34.1 4.3 3.4 
CTC-1230993957 553/302 590/3
66 
8 AC Good Good Poor Poor 38.7 50.1 46.6 44.7 
CTC-1230993957 553/302 590/3
66 
6 R Poor Good Good Good 2.5 21.4 1.6 20.8 
CTC-2394053080 194 66 8 TC Good Good Good Good 1.9 65.0 0.5 48.0 
CTC-3195907751 454 248/4
24 
7 TC Good Good Good Good 49.1 26.4 30.8 16.8 
CTC-8337000787 474/493/
532/461/
532/526/
520/532/
535/521 
438/4
99/45
9/514
/558/
482 
6 R Good Good Good Good 5.0 27.1 0.0 9.3 
CTC-8337000787 474/493/
532/461/
532/526/
520/532/
535/521 
9/514
/558/
482/5 
6 S Good Good Good Good 7.7 34.1 3.1 5.8 
1.3.6.1.4.1.9328.50.4.0136 Pos 
>=10mm 
148 
192 - 
at HF 
25 TC Good Good Poor Poor 18.7 22.2 37.6 7.8 
1.3.6.1.4.1.9328.50.4.0175 Pos 
>=10mm  
416 
455 30 R Good Good Good Good 57.5 22.6 52.9 22.3 
1.3.6.1.4.1.9328.50.4.0216 250 303 25 S Poor Good Poor Poor 85.8 92.0 95.9 87.7 
1.3.6.1.4.1.9328.50.4.0331 Pos 
>=10mm  
227 
240 12 AC Good Good Good Good 9.7 30.5 0.6 15.7 
CTC-1823912394 Pos 
>=10mm  
455/359 
500/3
76 
10 C Poor Good Poor Poor 11.7 37.0 0.8 3.5 
CTC-1823912394 Pos 
>=10mm  
455/359 
500/3
76 
10 DC Good Good Good Good 6.8 38.4 1.7 55.3 
CTC-2531578342 Pos 
>=10mm  
406 
373 11 R Good Good Poor Poor 12.2 19.8 5.4 6.4 
CTC-3105759107 Pos 
>=10mm  
423 
454 12 S Good Good Good Good 14.3 20.7 22.6 24.3 
CTC-3174825007 Pos 
>=10mm  
344/396 
311/3
96 
12 AC Good Good Good Good 8.2 26.4 8.4 19.3 
CTC-3174825007 Pos 
>=10mm  
344/396 
311/3
96 
10 TC Good Good Poor Poor 1.9 17.8 0.7 16.2 
CTC-3174825007 Pos 
>=10mm  
344/396 
311/3
96 
8 C Good Poor Poor Poor 2.0 18.5 0.6 15.1 
1.3.6.1.4.1.9328.50.4.0011 144 173 9 DC Poor Good Poor Poor 43.7 21.9 78.6 26.2 
1.3.6.1.4.1.9328.50.4.0152 425 435/1
12 
6 S Good Poor Good Good 3.9 12.0 5.8 9.2 
1.3.6.1.4.1.9328.50.4.0156 231/252 251 7 S Poor Good Good Good 15.6 20.7 8.8 19.3 
1.3.6.1.4.1.9328.50.4.0264 180/53 322/3
34/74 
9 DC Poor Poor Poor Poor 71.3 59.5 81.8 65.1 
1.3.6.1.4.1.9328.50.4.0264 180/53 322/3
34/74 
6 TC Good Good Poor Poor 34.9 28.3 27.8 39.2 
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ACRIN code Slice# 
polyp 
Supine 
Slice# 
polyp 
Prone 
Poly
p  
Size 
Polyp 
Location 
Disten
sion 
Prone 
Disten
sion 
Supine 
Residu
e 
Prone 
Residue 
Supine 
CASPR 
3D 
error 
(mm) 
NDAC 
3D 
error 
to 
polyp 
(mm) 
CASPR 
1D 
error 
along 
center 
line 
(mm) 
NDAC 
1D  
error 
along  
center 
linel 
(mm) 
1.3.6.1.4.1.9328.50.4.0264 180/53 322/3
34/74 
6 DC Good Poor Good Good 12.5 22.2 15.4 15.4 
1.3.6.1.4.1.9328.50.4.0269 465/429 490/4
35 
7 S Poor Poor Good Good 41.2 17.9 47.2 14.6 
1.3.6.1.4.1.9328.50.4.0455 302/185/
395/499 
305/4
47/53
2 
8 R Good Poor Good Good 20.2 23.8 21.4 2.0 
1.3.6.1.4.1.9328.50.4.0633 265 310 7 AC Good Good Poor Poor 50.4 31.6 48.0 19.6 
1.3.6.1.4.1.9328.50.4.0633 265 310 7 AC Good Poor Good Good 76.9 28.6 88.6 21.2 
1.3.6.1.4.1.9328.50.4.0635 307 338 8 DC Good Good Poor Poor 8.2 30.6 1.1 15.0 
1.3.6.1.4.1.9328.50.4.0635 307 338 6 DC Good Poor Good Poor 27.0 56.3 1.6 46.5 
CTC-1137132466 196 220 8 R Poor Good Good Good 6.9 25.9 0.0 17.1 
CTC-1626846173 382 373 7 S Good Poor Poor Poor 30.1 51.7 12.7 41.3 
CTC-1639466381 397 386 8 R Poor Good Good Good 31.4 23.9 31.2 21.9 
CTC-3105782108 226/165/
67 
285/1
66/60 
6 R Poor Good Good Good 12.7 24.5 8.0 1.2 
CTC-3105782108 226/165/
67 
285/1
66/60 
6 R Good Good Poor Good 40.7 21.9 19.4 8.7 
CTC-3304961391 277 308 6 C Poor Poor Good Poor 1.0 4.1 0.7 0.7 
CTC-6234351055 382 373 8 DC Good Poor Poor Poor 11.4 51.1 8.1 51.3 
1.3.6.1.4.1.9328.50.4.0233 Pos 
>=10mm  
353 
355 18 S Poor Good Good Poor 24.9 21.3 21.1 22.1 
1.3.6.1.4.1.9328.50.4.0259 Pos 
>=10mm  
259 
243 30 C Good Poor Good Good 33.3 34.3 57.1 37.0 
1.3.6.1.4.1.9328.50.4.0290 Pos 
>=10mm  
460 
266/5
26 
20 R Poor Poor Poor Poor 21.2 17.2 15.0 13.9 
1.3.6.1.4.1.9328.50.4.0326 Pos 
>=10mm  
194 
  21 C Poor Poor Poor Poor 2.7 5.5 1.1 2.0 
1.3.6.1.4.1.9328.50.4.0326 Pos 
>=10mm  
194 
  6 R Good Poor Good Poor 19.7 35.4 18.1 25.3 
1.3.6.1.4.1.9328.50.4.0434 Pos 
>=10mm  
251 
244 12 AC Poor Poor Good Good 10.8 28.7 0.9 11.2 
1.3.6.1.4.1.9328.50.4.0516 Pos 
>=10mm  
240 
257 20 AC Good Good Good Poor 3.3 23.1 1.2 7.7 
1.3.6.1.4.1.9328.50.4.0518 Pos 
>=10mm  
343/423/
400 
429/3
70 
19 S Poor Poor Poor Good 4.6 14.6 6.1 18.1 
1.3.6.1.4.1.9328.50.4.0518 Pos 
>=10mm  
343/423/
400 
429/3
70 
12 AC Good Poor Poor Poor 27.2 8.7 29.8 8.4 
1.3.6.1.4.1.9328.50.4.0552 Pos 
>=10mm  
178 
  11 C Good Good Poor Good 15.1 29.0 1.6 11.3 
1.3.6.1.4.1.9328.50.4.0552 Pos 
>=10mm  
178 
  6 AC Poor Poor Good Good 2.5 20.3 1.7 5.1 
1.3.6.1.4.1.9328.50.4.0660 Pos 
>=10mm  
256/246 
160 10 S Good Good Good Good 4.7 36.0 1.6 28.8 
CTC-1038654821 Pos 
>=10mm  
75 
87 40 AC Good Poor Poor Poor 1.2 22.2 11.6 25.6 
CTC-1968343337 Pos 
>=10mm  
189 
127/2
12 
14 S Poor Poor Poor Poor 78.2 55.3 72.6 52.4 
CTC-2414824407 Pos 
>=10mm  
524 
533 10 R Good Good Poor Poor 17.0 45.1 1.8 39.1 
CTC-3097916992 Pos 
>=10mm  
223 
142 25 AC Good Good Good Poor 31.6 26.3 32.8 27.7 
CTC-7657031778 Pos 
>=10mm 
428 
436 14 R Poor Poor Good Poor 20.9 14.5 7.9 12.3 
1.3.6.1.4.1.9328.50.4.0040 Pos 
>=10mm 
147/275 
148/3
11 
55 AC Good Poor Good Good 12.4 25.5 44.8 43.0 
1.3.6.1.4.1.9328.50.4.0104 Pos 
>=10mm  
392/68 
347/8
6 
30 C Poor Good Poor Poor 23.9 11.5 12.3 8.2 
                mean 19.9 27.4 17.9 21.0 
                std 20.7 15.1 23.9 18.5 
                median 11.9 23.5 8.0 15.5 
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